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Suboptimal primary care management of diabetes is associated with high use of acute health
services. In particular, regional areas experience a disproportionately hi gher burden of 
diabetes-related emergency presentations and hospitalisations than metropolitan areas. 
Previous research offers limited understanding of its determinants. Associations of 
socioeconomic status and geographical accessibility with diabetes-related hospitalisations
have not been studied in regional populations. Limited information is available on the 
demographic and clinical profiles of inpatients with diabetes in non-metropolitan hospitals. 
The association of intermediate deteriorations in glucose metabolism, such as impaired 
fasting glucose (IFG), with the use of hospital services is also unknown. Furthermore, few 
previous studies have explored the perspectives of ‘users’ of diabetes-related acute hospital 
services.  
Methods 
This project strategically utilised various study designs and settings to provide a better 
understanding of the factors associated with acute care utilisation in individuals with diabetes 
in a regional area that has been characterised in detail to describe the setting for this project. 
Then, using data from the Victorian Admitted Episodes Dataset, diabetes-related 
hospitalisation rates were mapped across the regional population and their associations with 
socioeconomic status and geographical remoteness were investigated. Second, an inpatient 
audit of electronic medical records was undertaken to determine prevalence of diabetes in 
patients admitted at three different-sized regional hospitals. Clinical profiles of individuals 
with and without diabetes were compared in terms of principal and additional reasons for 
hospitalisation. Third, data from a longitudinal study were linked with hospitalisations data 
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to compare the incidence, rate, length and causes of hospitalisation between adults with 
normoglycaemia, impaired fasting glucose and diabetes. Fourth, a mixed-methods study of 
inpatients with diabetes-related foot disease was undertaken to identify perceived enabling
and impeding factors for optimal diabetes care.
Results
This project affirmed the association of diabetes with a higher incidence, rate, and length of 
hospitalisation, however, no increased risk was observed in impaired fasting glucose. Social 
advantage and better accessibility were associated with higher rates of hospitalisation in
individuals with diabetes. One in five adult inpatients in regional hospitals had diabetes;
however, due to incomplete documentation and high prevalence of undiagnosed diabetes, the 
true prevalence is likely to be higher. Hospitalised individuals with diabetes differed from
those without, in terms of demographic characteristics and reasons for hospitalisation. There 
were several shortfalls in the primary care uptake of diabetes-related services, for instance, 
knowledge and testing of HbA1c, visits to dietitians and diabetes nurse educators, 
membership of the National Diabetes Support Scheme, and surveillance for complications. 
Finally, perceived enabling factors for optimal diabetes care included supportive health 
professionals, peer and social support, established routines for medication intake and 
improvement in lifestyle, whereas perceived impeding factors were delayed or incorrect 
diagnosis, ineffective communication from health professionals, lack of ongoing diabetes 
education, fear of complications and lack of patients’ involvement in clinical decision 
making.  
Conclusions
Diabetes is associated with increased use of acute hospital services. Strategies to reduce acute 
health service use should focus on prevention of progression from IFG to diabetes, early and 
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accurate diagnosis through targeted primary care vigilance, surveillance of complications, 
and facilitating uptake of primary services. 
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Thesis overview
Chapter  One includes a narrative review of existing literature on the patterns and 
determinants of acute health service use in individuals with diabetes. The review summarises 
the available research in this subject area, identifies limitations of its current understanding 
and highlights areas where further inquiry is warranted. The aims of this doctoral project are 
listed at the end of Chapter One. 
Chapter  Two provides a brief overview of the sub-studies that constitute this thesis. It
includes a manuscript entitled ‘Ageing, chronic disease and injury: a study in western 
Victoria (Australia)’, published in the Journal of Public Health Research (2016). The 
manuscript provides an introduction of the main study included in this thesis (ACDI), 
describes the study protocol and outlines key demographic features of the study region. 
Chapter  Three is an original research paper published in in BMJ Open  that describes 
analysis of hospital admissions data, undertaken as part of the ACDI study to map diabetes-
related hospitalisations across western Victoria. Furthermore, associations of socioeconomic 
status and geographic accessibility with diabetes-related hospitalisations were also 
investigated in the study. 
Chapter  Four is an original research paper submitted to  Journal of Diabetes Research. It 
describes findings from an audit of bed-occupancy data from three different-sized regional 
hospitals in western Victoria to determine the inpatient prevalence of diabetes. This study is 
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first of its kind as the inpatient burden of diabetes in regional Australian hospitals is 
unknown. This study also compared admitted patients with and without diabetes, in terms of 
principal and additional reasons for admission.  
Chapter  Five is an original research paper published in BMJ Open (2018), reporting a 
comparison of the incidence, rate and length of hospital admissions between adults with 
normoglycaemia, impaired fasting glucose (IFG) and diabetes. Baseline data on fasting
plasma glucose levels, self-report of diabetes and/or use of antihyperglycaemic medication 
were obtained retrospectively from Geelong Osteoporosis Study and linked with hospital 
admissions data.  
Chapter  Six is an original research paper submitted to  Diabetology and Metabolic 
Syndrome. It describes a mixed-methods study at a tertiary hospital that included a survey 
and semi-structured interviews of adults hospitalised with diabetes-related foot ulcers. The 
study aimed to highlight the perspectives of ‘users’ of diabetes-related acute care services, to 
provide fresh insights into their experiences related to diabetes management in primary care. 
Chapter  Seven includes the final discussion in which the findings from different sub-studies 
in this project are discussed in relation to each other and linked to highlight their broader 
implications. The chapter ends with emphasising the main outcomes, conclusions and 
providing directions for future research.   
10
Chapter One: Background and aims
Chapter One: Background and aims
11
Chapter One: Background and aims
Acute health service utilisation in
diabetes mellitus: a review of
literature
12
Chapter One: Background and aims
Overview
Diabetes mellitus is a complex chronic condition resulting from impaired insulin secretion,
peripheral insulin resistance or a combination of both [1]. It is one of the most rapidly
growing chronic conditions in the world. The International Diabetes Federation estimated that
in 2017, the global prevalence of diabetes among adults aged 20-79 years was 8.8% (95% CI
7.2-11.3%) [2]. The highest age-adjusted adult diabetes prevalence was reported in North
American and Caribbean Region at 10.8% (CI 9.1-12.3%), whereas the lowest was found in
the African Region at 4.2% (CI 2.7-7.7%) [2]. In Australia, an estimated 1.2 million (~6%) of
adult population have diabetes and an additional 500,000 are living with undiagnosed
diabetes [3, 4].
Diabetes is often describ ed as a protot ype ‘prim ar y c are s ensit ive condit ion’ [5-7] where
hospital admissions associated with it could be prevented through adequate and timely
primary care. By contrast, individuals with diabetes have significantly higher rates of
hospitalisation, longer hospital stays and more frequent readmissions, compared to those
without [8, 9]. The cost of hospital care for individuals and health systems is substantial, for
inst ance, in Aust rali a, ‘ a dmi tt ed pati ent hos pit al services’ ac count for ~40 % ex penditure on
diabetes followed by out-of-hospital medical services (29%), prescription pharmaceuticals
(27.8%) and support for diabetes research (5.6%) [10]. Reduced reliance on these services,
therefore, has become a health policy objective globally [11-13].
The use of acute health services among individuals with diabetes may reflect severe
aspects of the disease such as prolonged duration, multiple complications, comorbidities
13
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and risk factors [14]. It is also an indicator of inadequacy, poor access to, or low uptake of
primary health services in the community [7, 12]. These factors contribute to delays in
diagnosis, suboptimal management and complications surveil lance [11, 15]. It can,
therefore, be argued that the high use of acute hospital services by those with diabetes
represents deficiencies in its primary care management.
Despite the implications for individuals and health systems, the determinants of acute
health service use in diabetes remain poorly understood. Good quality research in this
area is lacking, particularly in regional and remote populations where hospitalisation rates
for people with diabetes are up to four times higher than metropolitan counterparts [4].
Availability of such data will inform policy and design interventions to cope with the
future increased need for diabetes-related hospital services [4]. Furthermore, the extent to
which the high use of acute health services reflects deficiencies in the primary care
management of diabetes is largely unknown. Research examining this important area is,
therefore, needed and will have far-reaching implications for health policy and clinical
practice.
Aims of literature review
The purpose of this narrative review  was to examine existing literature on the patterns
and determinants of acute health service use among individuals with diabetes mellitus
and to identify knowledge gaps where further inquiry is warranted. Citation database
Medline was searched using an OVID platform for studies from January 1980 to
January 2015. Search strategy included the te rms ‘diabetes-related hospitalisations or
admi ssi ons’ , ‘diabetes co mpl icati ons’ , ‘predictors of hospit ali sati on or admi ssi on’ , and
14
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‘ risk factors o f hospitalis ati on or admi ssi ons’ in re lation t o the broader te rm ‘diabetes
melli tus’ . Both i nternational and Australian studies and reports, published in English
language, were included. Moreover, reference lists were searched for other relevant
articles and included in the review.
Definitions
Blood glucose is regulated by insulin, a hormone produced by the pancreas. Diabetes
mellitus is a chronic condition resulting from deficient production of insulin or the
inability of the body cells to use insulin effectively (insulin resistance), or a combination
of both [1].
Type 1 Diabetes Mellitus (T1DM)
It results from an absolute deficiency of insulin due to partial or complete destruction,
predominantly by autoimmune processes, of the insulin-producing Beta cells in the
pancreas [1]. Between 10-15% of people with diabetes in Australia have T1DM [4]. It can
develop at any age although, in a majority of individuals, the onset is before the age of 30
years [4]. Type 1 diabetes ideally requires specialist (endocrinologist) oversight in addition
to primary care management and the mainstay of pharmacological treatment is insulin
therapy.
Type 2 Diabetes Mellitus (T2DM)
It is the most common type of diabetes mellitus (85-90%) that results from a combination
of insufficient insulin production and insulin resistance [1]. Unlike T1DM, a number of
modifiable risk factors are known for T2DM and its onset can be delayed and in some
cases, prevented by addressing them [16]. It usually develops in the fourth or fifth decade
15
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of life but is increasingly becoming common in younger age groups. Uncomplicated
T2DM (~90%) is managed by primary care physicians (General Practitioners) in
conjunction with dietitians, diabetes educators, and podiatrists and use of specialist care is
less common than for T1DM [17, 18]. Management initially involves dietary
modification, healthy weight management and regular physical exercise, which may later
be complemented with oral antihyperglycaemic agents, GLP1 agonists and/or insulin.
Gestational diabetes
This form of diabetes occurs in women during pregnancy. Blood glucose levels usually
revert to normal after delivery of the baby, although there is an increased future risk of
diabetes [19].
Other types of diabetes
Less commonly, other conditions affecting Beta cell function and some rare diseases of
the pancreas result in diabetes [1]. Moreover, prolonged use of certain drugs, for instance,
glucocorticoids and antipsychotics may result in drug-induced diabetes [1].
Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
These are intermediate categories between normal glucose metabolism and fully
developed diabetes mellitus [20]. Individuals with IFG and IGT are at an increased risk of
developing diabetes in their lifetime [20, 21]. In addition, IGT independently increases
the risk of cardiovascular disease [20]. Through appropriate lifestyle modifications,
glucose levels may revert to normal in individuals with IFG[22] and low fasting plasma
glucose and triglycerides, and lean body mass have been identified as predictors of
regression from IFG to normal blood glucose level [22].
16
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Diagnosis of diabetes mellitus
Traditional diagnostic methods for diabetes rely on measuring glucose levels in the
plasma either in a fasting state or two hours after a 75-gram oral glucose challenge (Oral
Glucose Tolerance Test) [20]. Another commonly used laboratory test for evaluating
plasma glucose level is the glycosylated haemoglobin or HbA1c, which is formed by the
attachment of glucose to haemoglobin and its concentration in the blood indicates average
glucose level over the preceding 8-12 weeks [23]. A 2011 WHO expert consultation
report [24] allowed the use of HbA1c as a diagnostic test for diabetes, provided stringent
quality tests, standardised assays and absence of conditions that preclude its accurate
measurement were ensured.
Causes of acute health service use in diabetes mellitus: Complications
Individuals with diabetes present to emergency departments and hospitals largely due to
its complications, both acute and chronic.
Acute complications
The most severe acute complications of diabetes, often requiring hospitalisation, include
diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemia. These are characterised
by an absolute or relative insulin deficiency, blood volume depletion, acid-base
abnormalities, and are precipitated by illness or from errors in administration of anti-
hyperglycaemic drugs [1].
Diabetic Ketoacidosis is defined as hyperglycaemia, metabolic acidosis and
increased total body ketone concentration. It occurs more often in people with
17
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T1DM and is a common reason for emergency presentations and hospital admissions
[25].
Hyperglycaemic Hyperosmolar State presents as altered mental status or coma caused by
hyperosmolarity, severe dehydration and hyperglycaemia without significant acidosis
[26]. It occurs mainly in people with T2DM [26].
Hypoglycaemic episodes usually occur due to errors with the administration of anti-
hyperglycaemic drugs, abrupt changes to diet and physical activity levels and may be
triggered by infections [26]. Hypoglycaemic awareness can be reduced in diabetes, making
patients prone to hypoglycaemic coma [26]. Hypoglycaemia poses a significant challenge in
the management of insulin-treated diabetes with ~90% experiencing an episode [27].
Chronic complications
In the longer term, suboptimally managed diabetes can cause damage to small and large
blood vessels leading to chronic complications, which are either microvascular (eye and
kidney complications, neuropathy) or macrovascular (cardiovascular, cerebrovascular,
peripheral artery disease).
Eye complications such as retinopathy, cataracts, macular degeneration and glaucoma
result from damage to small vessels in the eyes, which may result in impaired vision or
blindness in severe cases [28].
Kidney complications include diabetic nephropathy (reduced glomerular filtration
associated with release of protein in the urine), intracapillary glomerulonephrosis, and
Kimmelstiel-Wilson disease [28]. In advanced stages, diabetic nephropathy can lead to
End-Stage Kidney Disease, requiring regular dialysis or kidney transplantation [28].
Neuropathy of peripheral and autonomic nervous systems clinically manifests as pain,
18
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tingling and numbness in the arms or legs when peripheral sensory nerves are affected
or reduced muscle strength if nerves controlling motor function are damaged [28].
Diabetic autonomic neuropathy is a common and debilitating complication that
manifests in various organ systems including cardiovascular (postural hypotension),
gastrointestinal (gastroparesis, constipation, faecal incontinence), genitourinary (bladder
and sexual dysfunction), pupillary, sudomotor (loss of sweating and dry skin), and
neuroendocrine systems [29].
Macrovascular complications of diabetes can manifest as coronary artery disease,
cerebrovascular and peripheral artery diseases [28]. A combination of peripheral neuropathy
and peripheral artery diseases can increase the risk of foot ulcers, deformity and chronic
infections which may lead to gangrene and lower l imb amputation. In Australia, a limb is lost
every three hours as a direct consequence of diabetes-related foot disease [4, 30]. In the
United Kingdom (UK), diabetes-related foot problems are the most common diabetes-
specific cause of acute admissions in individuals with diabetes [31]. Individuals with diabetes
also have twice the risk of developing heart failure, both with reduced and preserved ejection
fraction, and the outcomes in terms of cardiovascular function, hospitalisation and prognosis
are worse than those without it [32].
In addition to the currently known complications of diabetes, conditions considered
‘unrelated ’ to diabetes ac count for a pr oportion of hospi tal service use in pe ople wit h diabetes
[25]. For instance, there is a growing body of evidence linking diabetes to an increased risk of
developing certain types of cancers [33].
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The preventable nature of acute health service use in diabetes mellitus
It is important to emphasize that both microvascular and macrovascular complications of
diabetes are preventable [34, 35]. The Diabetes Control and Complications Trial (DCCT)
[36] and the United Kingdom Prospective Diabetes Study (UKPDS) [35] provided robust
evidence in favour of the preventability of microvascular complications through optimal
glucose management in T1DM and T2DM, respectively. Macrovascular complications of
diabetes are also preventable through attention to blood pressure control as shown in the
UKPDS [35] or using multi-factorial interventions as demonstrated in the Steno Study
[34]. Other studies have also reported significant reductions in microvascular
complications (40-50%) and macrovascular complications (40-45%) with improved
outpatient management (home blood glucose monitoring, multiple insulin injections,
frequent outpatient visits) [9]. These findings support the argument that improvements in
primary care management of diabetes would reduce the need for acute hospitalisations by
preventing or delaying its complications. Australian data in this area, although scant, also
support this, for instance, the Australian Institute of Health and Welfare reports that up to
36% of hospit ali sati ons wit h diabetes ar e ‘potenti all y pr eventable ’ if ti mely and adequ ate
non-hospital care is provided [37]. For 2013-2014, diabetes complications accounted for
nearly 14% of the chronic disease-related preventable hospitalisations in Australian
hospitals [13]. Hence, there is an urgent need for reduced reliance on the hospital system
in individuals with diabetes, which could be achieved by preventing the disease itself
(primary prevention), early diagnosis and treatment (secondary prevention) and preventing
complications (tertiary prevention). With the advent of novel antihyperglycaemic
therapies in recent decades, diabetes management has become complicated [38], and
therefore, access to specialists and specialised diabetes care centres needs to be improved.
In are as with l im it ed specialist s avail abil it y, prim ar y ca re ph ysicians ’ abil it y to m ana ge
20
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diabetes could be enhanced by using simplified algorithms [38].
Determinants of acute health service use in diabetes mellitus: area of residence-,
individual-, and system-level factors
The determinants of acute health service use in diabetes can be classified into area of
residence-, individual-, and system-level factors.
Area of residence-level factors
These include socioeconomic status, remoteness and accessibility of place of residence.
Low socioeconomic status is associated with high rates of hospitalisation for many chronic
conditions [39]. Studies have shown a direct relationship between socioeconomic
disadvantage and acute all-cause and diabetes-related hospitalisations [40, 41].
Hospitalisations due to diabetes-related foot disease are reported to increase with area-level
socioeconomic disadvantage [42]. In another study from the United States of America (USA),
Billings et al [39] estimated that hospital admission rates for diabetic ketoacidosis and
hyperosmolar coma were 6.5 times higher in low-income areas, compared to high-income
areas. Similar associations have been reported between low socioeconomic status and the
incidence of hypoglycaemic episodes [43]. A study of 35,935 people with diabetes from
Scotland reported a significantly higher proportion of hospital admissions for diabetes-related
kidney disease, DKA, hypoglycaemia, ischaemic heart disease, stroke and peripheral artery
disease among residents of the lowest socioeconomic quintile versus the highest [44]. There
are some Australian data showing higher rates of diabetes hospitalisations in more
socioeconomically disadvantaged areas [4]; however, no previous studies have investigated
these associations in regional and remote areas.
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Remoteness and rurality of residence are known to be associated with a high prevalence of
chronic conditions and their risk factors. In a Canadian study, individuals with diabetes living
in ‘ rural’ are as, wer e twi ce as li kel y to have an a c ute diabetes compl icati on where as thos e
li ving in ‘ remot e’ ar eas were n earl y thric e as likely to experience an event than their urban
counterparts [45]. In Australia, hospital admission rates for diabetes increase with remoteness
and the gre atest di ffe renc es are obs erved b etwe en ‘major cit ies’ and ‘ver y r emot e’ ar eas [37].
Remoteness of residence can influence health outcomes due to poor access to health services
and health workforce shortage [46]. The health workforce in Australia is unevenly distributed
and there is a shortage of General Practitioners and endocrinologists in rural areas which
partially explains the greater reliance on acute hospital services in these areas [46]. Distance
from services and cost of care are often recognised by patients residing in more socially
disadvantaged areas as barriers to optimal care in diabetes [39, 47].
Individual-level factors
Factors related to individuals include demographic characteristics (age, sex, ethnicity), social
structure, body weight and lifestyle factors, diabetes-specific factors (severity, duration,
comorbid conditions), previous hospitalisation, and health literacy.
Demographic characteristics such as age, sex and ethnicity determine the propensity of an
individual to use acute health service [25, 48]. Both young and old age are associated with
increased risk of diabetes hospitalisations [9, 49]. Adolescents and young adults with
diabetes, predominantly T1DM, represent a particularly high risk group for acute
hospitalisations [9]. Younger persons with diabetes are more likely to miss medical
appointments and are known to struggle with adhering to medication regimes [50, 51].
Similarly, elderly persons with diabetes often present with multiple and advanced
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complications and are more likely to be readmitted, have longer lengths of hospital stay and
higher risk of mortality as compared to younger counterparts [52]. Australian data show a
rapid increase in hospital admissions in people with diabetes from the age range 45-84 years,
followed by a decline in those over 85 years [13]. In one study, male sex was associated with
higher all-cause hospitalisation but for diabetes-related hospitalisation it was the female sex
that carried higher risk [53].
Social structure is determined by factors such as indigenous status, ethnicity, social networks
and culture, all of which could influence the use of acute care [54]. Hospitalisations in the
Australian Aboriginal and Torres Strait Islanders with diabetes represent a significant
problem. Indigenous men and women are 8 and 10 times more likely to be hospitalised with
the principal diagnosis of T2DM as compared to non-indigenous population [55]. The
prevalence of diabetes is higher in Australians born in the Middle East, North Africa, South
Asia, North Africa, Oceania and Eastern Europe as compared to those born in Australia [10].
Cultural and language barriers result in delays in seeking care in people from non-English
speaking backgrounds leading to early onset of complications and increased acute care use,
however, currently, little previous data exist on the association with diabetes-related acute
health service use [56].
Body weight and lifestyle factors affect acute health service use in chronic conditions.
Studies report a higher incidence of all-cause hospitalisation with increases in body mass
index [57]. Obesity is an independent predictor of hospitalisation [58]; however, the
relationship has not been investigated in those with diabetes. Lifestyle factors (physical
inactivity, diet, smoking, alcohol consumption) have been shown to influence the use of acute
care in diabetes [55, 59]. An Australian study reported that regular physical activity is
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associated with fewer hospital admissions in indigenous adults with diabetes [59]. A higher
frequency of hospital admissions has been reported in smokers with diabetes as compared to
non-smokers [55]. Alcohol abuse may result in difficulties in management of diabetes and
increase the risk of acute service use [39]. One study reported an association between regular
physical exercise and fewer hospitalisations in a sample of individuals with T2DM [59]. The
association between smoking and the risk of developing diabetes is known [60, 61], however,
there are limited previous data on its relationship with diabetes-related hospitalisation. In a
study of Indigenous Australian adults, a higher frequency of hospital admissions was reported
in smokers with diabetes as compared to non-smokers [55], however, it has not been studied
in other population groups.
Suboptimal management, and comorbidities multiply the need for inpatient hospital care
[25]. A study from the USA reported that blood glucose level measured by HbA1c was
the strongest predictor of hospitalisations in both younger onset (<30 years) and older
onset (>30 years) diabetes [8]. Diabetes is a complex condition and affects multiple body
organs and systems [62]. Persons with diabetes are at a higher risk of developing many
mental health disorders, particularly depression [63, 64], and have poorer quality of life
and lower subjective wellbeing [17], as compared to those without it. A strong correlation
exists between the number of comorbidities and the use of hospital services (risk of
hospitalisation, length of hospital stay and frequency of hospital admission) [65].
C omorbid h ypertension , defined as s ystol ic blood pressure 140/90 m mH g [66], is
associated with a higher risk of hospitalisation in those with diabetes. Diabetes increases
the risk of nerve damage (neuropathy), foot ulcers, limb amputation, eye conditions
(cataracts, retinal detachment and macular degeneration) and kidney disease, all of which
are associated with a higher need for acute care [67].
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A significant proportion of morbidity and mortality associated with diabetes is due to
cardiovascular and cerebrovascular disease [68]. People with diabetes are 6-10 times
more likely to be admitted with cerebrovascular accident as compared to controls without
the condition [17]. Recent studies have shown a decline in incident cardiovascular disease
in people with diabetes, however, the risk is still double that of those without diabetes
[69].
Readmissions, particularly within a month of discharge, are common in diabetes with as high
as one readmission for every five patients discharged [70]. Previous hypoglycaemic episodes,
for instance, increase future hypoglycaemia-related hospitalisations with the highest
incidence observed in the year following an episode [27, 43, 71]. One study reported that the
strongest predictor for all-cause and diabetes-related hospitalisation was a hospitalisation in
the previous year, with almost double the risk [53]. Other predictors included advanced age,
high HbA1c values, insulin use, presence of kidney disease (low eGFR) and abnormal l iver
function [53].
Optimal blood glucose management is an important goal in diabetes care. According to one
study, reducing HbA1c levels by 1% resulted in a 14-20% reduction in hospitalisations [8].
However, intensive glycaemic control comes with increased incidence of hypoglycaemic
episodes, as reported in the Diabetes Control and Complications Trial. Hypoglycaemic
episodes discourage adherence to medication, in addition to causing distress [52]. Achieving
optimal glucose levels is, therefore, a tight balance to maintain and requires high level of
patient involvement and decision making around insulin/OHA dosage, food intake, and
physical activity levels [53].
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Low health literacy is associated with high use of acute health services [72-74]. The most
widely accepted definition of healt h li terac y desc ribes it as an indi vidual’s or group’s abil it y
to access, understand and utilise health information [75]. Inadequate health literacy is
associated with a low uptake of preventive health care resulting in increased reliance on acute
health services [74]. Diabetes is essentially a self-managed disease that requires active
participation by the patients, their interaction with health providers and their ability to
navigate the health system [76]. The extent to which health literacy determines the use of
acute health services in diabetes needs detailed investigation.
System-level factors
These refer to the structural aspects such as access to and adequacy of primary health
services. Access to and adequacy of primary health services is vital in reducing reliance on
acute services. In countries where universal health insurance is provided, primary care is
often the first point of contact with the health system [77]. In Australia, for instance, primary
care is subsidised through a universal public health insurance scheme referred to as Medicare
[75]. C hronic disease ma nagement in t he Australi an primar y c are us es ‘me dical hom e’ model
where ongoing, comprehensive and patient-centred care is provided at a practice chosen by
the patient [16]. The medical home model provides diabetes management across the disease
spectrum, starting from newly diagnosed, to those on multiple medications, to those dealing
with complications through to end-of-life care. Medical homes provide quality health care,
accessible to all population subgroups at subsidised costs [16]. Diabetes is managed through
specific services or processes involving General Practitioners and allied health care providers
and diabetes-specific primary care processes carried out over an 11-13 month period
const it ute an ‘annual c yc le of ca re’ (Table 1 ).
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Table 1: C omponents of an ‘annual c ycle o f ca re’ for diabetes [78]
Activity Frequency and descr iption
Assess diabetes control by measur ing
HbA1c
At least once.
Carry out a comprehensive
eye examination
At least once during current or previous cycle of care.
Measure weight and height and
calculate Body Mass Index
First visit and at least twice more.
Measure blood pressure At least twice.
Examine feet At least twice.
Measure total cholesterol,
tr iglycer ides and HDL cholesterol
At least once.
Test for microalbuminur ia
(protein in ur ine)
At least once.
Measu re men t of the patien t’s
estimated Glomerular Filtration
Rate (eGFR) to assess kidney
function
At least once.
Provide self-care education Education about management.
Review diet Review and provide information on dietary
choices.
Review levels of physical activity Review and give information on appropriate levels.
Check smoking status Encourage to stop smoking.
Review medication Review patient medication.
In addition to the primary care processes detailed above, supplementary payments are
offered to General Practitioners for preparing and reviewing a management plan
(GPMP) and providing multi-disciplinary care referred to as Team Care Arrangement
(TCA) for chronic disease management [78]. Since the implementation of these
measures, little research has focussed on the uptake of these measures in the community
and their role in reducing emergency department visits and acute hospital admissions in
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people with diabetes. The CareTrack study [79] provided some insight into the
appropriateness of primary care for common chronic conditions in the Australian
population. It showed that almost 40% of people presenting to primary care with
diabetes did not receive the recommended best practice management [79]. Completion
of an annual cycle of care in people with diabetes was associated with optimal blood
glucose levels in one study [80]. The study was limited, however, due to its cross-
sectional design and did not address whether completion of an annual cycle of care
reduced the risk of acute inpatient admissions. Higher uptake of the Medicare item
‘Review of G ener al P ract ice Mana gement P lan’ ha s been repo rted to be ass ociated with
a significant reduction in hospitalisations [5, 81]. To date, no other Australian data exist
on the role of specific primary care services in improving health outcomes for people
with diabetes, including lower use of acute health services. Furthermore, diabetes
education can be provided in various formats, either one-on-one, group based or via
telemedicine. Personal preferences, learning styles determine its efficacy and outcomes.
The effects are more pronounced on the psychosocial outcomes than biomedical
outcomes [82]. Despite some previous research on the beneficial impact of diabetes self-
management education, evidence on its efficacy remains scarce.
Structural factors related to hospital policies (acute care) and practice characteristics
(primary care) can also affect use of health services. While presenting to an acute health
service may be a personal choice, being admitted is a clinical decision, guided by clinical
judgement and may vary, based on organisational policies [39]. Diabetes-related hospital
service use is also affected by changes in disease classification and coding standards [83].
In Australia, for instance, during 2008-2012, onl y those condit ions t hat affe cted pati ents’
management in the hospital were to be coded as comorbidities that resulted in significant
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drops in the reported diabetes-related hospitalisation rates over that period [83]. Factors
associated with the quality of General Practice (formal quality assurance activities,
availability of clinical information and decision support systems) have shown to impact
glycaemic management and may reduce the need for acute care [84]. Availability of
hospital beds and admission thresholds are other structural factors that could impact acute
inpatient admissions [26]. Numbers of General Practitioners and nurse practitioners vary
by location in Australia where health workforce is unevenly distributed [46]. Furthermore,
despite the increasing emphasis on the role of pharmacists in diabetes management [85],
no Australian studies exist in this area.
Summary and the need for fur ther research
To date, socioeconomic deprivation, remoteness, unhealthy weight, smoking, physical
inactivity, suboptimal blood glucose management, and presence of comorbidities and
complications have all shown associations with a higher incidence and longer duration of
hospitalisations among those with diabetes [5, 55, 86]. However, previous studies
investigating acute care utilisation in diabetes were limited by a number of factors. A
majority of the studies used hospital admissions data only, limited to the more severe
aspects of the condition [9, 87, 88]. In other studies, participants were recruited from
diabetes clinics [86] or General Practice registers [89]. Comino et al [5], for the first time,
reported the risk of hospitalisations attributable to diabetes in a large, non-clinical sample
of Australian population. The authors reported that the age-standardised hospital
admission rates and lengths of hospital stay were slightly higher for participants with
diabetes [5]. The study included those aged 45 years and older and the participants were
followed up for a short period (12 months) from the baseline and risk of acute and non-
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acute (planned) admissions was not reported separately [5]. Previous research has also
established that higher rates of acute health service utilisation may indicate the inadequacy
or low uptake of primary health services in the community [5, 90, 91]. Little is known,
however, about the role of specific primary care processes in determining acute
hospitalisation in diabetes. Furthermore, previous studies have included only individuals
with diabetes and the associations of intermediate deteriorations in glucose metabolism
such as impaired fasting glucose and use of hospital services is currently unknown, in
essence due to the difficulty associated with identifying them in the general population.
Finally, many aspects of diabetes management in primary care cannot be completely
understood using a purely quantitative design. Management of diabetes requires an active
interaction between the individual and the healt h s ystem, hen ce, the consum ers’
perspective on their service needs is important to explore.
To summarise, the rising prevalence of diabetes in the Australian population poses a
significant challenge for the health system. The costs of inpatient management of
diabetes are substantially higher than those of primary care and globally, hospitals will
not be able to cope with the expected rise in the demand for acute services in the future.
Primary care remains the most cost-effective setting for diabetes management and there
is ample evidence to suggest that with access to timely and appropriate primary care,
acute health service use could be reduced significantly. The status and determinants of
acute care use in diabetes are not well understood, particularly in regional populations.
Previous studies provide an incomplete understanding of the problem due to study
design limitations (hospital-based only) and being limited to metropolitan cities. Further
research is warranted, employing a variety of designs (quantitative and qualitative) and
settings (general population and hospital) to highlight target areas for improved
management of diabetes in the primary care that will, in the long term, result in reduced
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reliance on acute health services.
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Chapter One: Background and aims
The review of literature in the previous section identified significant gaps in the current
understanding of the determinants of acute health service use in individuals with diabetes and
provided direction for further research. This doctoral project aims to fill the identified
research gaps by utilising a number of study designs and settings. Specific aims of this
project are as follows:
Aim 1: To document the association of area-level factors (socioeconomic status, remoteness,
accessibility) with diabetes-related hospitalisation in a regional population.
Aim 2: To determine the inpatient prevalence of diabetes and compare the socio-
demographic and clinical profiles of individuals hospitalised with diabetes at a tertiary public
hospital versus smaller regional hospitals.
Aim 3: To compare the incidence, frequency rate and length of hospitalisation in individuals
with normal glucose metabolism, impaired fasting glucose and diabetes mellitus.
Aim 4: To ascertain the enabling and impeding factors for optimal management of diabetes
in primary care from the perspective of individuals hospitalised for a diabetes complication.
A summary of the identified research gaps and thesis aims is presented in Table 2.
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Table 2: Summary of identified research gaps and thesis aims
Identified research gap Thesis aim
Although regional/rural areas experience a
disproportionately high burden of diabetes,
previous research on the area-level
determinants of acute health service use in
diabetes is l imited to metropolitan areas.
To document the association of area-level factors (socioeconomic
status, remoteness, accessibility) with diabetes-related
hospitalisation in a regional population.
Inpatient prevalence of diabetes in Australian
regional hospitals has not been reported before
and little is known about the socio-
demographic and clinical characteristics of
admitted patients with diabetes.
To determine the inpatient prevalence of diabetes and compare the
socio-demographic and clinical profiles of individuals hospitalised
with diabetes at a tertiary public hospital versus smaller regional
hospitals.
No previous studies have examined the
associations between intermediate
deteriorations in glucose metabolism (impaired
fasting glucose) and hospital admissions.
To compare the incidence, frequency rate and length of
hospitalisation in individuals with normal glucose metabolism,
impaired fasting glucose and diabetes mellitus.
Limited data are available on the perspectives
of diabetes-related acute care ‘users ’ .
To ascertain the enabling and impeding factors for optimal
management of diabetes in primary care from the perspective of
individuals hospitalised for a diabetes complication.
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This doctoral project employed various study designs and settings to address the aims 
highlighted in Chapter One. The following studies were undertaken as part of the project: 
1. An ecological study to map diabetes-related hospitalisation rates across a regional
Australian population and investigate their associations with socioeconomic status
and geographical accessibility (Ageing, Chronic Disease and Injury Study, ACDI)
(Chapter Three).
2. An audit of hospital medical records to compare inpatient diabetes prevalence and
clinical profiles at three different-sized hospitals in regional Victoria, Australia
(Chapter Four).
3. A retrospective cohort study to compare the incidence, rate, length and causes of
hospitalisation between adults with normoglycaemia, impaired fasting glucose and
diabetes (Geelong Osteoporosis Study, GOS) (Chapter Five).
4. A mixed-methods study of inpatients with a complication of diabetes to identify the
enabling and impeding factors for optimal diabetes management in primary care
(Chapter Six).
Detailed data collection procedures, sample descriptions, inclusion and exclusion criteria and 




Study One: An ecological study to investigate associations of diabetes-related 
hospitalisations with socioeconomic status and geographical accessibility
The ACDI study region 
The first part of this section is a manuscript published in Journal of Public Health Research 
(2016) that introduces key socio-demographic characteristics of the ACDI study region and 
the methods used.  
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Abstract
Background: An increasing burden of chronic disease and associat-
ed health service delivery is expected due to the ageing Australian pop-
ulation. Injuries also affect health and wellbeing and have a long-term
impact on health service utilisation. There is a lack of comprehensive
data on disease and injury in rural and regional areas of Australia. The
aim of the Ageing, Chronic Disease and Injury study is to compile data
from various sources to better describe the patterns of chronic disease
and injury across western Victoria.
Design: Ecological study.
Methods: Information on demographics, socioeconomic indicators
and lifestyle factors are obtained from health surveys and government
departments. Data concerning chronic diseases and injuries will be
sourced from various registers, health and emergency services, local
community health centres and administrative databases and compiled
to generate profiles for the study region and for sub-populations within
the region.
Expected impact for public health:This information is vital to estab-
lish current and projected population needs to inform policy and
improve targeted health services delivery, care transition needs and
infrastructure development. This study provides a model that can be
replicated in other geographical settings.
Introduction
Australia is facing a rapidly ageing population and with this, the
burden of chronic disease is increasing.1 The current fertility, life
expectancy and migration trends are expected to continue over the
coming decades and will have implications for delivery of health serv-
ices. It is projected that one quarter of Australians will be aged 65 years
and over by 2044-45, almost double the present proportion.2 An
increase in the proportion of government health spending is projected
from 5.7% of the Gross Domestic Product in 2002-03, rising to around
10.3% in 2044-45.2 The expected growth in regional and rural popula-
tions will further contribute to an increased need for health services in
these areas.3 Injuries also impact on health and wellbeing and can
exacerbate chronic health problems resulting in long-term health serv-
ice use.4 In order to inform policy and adequately plan improved deliv-
ery of health services, it is vital to establish the health service needs of
the population. Such information could assist in developing innovative
models of care to address the health service needs of an ageing popu-
lation as well as reducing the demand by implementing effective pre-
ventative strategies.
Inequalities in rural and regional health service delivery are evi-
dent, not just in Australia5 but also in other countries across the
world.6-8 While health statistics can be abstracted from large-scale
state and national surveys, locally-generated evidence is better poised
to characterise small area differences. Our data will relate to a range
of chronic diseases and injuries, some of which are peculiar to region-
al, remote and farming communities. The needs of such sub-popula-
tions are rarely addressed in broader surveys. The Ageing, Chronic
Disease and Injury (ACDI) study was launched in 2015 to address this
need.
Aim
The ACDI study aims to provide a comprehensive snapshot of the
health and wellbeing of older adults living in western Victoria. The pur-
pose of this paper is to describe the methods that will be utilised for
the study and discuss key demographic features of the study popula-
tion. Specific aims of the study are to: i) describe the extent of chronic
disease and injury in the region; ii) highlight age-, sex- and location-
Significance for public health
The pattern of chronic disease and injury and its relationship with age, sex
and location has not been described for the region. This study will collect
new data and collate existing databases to provide a comprehensive snap-
shot of the health and safety across western Victoria, Australia. Baseline
data collected in the project will be used to forecast disease burden into the
future, based on Australian Bureau of Statistics models. In order to deter-
mine gaps in service delivery, plan future interventions including prevention
strategies, and evaluate their effectiveness, it is essential to have a contem-
porary evidence base and processes in place for monitoring on-going
change. The profiles will provide important information for targeting appro-
priate allocation of resources and care transition needs, and to deal with bur-
den of disease and injury. This study establishes a profiling model that can
be replicated in other geographical regions, and will be particularly useful in
non-metropolitan settings.
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related variations in the patterns of chronic disease and injury
throughout the region; iii) document associations between socioeco-
nomic status, location remoteness and accessibility, lifestyle risk fac-
tors such as smoking, alcohol consumption, physical inactivity, obesity
and the burden of chronic disease and injury.
Where is the study region located?
Victoria is the second most populous state of the eight Australian states
and territories (Figure 1).9 There are 79 discrete geographical regions or
Local Government Areas (LGAs) in Victoria.10 The study region includes
21 of the 79 Victorian LGAs and represents nearly one-third of the state by
area (Figure 1). Based on the 2011 Census of Population and Housing,
the 2013 Estimated Resident Population (ERP) of the study region is
617,794.11 Greater Geelong (ERP=221,515), Ballarat (ERP=98,684) and
Warrnambool (ERP=33,300) are the three most populous LGAs in the
region (Table 1).1,12-14
What is already known about the study region?
Life expectancy
According to the most recent figures, life expectancy at birth for men
in the region ranges from 75.7 years in Northern Grampians to 81.2
years in Surf Coast.12 Life expectancy is 80.3 for all Victorian men12 and
79.3 for all Australian men.15 For women, life expectancy at birth
ranges between 82.0 years in Hepburn to 86.3 years for Surf Coast.12
Life expectancy is 84.4 years for all Victorian women12 and 83.9 years
for all Australian women.15
Accessibility and remoteness
The LGAs in the region range from  highly accessible  to  moderately
accessible based on Accessibility/Remoteness Index of Australia (ARIA)
classification (Table 1). ARIA scores are generated by taking into
account distance from localities to different town categories, access to
goods and services and opportunities for social interaction.16 Scores
are grouped into five categories ranging from highly accessible (ARIA
score 0.00-1.84), accessible (ARIA score >1.84-3.51), moderately acces-
sible (ARIA score >3.51-5.80), remote (ARIA score >5.80-9.08) and very
remote (ARIA score >9.08-12.00). Three LGAs in the region are classi-
fied as  moderately accessibleand the remaining are either  highly acces-
sible or  accessible; there are no LGAs in the  remote or  very remote cat-
egories.17 The study region covers highly productive agricultural areas
in the southwest for dairying and grazing to larger acreages suited to
broad acre farming in the west and north western regions. The majority
of these farms remain family owned and operated.13
Socioeconomic status
The study region has a wide range of socioeconomic status shown by
Index for Relative Socioeconomic Advantage and Disadvantage
(IRSAD) scores (Table 1). Scores lower than 1000 indicate relatively
lower socioeconomic advantage and higher disadvantage. The LGAs
falling in the lowest 10% are given a decile number of 1 (most disad-
vantaged) and those in the highest 10% are given a decile number of
10 (most advantaged).18 Central Goldfields has the lowest IRSAD score
in the entire state of Victoria. Surf Coast has the highest IRSAD score
(decile 10) in the region and ranks seventh out of 79 LGAs in Victoria.
Access to health services
Health services in the study region include a mix of public and private
providers. The major bulk of trauma services in the region are provided
through 24-hour Emergency Departments located in the cities of Geelong,
Ballarat, Warrnambool, Horsham and Hamilton.14 In addition, there are
rural trauma centres and hospitals (including Bush Nursing Hospitals) in
the study region providing primary care and referral services.19 The LGA
of Queenscliffe has the highest number of General Practitioners per 1000
population whereas West Wimmera has the lowest (2.9  versus 0.3) (Table
1). The proportion of adults having private health insurance is highest in
Surf Coast (54.0%) and lowest in Central Goldfields (28.9%). The LGAs of
Hindmarsh and Queenscliffe have the highest hospital inpatient separa-
tions in the region (694.3 per 1000 and 651.4 per 1000), whereas Surf
Coast has the lowest (338.7 per 1000).20
Lifestyle factors and obesity levels
Information on self-reported prevalence of current smoking, risk of
alcohol-related harm, obesity and physical inactivity corresponds to
data from the Victorian Population Health Survey (VPHS) 2011-2012.21
The VPHS is a Computer Assisted Telephone Interview of individuals
aged 18 years and over residing in private dwellings. For 2011-2012,
data were based on a sample of 33,673 with a response of 66.8%.
Detailed information on lifestyle factor definitions and methods
utilised by the VPHS is described in the survey report.21 Table 2 sum-
marises findings relevant to the study region some of which are dis-
cussed here.
Smoking status:adults living in Pyrenees reported the highest preva-
lence of current smoking in the region (23.2%) and those living in
Horsham reported the lowest (11.1%). The prevalence at the state level
was 15.7%. Prevalence of current smoking in men was also the highest
in Pyrenees (26.7%) as compared to the Victorian estimate of 18.5%.
The highest prevalence of current smoking in women was reported in
Yarriambiack (23.2%) as compared to the Victorian estimate of 12.9%.
LGAs with the lowest reported prevalence of current smoking in men
and women were Warrnambool (11.5%) and Horsham (5.9%) respec-
tively. Physical activity: adults living in Hepburn reported the highest
prevalence of insufficient physical activity/sedentary lifestyle in the
study region, 38.3% as compared to 32.1% in Victoria. LGAs with a high
prevalence of sufficient physical activity were Queenscliffe (78.3%),
Moyne (72.4%), Yarriambiack (71.3%) and Southern Grampians
(71.2%). The measure was 63.9% at state level.
Obesity: a higher proportion of adults living in Yarriambiack
Study Protocol
Figure 1. Location of the Ageing, Chronic Disease and Injury
study region. Local Government Areas included in the study are
shaded according to the percentage of individuals aged 40 years
and over. Data for graphic were obtained from the Department of




Table 1. Demographic and socioeconomic characteristics of the study region. Data were obtained from the Australian Bureau of
Statistics.1,12-14
Local Government ERP ERP ERP Median age, IRSAD score, IRSAD ARIA score, ARIA GPs per % PHI
Area 2013 2013 2013 total years median decile median category 10,000 pop.
(M) (F) (% of study region)
Ararat 5791 5416 11,207 (1.8) 45 938 2 1.8 Accessible 1.1 36.3
Ballarat 48,086 50,598 98,684 (15.9) 37 969 4 0.5 Highly accessible 1.2 38.7
Central Goldfields 6280 6322 12,602 (2.0) 48 888 1 1.3 Highly accessible 0.9 28.9
Colac-Otway 10,437 10,257 20,694 (3.3) 42 946 3 1.8 Highly accessible 1.1 36.6
Corangamite 8266 7871 16,137 (2.6) 43 970 5 2.0 Accessible 1.1 42.0
Glenelg 9940 9581 19,521 (3.1) 43 943 3 2.9 Accessible 1.2 33.9
Golden Plains 10,354 9797 20,151 (3.2) 39 1011 8 1.0 Highly accessible 0.5 45.0
Greater Geelong 109,221 112,294 221,515 (35.8) 39 980 5 0.5 Highly accessible 1.3 46.0
Hepburn 7253 7590 14,843 (2.4) 46 967 4 1.1 Highly accessible 1.6 35.7
Hindmarsh 2870 2825 5695 (0.9) 47 929 1 4.4 Moderately accessible 1.4 32.2
Horsham 9747 9940 19,687 (3.1) 40 971 5 3.2 Accessible 0.6 38.1
Moorabool 15,222 15,098 30,320 (4.9) 39 995 7 0.8 Highly accessible 0.7 42.5
Moyne 8126 8151 16,277 (2.6) 41 1005 7 1.9 Accessible 0.6 46.3
Northern Grampians 5984 5815 11,799 (1.9) 45 926 1 2.5 Accessible 1.0 33.8
Pyrenees 3359 3411 6770 (1.0) 47 930 1 1.5 Highly accessible 0.7 33.2
Queenscliffe 1430 1628 3058 (0.4) 55 1047 9 0.7 Highly accessible 2.9 51.6
Southern Grampians 7940 8205 16,145 (2.6) 44 978 5 2.7 Accessible 1.1 41.3
Surf Coast 14,233 14,049 28,282 (4.5) 40 1060 10 1.1 Highly accessible 1.2 54.0
Warrnambool 16,364 16,936 33,300 (5.3) 38 970 4 1.4 Highly accessible 1.6 36.0
West Wimmera 2077 2012 4089 (0.6) 46 977 5 4.1 Moderately accessible 0.3 36.2
Yarriambiack 3572 3446 7018 (1.1) 48 943 2 3.9 Moderately accessible 0.7 32.4
Study Region 306,552 311,242 617,794
ERP, Estimated Resident Population; IRSAD, Index of Relative Socioeconomic Advantage and Disadvantage; ARIA, Accessibility; GPs, General Practitioners, PHI, Private Health Insurance.
(30.9%), Central Goldfields (25.5%), and West Wimmera (24.3%)
reported being obese as compared to the state estimate of 17.3%. The
LGA with the lowest prevalence of self-reported obesity in the study
region was Queenscliffe (9.1%).
Risky/high risk alcohol intake:overall, a higher proportion of men report-
ed risky/high risk alcohol consumption as compared to women in each of
the LGAs in the study region as well as the state. Queenscliffe reported the
highest proportion of adults (60.1%) consuming alcohol at risky/high-risk
level for short-term harm. The prevalence at the state level was 45.3%.
Design and methods
The study population
The ACDI study is population-based, ecological in design and focuses
on the population aged 40 years or older residing in western Victoria;
this grouping makes up nearly 51% (~316,000) of the total population
in the study region.11 There is a general pattern of an increasing pro-
portion of population aged 40 years or older in the western parts of the
region with some exceptions (Figure 1). The LGAs with the highest
proportion of those over 40 years of age are Queenscliffe (67.0%),
Pyrenees (62.9%), Yarriambiack (61.9%), West Wimmera (60.9%),
Central Goldfields (60.7%), and Hindmarsh (60.5%).
Data sources for the ageing, chronic disease and
injury study
We will source data on chronic disease and injury incidence, preva-
lence and mortality from existing local, national and state registries
and databases. Prevalence data will be presented as aggregate summa-
ry statistics for disease and injury according to age, sex, year and loca-
tion. Registries to be accessed include, but are not limited to: i) the
Victorian Cancer Registry (VCR), a population-based cancer registry
that provides comprehensive information for cancer control.9
Notifications about cancer diagnoses are provided to the VCR by hospi-
tals, pathology laboratories and cancer screening registers; ii) the
National Diabetes Services Scheme, established in 1987, is adminis-
tered by Diabetes Australia to provide access to diabetes-related prod-
ucts at subsidised rates as well as other support services. Registration
is voluntary and free of charge for Australians with a diagnosis of dia-
betes mellitus with the number of registrants growing to over 1 million
since its inception;22 iii) the Victorian Admitted Episodes Dataset
(VAED) records details of inpatient admissions to all (i.e.  both Public
and Private) Victorian hospitals.23 The Victorian Emergency Minimum
Dataset (VEMD) is another state wide register that maintains records
of Emergency Department presentations.24 In addition to VAED and
VEMD, separations data from individual hospitals located within the
study region will also be abstracted; iv) Medicare Australia provides
access to health services for Australian residents and certain cate-
gories of visitors to Australia. It covers free or subsidised treatment by
health professionals under the Medicare Benefits Schedule (MBS) and
access to medicines under the Pharmaceutical Benefits Scheme
(PBS).25 MBS and PBS data will be accessed for providing patterns of
health service utilisation in terms of MBS claims and prescription dis-
pensing; v) the Australia Orthopaedic Association National Joint
Replacement Registry, established in 1999, receives data from all hos-
pitals undertaking joint replacement procedures and will be accessed
for the information within the region;26 vi) the Australia and New
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Zealand Dialysis and Transplant Registry collects and records inci-
dence, prevalence and outcome data for patients with end stage kidney
failure. Dialysis and kidney transplant units in Australia and New
Zealand also contribute to this registry;27 vii) Community
Rehabilitation Centres are located throughout the region and will pro-
vide vocational rehabilitation data that will complement data sourced
from hospital attendances and through Medicare.
Ethics approval
The study has been approved by the Human Research Ethics
Committee at Barwon Health (project 15/11).
Discussion
The ACDI study is the first of its kind to provide a comprehensive
account of the burden of disease and injury in western Victoria. A major
strength of the study is its inclusion of a large geographic study popu-
lation with varying degrees of remoteness. The importance of this
aspect of the study relates to reported regional differences in the level
of engagement with the health system by Australian residents.5 While
the numbers of public hospital separations are found to increase with
the remoteness of the patients’ place of residence, the instances of
contact with general practitioners and specialists are relatively low for
residents from regional and remote locations compared with those
from urban areas.5 There is thus a clear need to address this imbalance
and encourage greater availability and usage of primary health care in
rural, regional and remote communities to avert potentially preventable
hospital admissions. Our study region includes geographical areas
from the most socioeconomically disadvantaged to some of the most
advantaged in the state. This wide variation in demographic and
socioeconomic indicators provides an opportunity to investigate their
associations with disease burden and outcomes. Health inequities
relating to socioeconomic position in Australia are exemplified by the
greater mortality rates associated with chronic conditions such as
stroke, coronary heart disease and respiratory illnesses among socially
disadvantaged groups.28 Availability of quality datasets, mandatory
reporting for certain diseases (particularly cancers) and periodically
administered national and state level health surveys will enable esti-
mation of chronic disease and injury burden not only for our entire
study region but also for different sub-populations. This study provides
a framework for identifying sub-populations that would benefit from
targeted interventions for disease prevention, access to health services
and care transition needs to address health inequities in people who
are financially or otherwise disadvantaged.29 By collating data from
existing health and administrative databases and emergency service
records in combination with reported statistics for socio-demographic
indicators and lifestyle factors, we will develop an informative summa-
ry of the health and wellbeing of the older populations in western
Victoria. The aggregate data will be presented for the whole region and
for sub-populations stratified by age, sex and location. While this study
draws on a network of data pertinent to our study region, the methods
described here provides a framework that can be replicated to develop
detailed profiles for other clearly-defined geographical regions, partic-
ularly in non-metropolitan settings. These profiles will provide useful
information for predicting future health service needs and identifying
Study Protocol
Table 2. Prevalence of lifestyle risk factors in the study region.
Local Government Current Sedentary Mostly sitting Obese# Risky/high risk alcohol
Area smoker* or insufficient occupation user (short-term risk of harm)§
physical activity°
Male Female Person Person Person Male Female Person Male Female Person
Ararat 16.1 16.0 16.8 30.0 32.2 20.8 19.9 20.9 59.7 45.4 52.4
Ballarat 21.9 9.6 15.6 30.3 43.5 19.6 18.0 18.8 60.6 43.6 51.6
Central Goldfields 21.5 9.0 15.1 30.2 26.8 28.1 21.8 25.5 59.8 29.0 44.5
Colac-Otway 19.7 11.9 15.8 31.9 22.6 13.8 18.8 16.2 66.1 46.9 56.2
Corangamite 16.6 19.3 17.5 24.1 24.8 26.9 14.5 20.4 60.5 41.6 50.5
Glenelg 21.2 20.3 19.9 29.9 34.1 23.6 19.2 21.7 65.3 38.8 52.9
Golden Plains 17.3 9.2 13.4 26.5 40.2 15.7 17.2 16.2 55.6 45.4 50.9
Greater Geelong 25.1 14.8 20.8 28.3 41.2 17.2 22.0 19.4 61.4 44.7 52.4
Hepburn 15.2 12.8 14.4 38.3 43.7 12.8 19.7 16.6 58.0 43.8 49.9
Hindmarsh 22.1 17.3 19.8 30.4 24.9 19.9 23.7 22.0 68.7 36.3 53.0
Horsham 16.6 5.90 11.1 31.8 28.2 15.9 27.5 21.4 49.3 33.4 41.3
Moorabool 15.6 12.0 13.9 34.8 45.8 21.1 21.0 20.7 55.9 38.6 47.4
Moyne 23.4 10.5 16.7 22.8 25.4 20.1 18.0 18.7 68.6 43.0 53.7
Northern Grampians 13.1 15.7 14.3 36.3 33.8 20.4 20.9 20.6 54.9 27.0 54.9
Pyrenees 26.7 21.1 23.2 23.6 20.1 22.7 19.5 21.4 65.5 45.0 55.5
Queenscliffe 24.5 12.1 16.6 20.7 48.5 12.8 5.4 9.10 70.6 50.6 60.1
Southern Grampians 11.8 12.8 12.2 25.6 18.3 18.4 18.6 18.5 68.6 42.5 55.2
Surf Coast 21.4 8.1 14.1 27.8 42.0 11.7 12.9 12.5 70.7 41.3 55.6
Warrnambool 11.5 11.1 11.4 30.7 34.9 16.5 18.3 17.5 54.1 40.6 47.2
West Wimmera 15.1 14.2 14.6 31.3 23.9 17.2 32.1 24.3 67.3 48.2 58.0
Yarriambiack 20.3 23.2 20.9 25.4 24.5 34.2 28.3 30.9 62.1 50.3 55.3
Victoria 18.5 12.9 15.7 32.1 48.1 17.4 17.2 17.3 52.6 38.3 45.3
Data are presented as percentage of population aged 18 years and over and were obtained from the Victorian Population Health Survey 2011-2012.21 *Adults who reported smoking daily or occasionally. °Less than 150
minutes or fewer than five sessions of moderate intensity physical activity per week. #Body Mass Index >30 kg/m2. §Based on the 2001 National Health and Medical Research Council guidelines (consuming >7 standard
drinks on any one day for men and five to six standard drinks on any one day for women).
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gaps in service delivery. In Australia, due to universal access to free or
subsidised public health services through Medicare, a comprehensive
record of health service usage is maintained.30 Accessing Medicare
data will enable us to understand patterns of health service utilisation
by the study population in terms of consultations with health care
providers and having prescriptions filled. Ecological studies, however,
are subject to various limitations and biases.31 As data are analysed at
a population level rather than an individual level, inferring individual
associations can be erroneous; a phenomenon referred to as ecological
fallacy. For example, using a single median IRSAD score for an entire
LGA is based on the assumption that all residents have the same level
of socioeconomic advantage and disadvantage. Populations may be
socioeconomically heterogeneous especially in the more densely popu-
lated LGAs. Furthermore, it is likely that the actual number of persons
with chronic disease will be higher than what is being captured by a
collation of disease-specific databases, for example the National
Diabetes Services Scheme. Last, even though only de-identified aggre-
gate data will be used, registers generally do not release data for low
prevalence disorders to ensure confidentiality. This could lead to an
underestimation of disease burden in areas where disease numbers
are low. Within these constraints, this study aims to determine the bur-
den of chronic disease and injury in western Victoria and provide direc-
tion for future longitudinal and data linkage studies.
Conclusions
The ACDI study provides a model for utilising routinely collected data
for determining the burden of chronic disease and injury, which can be
replicated in other geographical regions.
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For the 21 Local Government Areas (LGAs) in the study region, hospitalisation data by age 
group, sex and LGA of residence were acquired from a comprehensive register of public and 
private hospital admissions, the Victorian Admitted Episodes Dataset (VAED) [1]. Primary 
and additional diagnoses were classified using the Australian Modification of International 
Classification of Disease, tenth revision (ICD-10-AM) [2]. All instances of type 1 (E10) and
type 2 (E11) diabetes mellitus during 2011-2014 inclusive, were included in the analysis. 
‘Other specified diabetes mellitus’ (E13), ‘unspecified diabetes mellitus’ (E14) and 
gestational diabetes (O24) were excluded. 
Socioeconomic status 
LGA-level socioeconomic status was determined using the Index of Socioeconomic 
Advantage and Disadvantage (IRSAD), which is one of the four indices of area-level 
socioeconomic status, developed by the Australian Bureau of Statistics [3]. The IRSAD 
scores reflect both socioeconomic advantage and disadvantage, and are divided into deciles 
using cut-points for the state. Decile 1 is the most disadvantaged whereas decile 10 is the 
most advantaged. The ACDI study region has areas spanning the range of socioeconomic 
status, from the most disadvantaged to the most affluent LGAs [4].   
Accessibility and Remoteness 
Accessibility/Remoteness Index of Australia (ARIA) was used to measure accessibility, 
based on distance from towns and cities, access to goods and services and opportunities for 
social interaction [5]. There are five ARIA categories ranging from hi ghl y  acc es s i bl e ( 1.84), 
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acc es s i bl e (1.84-3.51), moderately accessible (3.51-5.80), rem ot e  (5.80-9.0 8) and ver y 
rem ot e ( 9.08). Th e LGAs in the ACDI study region are in the ‘highly accessible’ 
‘accessible’ or ‘moderately accessible’ categories [4]. There are no LGAs in the ‘remote’ or 
‘very remote’ categories 
Study Two: An audit of hospital medical r ecords to compare inpatient diabetes 
prevalence and clinical profiles at three different-sized hospitals in r egional Victor ia, 
Australia
Study sites 
Public acute hospitals in Australia are categorised based on peer-group classification that 
takes into account number of acute admissions, major patient groups, primary role and 
location [6]. To include a range of hospitals providing acute care in regional Victoria, a 
‘principal referral hospital’, a ‘public acute group A hospital’ and a ‘public acute group C 
hospital’ were included in the audit.  
•  University Hospital Geelong (UHG), a 370-bed principal referral hospital with a 24-
hour emergency department, providing intensive care and services across all major
specialties.
•  South West Healthcare, Warrnambool (SWH), a 172-bed public acute group A
hospital that provides most of the services provided by the principal referral centre but
does not offer the same breadth of services.
•  Western District Health Service, Hamilton (WDHS), a 91-bed hospital in public acute
group C category that provides a limited range of acute services.
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Data acquisition for inpatient audit 
From each hospital included in the study, over a 7-day period, data on age, sex, area of 
residence, date of admission and discharge, and outcome of hospitalisation were acquired. 
Furthermore, for all admitted patients, ‘principal diagnoses’ were classified according to 
ICD-10 categories, and compared between those with and without diabetes at each hospital in 
the study. Given the high number of additional diagnoses for each patient, only selected 
additional diagnoses were compared between diabetes and non-diabetes groups, including 
hypertension, cardiovascular disease, mental health condition predominantly depression, 
chronic obstructive pulmonary disease, arthritis, cancer, asthma and back pain and related 
problems. These conditions were included in the National Health Survey (2015) because of 
their significance as common, preventable chronic health conditions in Australia [7].     
Study Three: A retrospective cohor t study to compare the incidence, r ate, length and 
causes of hospitalisation between adults with normoglycaemia, impair ed fasting glucose 
and diabetes (GOS)
This study utilised data from the Geelong Osteoporosis Study, a longitudinal cohort study of 
more than 3,000 adult residents of a well-defined geographical region in south-eastern 
Australia [ 8]. 
Participant recruitment 
The study originally recruited an age-stratified sample of 1,494 women aged 20-94 years 
during 1993-1997, from Commonwealth electoral rolls (77.1% participation). Since then, 
participants have been assessed at regular intervals and 881 wom en part i ci pat ed i n t he 10-
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year follow-up. An additional 246 women aged 20-29 years were recruited during 2006-2008 
using the same recruitment strategies. Of the total cohort, this study included women for 
whom glycaemic status could be ascertained, retrospectively, using fasting plasma glucose 
(FPG) measurements, self-reported diabetes and/or use of antihyperglycaemic agents 
(n=924). A cohort of men (n=1,540) was similarly recruited and assessed during 2001-2006 
and 5-year follow-up commenced in 2006. ‘Cohort entry’ for men was defined based on 
when FPG was measured and the final sample consisted of men for whom glycaemic status 
was confirmed using the same criteria (n=971).   
Ascertainment of glycaemic status 
Fasting plasma glucose was measured from a venous sample after an overnight fast, using an 
adaptation of the hexokinase-glucose-6-phosphate dehydrogenase method [9]. 
Normoglycaemia, IFG and diabetes were defined according to the 2003 American Diabetes 
Association’s diagnostic criteria, diab et es ( FP G  7.0 m m ol / L, self-report or use of 
antihyperglycaemic agents), IFG (FPG 5.5-6.9 mmol/L) and normoglycaemia (FP G  5.5 
mmol/L without self-report or use of antihyperglycaemic agents).
Other baseline measures 
Body weight and height were measured at baseline using standard equipment. A series of 
questionnaires provided information on physical activity levels, smoking, alcohol use and 
socioeconomic status. Physical activity levels were assessed using a six-level mobility 
question and responses were dichotomised into ‘high mobility’ (very active and active) and 
‘low mobility’ (sedentary, limited, inactive, chair/bedridden and bedfast). Alcohol use was 
assessed using the Cancer Council Victoria Dietary Questionnaire for Epidemiological 
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Studies [10]. ‘Low’ alcohol use was defi n ed as  2 s t andard dri nks pe r day and ‘high’ use 
as >2 standard drinks per day (one standard drink = 10 g of alcohol). The IRSAD deciles 
were derived from the participants’ address and used as a measure of socioeconomic status 
[3].  
Primary outcome measure 
The participants were followed from when FPG was measured (baseline), up to 31 December 
2012 or date of death, where applicable. Primary outcome measure was any admission to 
University Hospital Geelong during the follow-up period, the largest tertiary public hospital 
in the study region and the only hospital with a 24-hour Emergency Department during the 
study period. Unique identifiers (Unit Record numbers) were used to link baseline data with 
hospital medical records.
Secondary outcome measures 
Secondary outcomes included rate of admissions over the follow-up period and length of 
admission in days, calculated from the admission and discharge dates for each admission. 
Reasons for hospitalisation
Principal diagnoses were classified into broad categories by aggregating individual ICD-10 
diagnostic codes, to compare primary reasons for admission between glycaemic categories.
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Study Four : A mixed-methods study of inpatients with a complication of diabetes to 
identify the enabling and impeding factors for  optimal diabetes management in pr imary 
care
Study setting and design 
As part of the doctoral project, a mixed-methods study was conducted at the University 
Hospital Geelong during July 2017-Apri l 2018. A s urve y of pat i ent s adm i t t ed t o t he hos pi t al 
with diabetes-related foot ulcers was conducted (n=31), which was followed by semi-
structured interviews of 30 participants. One person was not interviewed as the diagnosis of 
diabetes was made during the current admission.     
Survey questionnaires 
Survey questionnaires were used to seek information on demographic characteristics, diabetes 
status, type and duration of diagnosis, medication use, and co-existing conditions. Details of 
diabetes management were documented, including visits to health professionals, general 
practice management plan, knowledge and testing for glycosylated haemoglobin (HbA1c), 
complications surveillance and membership of diabetes support scheme.     
Patient interviews
Detailed semi-structured interviews were undertaken to explore the perceived enabling and 
impeding factors for optimal management of diabetes in primary care. In the first two 
interviews, participants were encouraged to describe their experiences of living with diabetes. 
These ‘pilot’ interviews were used to generate the prompts for the remaining interviews. 
Specific areas explored included, 
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•  Accounts of diagnosis
•  Impact of diabetes on life
•  Enabling/helpful factors in diabetes management
•  Impeding/unhelpful factors in diabetes management
•  Health professionals’ support
•  Adherence to medication
•  Family/social support
•  Diabetes-related stressors
Participant responses were recorded on paper by the interviewer (PhD candidate) and each 
interview lasted 30-45 minutes. The notes were later transferred to a computer for analysis. 
The interviews were continued until thematic saturation was reached [11].    
Ethics approval 
The Ageing, Chronic Disease and Injury Study and sub-studies included in this thesis were 
approved by Human Research Ethics Committees at Barwon Health (project 15/11) and 
Deakin University (project 2015-117). The Geelong Osteoporosis Study was approved by the 
Barwon Health Human Research Ethics Committee (projects 92/01 and 00/56). Where data 
pertained to individuals, all participants provided written, informed consent. 
Data analyses 
Details of statistical analyses performed in this project are described in the relevant chapters 
and manuscripts. In brief, Poisson regression analysis was used to calculate incidence rate 
ratios for diabetes-related hospitalisation by age group, socioeconomic status decile and 
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remoteness categories (Chapter Three). Logistic regression was used to compare inpatient 
prevalence of diabetes at three study hospitals (Chapter Four). The ‘diabetes’ and ‘non-
diabetes’ groups were compared using t-tests or Mann-Whitney U non-parametric tests for 
continuous variables and 2 or Fisher’s exact tests for categorical variables (Chapters Four 
and Five). In Chapter Five, logistic regression, Poisson regression and two-way analyses of 
variance (ANOVA) were used to compare the incidence, rate and length of hospitalisation 
between glycaemic categories, respectively. For interpretation and analysis of interview data 
(Chapter Six), Graneheim and Lundman’s (2004) protocol for content analysis was used [12]. 
To summarise, this project utilised various epidemiological research tools and study designs 
to address some key issues related to acute care use in diabetes. The strengths and limitations 
related to study designs, data acquisition, analyses and interpretation of results are discussed 
in relevant chapters of this thesis. Although the findings from this project are mainly based on 
cross-sectional and observational data, they have potential implications for informing health 
policy and providing direction for future research.   
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Abst r ACt
Objective Hospitalisation rates for many chronic
conditions are higher in socioeconomically disadvantaged
and less accessible areas. We aimed to map diabetes
hospitalisation rates by local government area (LGA)
across Western Victoria, Australia, and investigate
their association with socioeconomic status (SES) and
accessibility/remoteness.
Design Cross-sectional study
Methods Data were acquired from the Victorian Admitted
Episodes Dataset for all hospitalisations (public and
private) with a diagnosis of type 1 or type 2 diabetes
mellitus during 2011–2014. Crude and age-standardised
hospitalisation rates (per 1000 population per year)
were calculated by LGA for men, women and combined
data. Associations between accessibility (Accessibility/
Remoteness Index of Australia, ARIA), SES (Index of
Relative Socioeconomic Advantage and Disadvantage,
IRSAD) and diabetes hospitalisation were investigated
using Poisson regression analyses.
r esults Higher LGA-level accessibility and SES were
associated with higher rates of type 1 and type 2 diabetes
hospitalisation, overall and for each sex. For type 1 diabetes,
higher accessibility (ARIA category) was associated with
higher hospitalisation rates (men incidencerate ratio
[IRR]=2.14, 95%CI 1.64 to 2.80; women IRR=2.45, 95%CI
1.87 to 3.19; combined IRR=2.30, 95%CI 1.69 to 3.13; all
p<0.05). Higher socioeconomic advantage (IRSAD decile)
was also associated with higher hospitalisation rates
(men IRR=1.25, 95%CI 1.09 to 1.43; women IRR=1.32,
95%CI 1.16 to 1.51; combined IRR=1.23, 95%CI 1.07
to 1.42; all p<0.05). Similarly, for type 2 diabetes, higher
accessibility (ARIA category) was associated with higher
hospitalisation rates (men IRR=2.49, 95%CI 1.81 to 3.43;
women IRR=2.34, 95%CI 1.69 to 3.25; combined IRR=2.32,
95%CI 1.66 to 3.25; all p<0.05) and higher socioeconomic
advantage (IRSAD decile) was also associated with higher
hospitalisation rates (men IRR=1.15, 95%CI 1.02 to 1.30;
women IRR=1.14, 95%CI 1.01 to 1.28; combined IRR=1.13,
95%CI 1.00 to 1.27; all p<0.05).
Conclusion Our observations could indicate self-
motivated treatment seeking, and better specialist and
hospital services availability in the advantaged and
accessible areas in the study region. The determinants
for such variations in hospitalisation rates, however, are
multifaceted and warrant further research.
Int r ODuCt IOn
Diabetes mellitus is a major risk factor for
hospitalisation, repeated admissions and
longer hospital stays.1–4 The incidence of both
planned and unplanned hospital admissions
in individuals with diabetes is substantially
higher than those without.5 6 Hospital care
is the largest component of the expenditure
attributable to diabetes mellitus.7 8 The Amer-
ican Diabetes Association reported that during
2011–2012, inpatient care accounted for 43%
of the direct medical costs for diabetes in the
USA.7 Similarly, diabetes accounted for 14%
of hospital admissions for chronic disease in
Australia during 2013–2014.2 3 Furthermore,
strengths and limitations of this study
Hospitalisation data were acquired from a compre-
hensive register of admissions to all hospitals in the
state, both public and private.
Large study area spanning a wide range of socio-
economic status (SES).
Diabetes hospitalisation data included all admission
records with diabetes, which could have resulted
in overestimation of diabetes hospitalisation due to
multiple admissions.
SES and accessibility indices represent geographi-
cal areas rather than individuals.
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in Australia, hospital care contributed nearly half of the 
annual direct costs for type 1 diabetes mellitus (T1DM) 
and one-third for type 2 diabetes mellitus (T2DM).8 
According to a national inpatient audit report for 2016, 
one in six hospital beds in the UK were occupied by a 
person with diabetes.9 An audit of 11 hospitals across 
Melbourne, Australia, reported an overall diabetes preva-
lence of 24.7% among hospitalised patients.10 
The global prevalence of diabetes is rising rapidly, 
with one in ten adults expected to have the condition 
by 2040.11 Population ageing, increasing rates of obesity 
and unhealthy lifestyle are some of the factors contrib-
uting to this global pandemic.3 12 Consequently, health 
systems in developing and developed countries will have 
to cope with an increased demand for diabetes-related 
acute health services.13 Some of the known determi-
nants of diabetes-related hospitalisations are advancing 
age,6 suboptimal glycaemic management,14 comorbidi-
ties,6 15 16 previous admission,14 physical inactivity17 as well 
as minimal and excessive contact with primary care.18
Globally, residents of regional and remote areas experi-
ence adverse health outcomes, including higher hospital-
isation rates for chronic diseases, as compared with those 
living in metropolitan areas.19 20 Various factors are impli-
cated in this disparate healthcare experience including 
lower socioeconomic status (SES),19 higher prevalence 
of lifestyle risk factors,21 lower access to primary care 
services20 and shortage of healthcare professionals.22 In 
Australia, those living in ‘rural and remote areas’ tend 
to have lower life expectancy, higher rates of disease and 
injury, and poorer access to and use of health services 
than people living in ‘major cities’.23 Diabetes hospital-
isation rates also vary by place of residence, which could 
be explained by differences in area-level SES and acces-
sibility.24–26 There are limited data on the relationship 
between SES, accessibility and diabetes hospitalisation 
in regional populations. Such information could aid in 
planning future diabetes-related service delivery, identi-
fying discrepancies between the need for and uptake of 
health services, and to devise strategies to reduce service 
demand by addressing its community-level determinants.
These analyses were undertaken as part of the Ageing, 
Chronic Disease and Injury (ACDI) study,27 launched in 
2015 with the overarching aim to describe chronic disease 
and injury patterns in the western region of the state of 
Victoria, Australia. There are no previous reports on 
diabetes hospitalisation for the region; we aimed to map 
the geographical variations in diabetes hospitalisation 
rates and investigated their relationship with area-level 
SES and accessibility indicators.
MethODs
study region
The ACDI study region comprises 21 of the 79 local govern-
ment areas (LGAs), which are administrative boundaries 
that cover legally designated parts of the state of Victoria 
(Australia) over which incorporated local governing 
bodies have responsibility. As of 2011, the estimated resi-
dent population of the ACDI study region was 617 794, 
representing almost one-tenth of the state’s population.27 
The median LGA population was 16 145 and ranged 
from 3058 (Queenscliffe) to 221 515 (Greater Geelong). 
A profile of the study region describing its key sociode-
mographic characteristics has been published previ-
ously.27 This region is often described as a microcosm, 
ideally placed for epidemiological research due to its 
close resemblance with the overall national demographic 
structure.28 There is a major urban centre (Geelong) and 
areas of varying SES and remoteness levels.27 The study 
region also includes large agriculture areas with farming 
communities, involved in dairy production and broad 
acre farming (cropping, wool and meat production).27
ses and accessibility/remoteness
We cross-referenced residential addresses to the Austra-
lian Bureau of Statistics (ABS) census data, and also 
ascertained the region of residence according to LGAs. 
We defined deciles of area-level SES using the composite 
Index of Relative Socioeconomic Advantage and Disad-
vantage (IRSAD), which is one of the four Socio-Eco-
nomic Indexes For Areas, developed by the ABS, using 
the 2011 Census data.29 The IRSAD accounts for high and 
low area-based income and occupation types including 
unskilled employment to professional positions, among 
other variables. The IRSAD values of the LGA of usual 
residence were mapped for the study region.29 The IRSAD 
scores are equivalised for both advantage and disadvan-
tage, therefore, providing values that span the continuum 
from the most socially disadvantaged decile (lowest 
10%=decile 1) to the most socially advantaged decile. 
Deciles cut-points for IRSAD values were based on the 
Victorian population.29 Our study region included LGAs 
that spanned the range of SES deciles, ranging from the 
most disadvantaged (Central Goldfields, Northern Gram-
pians, Hindmarsh and Pyrenees) to the most advantaged 
(Surf Coast).27 Importantly, Central Goldfields is also the 
lowest ranking LGA in the state of Victoria in terms of 
SES while Surf Coast is the seventh most socioeconomi-
cally advantaged.27
Accessibility/Remoteness Index of Australia (ARIA) was 
used as the measure of LGA-level accessibility.27 The ARIA 
was developed by the Australian Government’s Depart-
ment of Health and Aged Care and uses a geographical 
approach to defining remoteness.30 The scores are deter-
mined by distance from towns and cities, access to goods 
and services, and opportunities for social interaction.30 
A low ARIA score indicates high accessibility and there 
are five categories ranging from highly accessible (≤1.84), 
accessible (1.84–3.51), moderately accessible (3.51–5.80), 
remote (5.80–9.08) and very remote (≥9.08).30 In our 
study region, the LGAs of Hindmarsh, West Wimmera 
and Yarriambiack were classified as ‘moderately acces-
sible’, which is the lowest accessible category in the state 
of Victoria as there are no LGAs in the ‘remote’ or ‘very 
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remote’ categories.27 The remaining LGAs were either in 
the ‘accessible’ or ‘highly accessible’ categories.
Diabetes hospitalisation data
Data on hospital admissions were acquired from the 
Victorian Admitted Episodes Dataset, which maintains a 
comprehensive record of hospitalisations in the state. All 
state hospitals, public and private, are required to submit 
data for each admitted episode. The ‘primary’ and ‘addi-
tional’ diagnoses are classified using the Australian Modi-
fication of International Classification of Disease, 10th 
revision.31 For each episode of admission, one primary 
and up to 40 additional diagnoses can be recorded.31
As we intended to capture all admission episodes in 
individuals ‘with’ diabetes, not limited to those specifi-
cally ‘for’ diabetes or its complications, we included all 
instances with a T1DM (code E10) or T2DM (code E11) 
diagnosis, during 2011–2014, inclusive. Admissions for 
other forms of diabetes, including gestational diabetes 
were excluded (codes E13, E14 and O24). Repeated 
admissions in the same individuals were also included in 
the aggregated hospitalisation data.
Patient and public involvement
There was no direct patient or public involvement.
statistical analysis
We used aggregated data for our analysis over 2011–
2014, inclusive. Initially, crude T1DM-hospitalisation 
and T2DM-hospitalisation rates were calculated by age 
group (<40 years, 40–49 years, 50–59 years, 60–69 years, 
70–79 years and 80+ years), sex and LGA of residence. 
Age-standardisation was performed using the Austra-
lian population (2011) as the standard. Population esti-
mates were obtained from the ABS.32 All hospitalisation 
rates were expressed as ‘per 1000 population per year’ 
and presented separately for men and women, as well as 
combined for both sexes.
To investigate the associations between sociodemo-
graphic indicators and diabetes-hospitalisations, Poisson 
regression analysis was performed and incidence rate 
ratios (IRRs) were calculated by age group, SES (SES 
decile) and accessibility (ARIA category) for men, 
women and combined data. Due to high level of correla-
tion between SES and ARIA, separate regression models 
were used considering both individually. All models were 
weighted according to LGAs’ population to account for 
heterogeneity in population size. Statistical analyses were 
performed using Stata (V.14).
results
Table 1 provides an overview of diabetes hospitalisations 
in the ACDI region during 2011–2014, inclusive. In total, 
there were 104 126 T1DM-hospitalisations or T2DM-hos-
pitalisations in the region, of which, 57 077 (54.8%) were 
in men. Overall, only 5.0% of diabetes-related admis-
sions had diabetes as a ‘primary’ diagnosis, whereas in 
most cases, diabetes was recorded as an ‘additional’ diag-
nosis. This differed between T1DM-hospitalisation and 
T2DM-hospitalisation, with 22.0% of T1DM-hospitalisa-
tions recorded as primary diagnosis, compared with 2.7% 
of T2DM-hospitalisations. Type 2 diabetes accounted for 
almost 90.0% of all diabetes hospitalisations overall, as 
well as for men (91.5%) and women (90.0%) separately 
(table 1).
Of the 10 617 total T1DM-hospitalisations, 3886 (~36%) 
were <40 years of age (29.3% men and 43.3% women), 
whereas just under 11% were in the 80+ years group 
(table 1). A significantly higher proportion of T2DM-hos-
pitalisations were in the older age groups (table 1). On 
the basis of the ARIA scores, 74.1% of diabetes hospital-
isations represented residents of ‘highly accessible’ LGAs 
(table 1)
The rate of T1DM-hospitalisations in men was 2.6 per 
1000 population per year in the <40 years age group 
(95% CI 2.5 to 2.7), increasing to 7.8 per 1000 population 
per year in the 60–69 years age group (95% CI 7.3 to 8.3) 
and declining afterwards in the 70–79 years and >80 years 
age groups (figure 1A). A similar pattern was evident in 
women with the highest rate of T1DM-hospitalisations in 
the 60–69 years age group, that is, 5.3 per 1000 popula-
tion per year (95% CI 4.9 to 5.6) (figure 1A).
A linear increase in T2DM-hospitalisation rates was 
observed with increasing age (figure 1B). In men, 
T2DM-hospitalisation rate was 0.6 per 1000 population 
per year in the <40 years age group (95% CI 0.6 to 0.7) to 
252.9 per 1000 population per year in the 80+ years age 
group (95% CI 248.4 to 257.5). For women, the rate was 
1.2 per 1000 population per year in the <40 years age 
group (95% CI 1.1 to 1.3), increasing to 163.6 in the >80 
years age group (95% CI 160.6 to 166.5)
For the whole study region, both T1DM-hospitalisa-
tion and T2DM-hospitalisation rates were higher in men 
compared with women. Unadjusted T1DM-hospitalisa-
tion rate was 6.1 per 1000 population per year in men 
(95% CI 5.9 to 6.5) versus 3.5 per 1000 population per 
year in women (95% CI 3.4 to 3.9) and T2DM-hospitalisa-
tion rate was 85.6 per 1000 population per year in men 
(95% CI 84.0 to 88.2) versus 64.3 per 1000 population per 
year in women (95% CI 63.2 to 67.1).
Figures 2 and 3 show the geographical variation 
in T1DM-hospitalisation and T2DM-hospitalisation 
rates across the study region, for men and women 
combined (figures 2A and 3A), men only (figures 2B and 
3B) and women only (figures 2C and 3C), respectively. 
Overall, the LGA of Central Goldfields, which has the 
lowest SES in the study region (decile 1), had the highest 
T1DM-hospitalisation rate, whereas Surf Coast (decile 
10), Glenelg (decile 3) and Hepburn (decile 4) had the 
lowest (figure 2A). The LGA of Hindmarsh (decile 1) 
had the highest T2DM-hospitalisation rate and Surf Coast 
(decile 10) had the lowest (figure 3A).
In univariate analysis, compared with <40 years age 
group, T1DM-hospitalisation rate was three times higher 
in the 50–59 years and 60–69 years groups, but not 
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significantly different in the 40–49 years, 70–79 years 
and 80+ years age groups. Rate of T2DM-hospitalisation 
was significantly higher in older age groups as compared 
with <40 years group. Furthermore, being male was asso-
ciated with higher rates of both T1DM-hospitalisation 
and T2DM-hospitalisation.
After adjusting for age, rates of both T1DM-hospital-
isation and T2DM-hospitalisation were associated with 
accessibility (residence in more accessible LGA) and SES 
(socioeconomic advantage) (table 2). These associations 
were observed for the overall data, as well as for men and 
women separately.
DIsCussIOn
As part of the larger ACDI study, we have previously 
proposed a methodology for using routinely collected 
data to provide contemporary information on region-spe-
cific health outcomes for Western Victoria, Australia, 
which could be replicated in other settings.27 We also 
reported associations between socioeconomic position, 
place of residence and utilisation of primary total knee 
and hip joint replacements,33 and hospital admissions for 
hip fractures,34 for this region. In this paper, we examine 
rates of T1DM-hospitalisations and T2DM-hospitalisa-
tions by age, sex and place of residence across the ACDI 
region and their association with SES and accessibility. 
Increasing accessibility and higher SES were associated 
with higher rates of T1DM-hospitalisation and T2DM-hos-
pitalisation overall, and for both men and women sepa-
rately. The rate of T1DM-hospitalisation increased with 
age and was highest in those aged 60–69 years, followed 
by a decline in the 70–79 and >80 years age groups. In 
contrast, rates of T2DM-hospitalisation increased steadily 
with age, the highest being in the >80 years age group. 
Rates of both T1DM-hospitalisation and T2DM-hospital-
isation were higher in men as compared with women.
Table 1 Overview of T1DM-hospitalisations and T2DM-hospitalisations in the ACDI region during 2011–2014 inclusive, by age 






(49.6%) Total n=93 508





 <40 3886 (36.6%) 1596 (29.3%) 2290 (43.4%) 1137 (1.2%) 409 (0.7%) 728 (1.5%)
 40–49 1348 (12.6%) 648 (11.9%) 700 (13.2%) 3589 (3.8%) 1692 (3.2%) 1894 (4.0%)
 50–59 1902 (17.9%) 1046 (19.2%) 856 (16.2%) 11 848 (12.6%) 6860 (13.2%) 4988 (10.6%)
 60–69 1858 (17.5%) 1105 (20.3%) 753 (14.2%) 23 791 (25.4%) 14 529 (28.0%) 9262 (19.6%)
 70–79 991 (9.3%) 627 (11.5%) 364 (6.8%) 29 248 (31.2%) 16 400 (31.6%) 12 848 (27.3%)
 ≥80 632 (5.9%) 319 (5.8%) 313 (5.9%) 23 898 (25.5%) 11 846 (22.8%) 12 052 (25.6%)
Socioeconomic status (IRSAD) of local government area
 Decile 1 (most 
disadvantaged)
775 (7.2%) – – 7595 (8.1%) – – 
 Decile 2 381 (3.5%) – – 3714 (3.9%) – – 
 Decile 3 441 (4.1%) – – 6298 (6.7%) – – 
 Decile 4 3046 (28.6%) – – 21 351 (22.8%) – – 
 Decile 5 4832 (45.5%) – – 43 805 (46.8%) – – 
 Decile 6 – – – – 
 Decile 7 614 (5.7%) – – 5936 (6.3%) – – 
 Decile 8 266 (2.5%) – – 1930 (2.0%) – – 
 Decile 9 31 (0.2%) – – 651 (0.6%) – – 
 Decile 10 (most 
advantaged)
231 (2.1%) – – 2229 (2.3%) – – 
Accessibility/remoteness (ARIA) of local government area
 Moderately accessible 
(lowest accessibility)
287 (2.7%) – – 3806 (4.0%) – – 
 Accessible 1835 (17.2%) – – 21 015 (22.4%) – – 
 Highly accessible 
(highest accessibility)
8495 (80.0%) – – 68 688 (73.4%) – – 
ACDI, Ageing, Chronic Disease and Injury; ARIA, Accessibility/Remoteness Index of Australia; IRSAD, Index of Relative 
Socioeconomic Advantage and Disadvantage; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus. 
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We observed that better geographic accessibility was 
associated with higher rates of T1DM-hospitalisation and 
T2DM-hospitalisation. Although diabetes is an ambula-
tory care sensitive condition,35 meaning better access to 
primary care services helps to reduce hospitalisations, 
the evidence is mixed.36 The major reason for the varia-
tion is that primary care delivery structures differ among 
countries and regions. In Australia, for instance, general 
practitioners (GPs) are usually the first point of contact 
between individuals and health system. They provide 
referrals to specialists and may often facilitate hospital 
admissions, particularly in areas with limited specialist 
availability. A survey of 28 207 Australians aged 15 years 
and older showed that during 2016–2017, 83% of the 
responders had seen their GP.37 Hence, the proposition 
that frequent use of primary health services translates 
into fewer diabetes hospitalisations may be too simplistic. 
In a cross-sectional study of indigenous Australians, 
Zhao et al18 reported an overall U-shaped relationship 
between the number of diabetes-related primary health-
care visits and hospitalisation. The lowest hospitalisation 
rates were observed in those with 20–30 primary care 
visits per year, increasing in those with <20 or>30 visits 
per year.18 A similar relationship was reported between 
avoidable hospitalisation rates and distance from hospital 
in a Canadian study.38 The study reported that living <35 
km and >50 km from a hospital were associated with 
higher rates of avoidable hospitalisations38; thus, both 
availability and lack of hospital services close to places 
of residence may contribute to higher hospitalisation 
rates. As our data were aggregated by patients’ area of 
residence, rather than admitting hospital, we were unable 
to examine this possibility in our study. However, in our 
study, more than 70% of diabetes admissions represented 
residents of ‘highly accessible’ areas, which are more 
Figure 1 Age group stratified hospitalisation rate for (A) 
T1DM and (B) T2DM per 1000 population per year during 
2011–2014 inclusive, across ACDI study region presented for 
men, women and combined data, with error bars showing 
95% CIs. ACDI, Ageing, Chronic Disease and Injury; T1DM, 
type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.
Figure 2 Density map showing T1DM-hospitalisation rate for (A) men and women combined (B) men only and (C) women 
only for the ACDI study region during 2011–2014 inclusive (age-standardised rates per 1000 population per year). LGAs are 
shaded according to the legend from the lowest to highest hospitalisation rates. ACDI, Ageing, Chronic Disease and Injury; AR, 
Ararat; BA, Ballarat; C, Corangamite; CG, Central Goldfields; CO, Colac Otway; GE, Greater Geelong; GL, Glenelg; GP, Golden 
Plains; HI, Hindmarsh; HP, Hepburn; HS, Horsham; LGAs, local government areas; MO, Moyne; MR, Moorabool; NG, Northern 
Grampians; PY, Pyrenees; Q, Queenscliffe; SC, Surf Coast; SG, Southern Grampians; T1DM, type 1 diabetes mellitus; WA, 
Warrnambool; WW, West Wimmera; Y, Yarriambiack.
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likely to live in close proximity of a hospital. Other studies 
have shown that availability of hospital beds or special-
ists could increase hospitalisation rates.39 Connell et al40 
argued that higher rates of diabetes hospitalisations do 
not necessarily indicate inadequate primary care but 
may just reflect availability of hospital services and vari-
able thresholds of disease severity at which physicians 
recommend admissions. The study, conducted in the US 
state of Washington, showed that severity of diabetes in 
admitted patients (determined by blood glucose levels, 
admissions for coma, surgery, intensive care or terminal 
episodes) was considerably higher in counties with lower 
bed supply.40 Over-servicing may also play a role in areas 
where hospital beds and admitting physicians are in over-
supply, although this needs further investigation.
We observed a direct association between socioeco-
nomic advantage and diabetes-hospitalisation. This is not 
consistent with previously reported hospitalisation data 
from the Australian Institute of Health and Welfare that 
show higher hospital separations for diabetes complica-
tions in more disadvantaged and remote areas, compared 
with more affluent and easily accessible areas.2 3 In another 
Australian study, Bergin et al25 reported higher rates of 
diabetic-foot-related hospitalisations among residents of 
socially disadvantaged areas. Furthermore, limb amputa-
tions due to diabetes are lowest in major cities and inner 
regional areas and highest in remote and disadvantaged 
areas.41 These social patterns of hospitalisations have 
been observed in other countries, for instance, in a Scot-
tish study of 35 935 individuals with diabetes reported a 
significantly higher proportion of hospital admissions for 
people presenting with both acute and chronic complica-
tions of diabetes in the lowest socioeconomic quintile as 
compared with those in the highest.24
Social disadvantage has been identified as a barrier to 
treatment-seeking.42 Given that admission to a hospital 
may result in loss of income, people, particularly those 
self-employed, such as farmers and small business owners, 
may delay necessary inpatient treatment only to end up in 
the hospital at a later stage with serious complications. A 
possible explanation for our findings could be that socio-
economic disadvantage and geographic remoteness act as 
risk factors for ‘emergency’ hospitalisation while acting as 
barriers to ‘elective’ hospitalisation. Our data, however, 
did not have the necessary detail to distinguish between 
elective and emergency hospitalisations, specific reasons 
for admission or whether there were delays in treatment 
seeking.
Our results are consistent with previous data showing 
that six out of every seven hospital admissions for diabetes 
are T2DM-related.3 In our study, approximately 90% of 
diabetes-hospitalisations were T2DM-related, which 
could reflect a similarly higher proportion of T2DM as 
compared with T1DM in the population. The association 
between advancing age and hospitalisation was different 
for T1DM-hospitalisation and T2DM-hospitalisation 
where more than one-third of T1DM-hospitalisations were 
in individuals under 40 years of age, compared with less 
than 2% of T2DM-hospitalisations. This is not surprising 
as T2DM is less common in this age group and until 
recently, survival into old age for those with T1DM has 
been rare. Adolescents and young adults with diabetes, 
predominantly T1DM, represent a particularly high-risk 
group for acute hospitalisations.6 Younger persons with 
diabetes are more likely to miss medical appointments, 
have worse self-care practices and behaviours, and are less 
likely to follow medication regimes.43 44 Similarly, elderly 
persons with diabetes often present with multiple and 
advanced complications, and are more likely to be read-
mitted, have longer lengths of hospital stay and higher 
risk of mortality as compared with younger counterparts.35
Figure 3 Density map showing T2DM-hospitalisation rate for (A) men and women combined (B) men only and (C) women 
only for the ACDI study region during 2011–2014 inclusive (age-standardised rates per 1000 population per year). LGAs are 
shaded according to the legend from the lowest to highest hospitalisation rates. ACDI, Ageing, Chronic Disease and Injury; AR, 
Ararat; BA, Ballarat; C, Corangamite; CG, Central Goldfields; CO, Colac Otway; GE, Greater Geelong; GL, Glenelg; GP, Golden 
Plains; HI, Hindmarsh; HP, Hepburn; HS, Horsham; LGAs, local government areas; MO, Moyne; MR, Moorabool; NG, Northern 
Grampians; PY, Pyrenees; Q, Queenscliffe; SC, Surf Coast; SG, Southern Grampians; T2DM, type 2 diabetes mellitus; WA, 
Warrnambool; WW, West Wimmera; Y, Yarriambiack.
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Our study has some strengths and limitations. A major 
strength of our study is that we acquired hospitalisation 
data from the Victorian Admitted Episodes Dataset, a 
comprehensive register that collates data from both 
public and private hospitals and maintains standards for 
quality and consistency.45 Furthermore, our study region 
includes areas with a wide range of SES, which makes it 
suitable to investigate this factor. One of the limitations 
of our study is that the data presented do not repre-
sent ‘individuals’ or ‘separations’ but the total number 
of admission records with a diagnosis of diabetes. This 
could have resulted in an overestimation of hospital-
isation rates where small numbers of individuals were 
admitted multiple times. Furthermore, diabetes coding 
standards in Australian hospitals have undergone signifi-
cant changes between 2009–2010 and 2013–2014,2 which 
may have caused inaccuracies in estimation of diabe-
tes-related hospitalisations. Our purpose, however, was 
not to compare hospitalisation rates over time; therefore, 
changes in the coding standards would not have had 
an impact on the interpretation of our data. Moreover, 
although our study region had no LGAs in the ‘remote’ 
or ‘very remote’ category, it resembles the accessibility 
pattern of the state of Victoria, which also does not have 
any LGAs in these categories. In the absence of reliable 
diabetes prevalence estimates, we are unable to compare 
diabetes hospitalisation rates with its prevalence in our 
study region. However, in the Victorian Population Health 
Survey (2011–2012),21 the adult prevalence of self-re-
ported, doctor-diagnosed type 2 diabetes was reported. 
According to the survey, the LGA of Surf Coast (highest 
SES) had the lowest type 2 diabetes prevalence (2.8%; 
95% CI 1.7 to 4.5), whereas Central Goldfields (lowest 
SES) had the highest (6.1%; 95% CI 4.5 to 8.3). The prev-
alence was significantly higher among men ‘not in labour 
force’ or earning <$A40 000 annually (higher socioeco-
nomic disadvantage). The survey did not find any differ-
ences in the prevalence of type 2 diabetes between LGAs, 
or metropolitan versus rural areas. Finally, our study is 
ecological in nature and uses area-level measures of SES 
Table 2 Regression analysis showing associations of diabetes-hospitalisation with socioeconomic status and accessibility/
remoteness for men, women and combined data, adjusted for age
T1DM-hospitalisation T2DM-hospitalisation
IRR (95% CI) P value IRR (95% CI) P value
Men 
 Model: age and ARIA
 Age (years) 0.85 (0.78 to 0.92) <0.001 1.63 (1.51 to 1.75) <0.001
 ARIA category of LGA 2.14 (1.64 to 2.80) <0.001 2.49 (1.81 to 3.43) <0.001
 Model: age and SES
 Age (years) 1.07 (0.95 to 1.20) 0.22 2.39 (2.15 to 2.65) <0.001
 SES decile of LGA 1.25 (1.09 to 1.43) 0.001 1.15 (1.02 to 1.30) 0.020
Women
 Model: age and ARIA
 Age (years) 0.69 (0.64 to 0.74) <0.001 1.61 (1.49 to 1.73) <0.001
 ARIA category of LGA 2.45 (1.87 to 3.19) <0.001 2.34 (1.69 to 3.25) <0.001
 Model: age and SES
 Age (years) 0.88 (0.77 to 1.00) <0.060 2.30 (2.07 to 2.56) <0.001
 SES decile of LGA 1.32 (1.16 to 1.51) <0.001 1.14 (1.01 to 1.28) 0.027
Combined
 Model: age, sex and ARIA
 Age (years) 0.77 (0.73 to 0.80) <0.001 1.61 (1.50 to 1.72) <0.001
 Sex (female) 0.98 (0.76 to 1.28) 0.930 1.30 (1.11 to 1.53) 0.001
 ARIA category of LGA 2.30 (1.69 to 3.13) <0.001 2.32 (1.66 to 3.25) <0.001
 Model: age, sex and SES
 Age (years) 0.94 (0.86 to 1.03) 0.190 2.20 (2.00 to 2.43) <0.001
 Sex (female) 1.93 (1.50 to 2.49) <0.001 1.85 (1.63 to 2.10) <0.001
 SES decile of LGA 1.23 (1.07 to 1.42) 0.003 1.13 (1.00 to 1.27) 0.035
P values <0.05 are shown in bold.
ARIA, Accessibility/Remoteness Index of Australia; IRR, incidence rate ratio; LGA, local government area; SES, socioeconomic status; T1DM, 
type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.
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and accessibility/remoteness, which may not capture 
the socioeconomic diversity among individuals in the 
community. Results of ecological studies need to be inter-
preted with caution to avoid making assumptions about 
individuals based on aggregated population data.
COnClusIOn
This is the first report of age-related, sex-related, SES-re-
lated and accessibility-related variations in rates of 
diabetes hospitalisation across Western Victoria, Australia. 
We report that higher SES and accessibility were associ-
ated with increased rates for diabetes hospitalisation for 
both T1DM and T2DM. These results contradict previous 
reports linking social disadvantage and lower accessi-
bility with higher diabetes-related hospitalisation rates. 
Health service use for chronic conditions is determined 
by complex individual, organisational and ecological 
factors, which need to be addressed in more detail. While 
we speculate that higher diabetes-related hospitalisation 
rates may indicate better access to hospital services and 
social advantage as discussed in this paper, other factors, 
such as availability of specialists and hospital beds, physi-
cians’ care preferences, health literacy and policies/
protocols guiding hospital admissions, also play a role. 
We have discussed possible explanations of variations in 
diabetes hospitalisation rates by place of residence, and 
provided direction for further inquiry into specific deter-
minants, which will inform future planning of hospital 
services for diabetes.
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a) T1DM-hospitalisation rates per 1000 population per year and SES (Men and women
combined)
a) T2DM-hospitalisation rates per 1000 population per year and SES (Men and women
combined)
Figure 4: Bubble plots showing association between socioeconomic status and a) T1DM-
hospitalisation rate and b) T2DM-hospitalisation rates per 1000 population (men and women
combined) during 2011-2014 (inclusive) across the 21 Local Government Areas in the study
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Abstract
Background
Prevalence of diabetes mellitus and its complications is rising in Australia, however, data on 
its burden on the public hospital system are limited, particularly in regional areas. 
Methods
We analysed 7-day bed-occupancy from a principal referral hospital (University Hospital 
Geelong, UHG), a medium-sized hospital (South West Healthcare Warrnambool, SWH) and 
a small regional hospital (Western District Health Service Hamilton, WDHS). Patients aged 
<18 years, maternity ward patients and same day admissions were excluded. A comparison of 
diabetes prevalence and patient profiles between those with and without diabetes is presented 
overall, and at each hospital.  
Results
Among 1,020 patients (UHG=753, SWH=196, WDHS=71), 211 (20.6%) had diabetes with 
inpatient prevalence 21.3%, 17.3% and 22.5%, respectively, that did not vary between 
hospitals. Inpatients with diabetes were older, majority had type 2 diabetes (~95%), and had a 
two days longer median length of stay than those without.  
Inpatients with diabetes were significantly more likely to be admitted for principal diagnostic 
categories of ‘diseases of the circulatory system’ (17.5%-versus-12.3%), ‘endocrine, 
nutritional and metabolic diseases’ (9.4%-versus-1.7%), ‘certain infectious and parasitic 
diseases’ (5.6%- versus-2.3%), and ‘diseases of the skin and subcutaneous tissue (4.2%-
versus-1.9%; al l p 0.05). Thos e wi t hout di abet es  were significantly more likely to be 
admitted for ‘injury, poisoning and certain other consequences of external causes’ (16.5%-
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versus-9.9%) and ‘diseases of the digestive system (10.7%-versus-4.7%; a l l p 0.05). The t wo 
groups did not differ in terms of admissions for other principal diagnostic categories. 
Conclusion
One in five inpatients in regional hospitals have diabetes, however, considering 
underreporting in medical records and undiagnosed diabetes, the true prevalence is likely to 
be higher. Prevention of complications and capacity building of hospitals are needed to cope 
with the projected high demand for diabetes-related hospital services in future.  
Keywords Diabetes; prevalence; hospitalisation; acute health service use
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Background
Diabetes mellitus is associated with an increased risk of premature mortality, ill-health and 
acute health service use [1-3]. Hospital care forms the largest component of annual 
expenditure on diabetes in Australia (34.9%) [4], United States (30.0%) [5], and Canada 
(43.2%) [6]. The prevalence of diabetes among hospitalised patients reflects its prevalence in 
the community and the quality of primary care. For resource planning and targeted service 
delivery, it is vital to quantify the burden of diabetes on public hospital systems, however, 
few previous Australian studies have addressed this. Bach et al conducted a study across 11 
metropolitan hospitals in Melbourne and reported an overall diabetes prevalence, ascertained 
through measurement of haemoglobin A1c, of 24.7% (range 15.7%-35.1%) [7]. Residents of 
rural and regional areas are reported to have an increased risk of diabetes and its 
complications [8]. This is attributable to a high prevalence of lifestyle risk factors such as 
physical inactivity, unhealthy diet, and smoking [9], lower socioeconomic status [10], and 
shortages of health workforce [11]. We, therefore, hypothesised that regional hospitals would 
have a higher burden of diabetes and its comorbidities, as compared to those in urban areas. 
Currently, there are no estimates of inpatient diabetes prevalence in regional Australian 
hospitals, thus we aimed to determine it at three regional public hospitals in the Australian 
state of Victoria. Furthermore, we compared the demographic and clinical profiles of 
inpatients with and without diabetes.  
Methods
Study sites 
This study was undertaken as part of the Ageing, Chronic Disease and Injury Study, which 
aims to describe the health status of a regional population across west Victoria, Australia 
[12]. The study region includes a mix of urban, rural and agricultural areas, spanning the 
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range of socioeconomic status and remoteness. We intended to compare diabetes prevalence 
and patient profiles at regional hospitals providing varying levels of acute care. Thus our 
study included a ‘principal referral hospital’, a ‘public acute category A’ hospital and ‘public 
acute category C’ hospital, in regional Victoria, Australia (Figure 1). These categories are 
based on the peer-group classification of public acute hospitals, which takes into account the 
size of hospitals (number of acute admissions), demographic characteristics of major patient 
groups, primary role (teaching or non-teaching), and remoteness of location [13].  
Principal referral hospitals provide a broad range of services, have highly specialised units, 
and serve large patient volumes. They typically have a 24-hour emergency department (ED), 
intensive care unit (ICU) and all or most of cardiac surgery, neurosurgery and infectious 
disease, bone marrow transplant, organ transplant and burns units [13]. From this category, 
we included University Hospital Geelong (UHG), a 370-bed tertiary hospital that serves a 
population of ~350,000 in the region [14]. 
Public acute group A hospitals provide a wide range of services including a 24-hour ED, 
ICU, coronary care unit (CCU) and oncology unit, but lack the breadth of services provided 
by principal referral hospitals [13]. We included South West Healthcare, Warrnambool 
(SWH), a public acute group A hospital with 172 beds that serves a population of ~35,000 
[15].  
Public acute group C hospitals provide a more limited range of services but do have an 
obstetric unit, provide surgical services and/or some emergency services [13]. From this 
category, we included Western District Health Service, Hamilton (WDHS), a 91-bed hospital 
providing health services to a population of ~16,200 [16]. 
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Data acquisition 
We acquired 7-day de-identified bed-occupancy data between August 1 to August 7, 2016 
(inclusive), for all hospitalised patients aged 18 years and older for each hospital in the study. 
Specifically, the following information was obtained:
•  Demographic characteristics including age, sex and area of residence.
•  Admission-related information including date of admission and discharge and
outcome of hospitalisation (discharge, transfer or death).
•  Principal diagnoses classified into International Classification of Diseases, Tenth
Revision, (ICD-10) categories as follows, ‘certain infectious and parasitic diseases’
(A00-B99), ‘neoplasms’ (C00-D49), ‘diseases of the blood and blood-forming organs
and certain disorders involving the immune mechanism’ (D50-D89), ‘endocrine,
nutritional and metabolic diseases’ (E00-E89), ‘mental, behavioural and
neurodevelopmental disorders’ (F01-F99), ‘diseases of the nervous system’ (G00-
G99), ‘diseases of the eye and adnexa’ (H00-H59), ‘diseases of the circulatory
system’ (I00-I99), ‘diseases of the respiratory system’ (J00-J99), ‘diseases of the
digestive system’ (K00-K95), ‘diseases of the skin and subcutaneous tissue’ (L00-
L99), ‘diseases of the musculoskeletal system and connective tissue’ (M00-M99),
‘diseases of the genitourinary system’ (N00-N99), ‘symptoms, signs and abnormal
clinical and laboratory findings, not elsewhere classified’ (R00-R99), ‘injury,
poisoning and certain other consequences of external causes’ (S00-T88), and ‘factors
influencing health status and contact with health services’ (Z00-Z99).
•  Additional diagnoses. Given the number of additional diagnoses recorded for each
admission episode (up to 40), we limited our comparison between inpatients with and
without diabetes, to the following chronic conditions; hypertension, cardiovascular
disease including stroke, mental health condition, chronic obstructive pulmonary
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disease, arthritis, cancer, asthma and back pain and related problems. These 
conditions were selected since the National Health Survey (2015) previously reported 
on them, as they are common in Australia, pose significant health problems, have 
been the focus of ongoing national surveillance efforts, and are preventable [17].     
Statistical analysis
Continuous variables are presented as medians with interquartile ranges. We compared 
‘diabetes’ and ‘non-diabetes’ groups using t-tests or Kruskal-Wallis non-parametric test for 
continuous variables. Categorical variables are presented as frequencies and proportions and 
t he t wo groups wer e com pared us i n g 2 or Fisher’s exact test, as appropriate. We used 
binomial exact methods to calculate 95% confidence intervals for proportions. Inpatient 
diabetes prevalence at the three hospitals was compared using logistic regression after 
adjusting for age and sex. Statistical analyses were performed using Minitab statistical 
software (version 18; Minitab, Inc., State College, PA).    
Results
Prevalence of diabetes
For the three hospitals combined, there were 1,020 bed occupants over the 7-day period, of 
whom 211 had diabetes (20.6%): type 1 diabetes (~5%) and type 2 diabetes (~95%). Inpatient 
prevalence of diabetes at the individual hospitals was 21.3% (UHG), 17.3% (SWH) and 
22.5% (WDHS), respectively (Figure 2). At UHG, among 161 admitted patients with 
diabetes, 149 had type 2 diabetes (90.8%) and 11 had type 1 diabetes (7.9%). At SWH and 
WDHS, there were no patients with type 1 diabetes.  
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Overall, inpatients with diabetes were older than those without (median age 72 years, 
IQR=17 versus 63 years, IQR=34; p<0.05). At UHG and SWH, a higher proportion of 
inpatients with diabetes were men, however, at WDHS, a higher proportion of inpatients with 
diabetes were women (Table 1). Overall, median length of stay for inpatients with diabetes 
was longer than the non-diabetes group (6 days, IQR=12 versus 4 days, IQR=9; p<0.05). 
Logistic regression analysis showed that after adjusting for age and sex, the three hospitals 
did not differ in terms of inpatient diabetes prevalence.   
Principal and additional reasons for admission 
In a small proportion of inpatients with diabetes (n=18), the principal reason for admission 
was directly related to diabetes, of which the majority was admitted for diabetes-related foot 
ulcers or peripheral angiopathy (n=11), followed by diabetic ketoacidosis (n=4) and ‘poor 
control’ (n=3). Diabetes was mostly recorded as an additional diagnosis (91.4% of inpatients 
with diabetes).
Admitted individuals with diabetes, compared with those without, were more likely to be 
admitted for principal diagnosis categories of ‘diseases of the circulatory system’, ‘endocrine, 
nutritional and metabolic diseases’, ‘certain infectious and parasitic diseases’, and ‘diseases 
of the skin and subcutaneous tissue (Table 1). Inpatients without diabetes were more likely to 
be admitted for ‘injury, poisoning and certain other consequences of external causes’ and 
‘diseases of the digestive system’. The two groups were similar in terms of admissions for 
other principal diagnosis categories (Table 1). 
The prevalence of hypertension and chronic obstructive pulmonary disease was higher in the 
diabetes group (Figure 3). Patients in the two groups did not differ in terms of having 
comorbid arthritis, mental health condition, cancer, cardiovascular condition, asthma, and 
back pain.  
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Prevalence of microvascular complications among inpatients with diabetes  
Overall, one-fifth of inpatients with diabetes had diabetes-related nephropathy, whereas 
neuropathic and ophthalmic complications were present in 6.1% and 2.8%, respectively. At 
UHG, the prevalence of nephropathy, neuropathy and retinopathy among inpatients with 
diabetes was 15.5%, 7.1% and 2.3%, respectively. At SWH, the prevalence of nephropathy 
among inpatients with diabetes was 38.2%, neuropathy (17.6%) and retinopathy (2.9%) and 
at WDHS, nephropathy (25.0%), neuropathy (6.2%) and retinopathy (0.0%).    
Patient outcomes and discharge  
At UHG, among 753 inpatients, the majority was discharged to home (77.5%), followed by 
transfer to acute care or rehabilitation (12.0%), nursing home (3.1%), whereas ~2% resulted 
in death. AT SWH, 72.9% admissions ended in discharge to home, followed by 8.1% being 
transferred to acute care or rehabilitation and 2.0% deaths. At WDHS, 76.0% were 
discharged to home, 8.4% transferred to acute care or rehabilitation and 2.8% deaths. There 
were no differences between hospitals in terms of the reported patient outcomes.   
Discussion
To the best of our knowledge, this is the first Australian study to report the inpatient diabetes 
prevalence at regional public hospitals, and compare profiles of admitted patients with and 
without diabetes. We found that one-fifth of adult inpatients had diabetes, of whom 95% had 
type 2 diabetes. The prevalence of diabetes was the highest in patients aged 60-79 years and 
inpatients with diabetes stayed longer in hospital than those without it. Compared with the 
principal referral centre (UHG), diabetes prevalence was not different in the medium-sized 
hospital (SWH) and the small regional hospital (WDHS). Individuals with diabetes were 
more likely to be admitted for diseases of circulatory and endocrine systems, infectious and 
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parasitic diseases, and skin and subcutaneous tissue disorders. The prevalence of 
hypertension and chronic obstructive pulmonary disease was higher among inpatients with 
diabetes, whereas the prevalence of arthritis, mental health condition, cancer, asthma, and 
back pain was similar between the two groups. 
The key finding of this study is that one in five adult patients in regional hospitals in the 
Australian state of Victoria have diabetes and the prevalence does not vary considerably 
between hospitals of different rankings. We consider that the diabetes prevalence reported 
here is likely an underestimate due to the underreporting of diabetes in medical records [1]. A 
study from Scotland assessed the completeness of diabetes coding among hospitalised 
patients and reported non-documentation in ~40% of admitted patients with previously 
known diabetes [18]. A Spanish study also concluded that use of medical records 
underestimated inpatient diabetes prevalence [1]. A large number of individuals with 
undiagnosed diabetes in the population is another reason for the likely underestimate. In a 
French study, screening of hospitalised patients identified one person with undiagnosed 
diabetes for every two with known diabetes [19]. Currently, an estimated half a million 
Australians have undiagnosed diabetes, [20] thus it is likely that the true inpatient diabetes 
prevalence is much higher.   
A majority of the inpatients with diabetes had type 2 diabetes. There were only 11 patients 
with type 1 diabetes and all of them were admitted at the principal referral hospital (UHG). 
Neither SWH nor WDHS had any inpatients with type 1 diabetes during the study period. 
This could be coincidental, however, it is possible that individuals with type 1 diabetes who 
reside in small regional towns and require hospitalisation have severe complications or more 
complex management needs, resulting in referral to tertiary hospitals. This could indicate the 
inability of small regional hospitals to care for patients with more complex management 
needs.    
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In our study, the most prevalent condition both as a principal and additional diagnosis in 
inpatients with diabetes was cardiovascular disease. Many studies show that individuals with 
diabetes are often hospitalised for other conditions, particularly heart conditions [3, 21]. 
Moreover, the category of ‘certain infectious and parasitic diseases’ as a principal reason for 
admission was also more common in the diabetes group. Individuals with diabetes are at up 
to 50% higher risk of infections due to the associated hyperglycaemic environment and 
impaired immunity [22]. The category ‘injury, poisoning and certain other consequences of 
external causes’, that mainly includes fractures, was more common in the non-diabetes group. 
Individuals with diabetes are at an increased fracture risk [23, 24], therefore, a likely 
explanation of this finding is that most fractures are managed in an out-of-hospital setting and 
only a small proportion of patients is hospitalised. Furthermore, these findings are based on a 
comparison of principal reasons for admission, which in individuals with diabetes were 
related to conditions other than fractures, primarily cardiovascular disease. It is likely that a 
comparison of community-dwelling individuals with and without diabetes would still show a 
higher risk of fractures in those with diabetes.   
A small number of inpatients in our study were admitted specifically for a diabetes-related 
condition (n=18), more than half of whom had foot ulcers or peripheral angiopathy. Diabetes-
related foot disease is a leading cause of unplanned hospitalisation and lower limb 
amputations in Australia [25, 26]. It is preventable, however, studies show inadequate 
screening where less than half of the Australian population with diabetes are reported to 
undergo regular screening by a health professional [27].   
Reliable estimates of diabetes prevalence in the areas where the three hospitals in our study 
are situated are not available, hence a comparison of inpatient diabetes prevalence with its 
prevalence in general population is not possible. The International Diabetes Federation 
(2017) estimates that the prevalence of diabetes in the Australian population aged between 
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20-79 years is 6.5% (95% CI 5.0-7.8) [28]. The UHG, SWH and WDHS are located in the
Local Government Areas (LGAs) of Greater Geelong, Warrnambool and Southern 
Grampians, respectively [29]. The reported prevalence of diabetes in these LGAs, based on 
the membership of the National Diabetes Support Scheme, ranges from 5.0-5.7% [29]. Based 
on these estimates, the inpatient prevalence of diabetes is three to four times its prevalence in 
general population. Other studies also reported similar relationship between the inpatient and 
population prevalence of diabetes [7].  
Our study had some strengths and limitations. The study focused on three regional health 
services providing acute care services to a diverse population with a mix of urban and rural 
areas, farming and cropping land, and a wide range of socioeconomic status and accessibility 
[12]. Well-developed health information systems at these hospitals allowed for a 
comprehensive capture of bed-occupancy data and admission-related information. Some 
limitations of this study include short study duration and small number of patients in the 
public acute group C hospital (WDHS). Another limitation of this study is that bed 
occupancy data were collected over a 7-day period in August, which did not allow for 
investigating possible seasonal variations in diabetes-related hospitalisations. Furthermore, 
we could not ascertain some key determinants of acute care utilisation, for instance, 
socioeconomic status, ethnicity and Indigenous status of patients, from the medical records. 
Finally, the data reported in this study represent inpatients and are, therefore, not 
generalisable to general population.    
Conclusion
Our study reports that one-fifth of adult inpatients admitted to the regional hospitals had 
diabetes, however, considering the underreporting of diabetes in hospital medical records and 
undiagnosed diabetes in the population, its true prevalence is likely to be higher. The 
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projected increase in the prevalence of diabetes in Australia in the coming decades would 
increase the burden on the public hospital system. Resource allocation should target 
prevention of complications to reduce the disproportionately high use of hospital services by 
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Table 1: Profile of adult inpatients with and without diabetes at the three hospitals in the study. P va l ues   are s hown i n bol d.
IQR, Interquartile range; UHG, University Hospital Geelong; SWH; South West Healthcare; WDHS, Western District Health Service.

















Age groups n (% ) Under 40 years 13 (8.0%) 130 (21.9%) - 1 (2.9%) - - 0 (0.0%) 4 (7.2%) -
40-59 years 17 (10.5%) 152 (25.6%) - 9 (26.4%) - - 5 
(31.2%)
16 (29.0%) -
60-79 years 96 (59.6%) 196 (33.1%) - 14 (41.1%) - - 7 
(43.7%)
17 (30.9%) -
80+ years 35 (21.7%) 114 (19.2%) - 10 (29.4%) - - 4 (25.0%) 18 (32.7%) -
Age Median (IQR) 72 (15.5) 61 (35.0) 0.050 73.0 (21.5) 63.5 (34.2) 0.034 68 (24.5) 73 (27) 0.810
Sex n (% ) Men 105 (65.2%) 313 (52.8%) 0.005 19 (55.8%) 83 (51.2%) 0.620 5 (31.2%) 21 (38.1%) 0.610
Women 56 (34.7%) 279 (47.1%) - 15 (44.1%) 79 (48.7%) - 11 (68.7%) 34 (61.8%) -
Diabetes type n(% ) Type 1 11 (7.9%) - - 0 (0.0%) - - 0 (0.0%) - -
Type 2 149 (90.8%) - - 34 (100.0%) - - 16 (100.0%) - -
Diabetes as pr imary 
diagnosis n (% )
11 (7.9%) - - 2 (5.8%) - - 1 (6.2%) - -
Admission days
Median (IQR)
7 (12.5) 4.0 (9.0) 0.009 7.5 (17.5) 6.0 (11.0) 0.121 4 (8) 3 (5) 0.940




Certain infectious and parasitic diseases (A00-B99) 11 (6.8%) 13 (2.2%) 0.003 0(0.0%) 5(3.0%) 0.589 1 (6.2%) 1 (1.7%) 0.402
Neoplasms (C00-D49) 15 (9.3%) 58 (9.8%) 0.855 0 (0.0%) 12 (6.8%) 0.116 1 (6.2%) 9 (15.5%) 0.337
Diseases of the blood and blood-forming organs and 
certain disorders involving the immune mechanism (D50-
D89)
2 (1.2%) 10 (1.6%) 0.688 1 (2.9%) 3 (1.8%) 0.536 0 (0.0%) 1 (1.7%) 1.000
Endocrine, nutritional and metabolic diseases (E00-E89) 17 (10.5%) 9 (1.5%) <0.001 2 (5.8%) 2 (1.1) 0.078 1 (6.2%) 4 (6.9%) 0.927
Mental, Behavioural and Neurodevelopmental disorders 
(F01-F99)
6 (3.7%) 47 (7.9%) 0.064 4 (11.7%) 24 (13.7%) 0.760 2 (12.5%) 0 (0.0) 0.048
Diseases of the nervous system (G00-G99) 5 (3.1%) 26 (4.3%) 0.466 1 (2.9%) 3 (1.7%) 0.536 2 (12.5%) 5 (8.6%) 0.639
Diseases of the eye and adnexa (H00-H59) 1 (0.6%) 5 (0.8) 0.777 0 (0.0%) 0 (0.0%) - 0 (0.0) 1 (1.7%) 1.000
Diseases of the circulatory system (I00-I99) 31 (19.2%) 72 (12.1%) 0.020 3 (8.8%) 25 (15.4%) 0.317 3 (18.7%) 3 (5.1%) 0.078
Diseases of the respiratory system (J00-J99) 17 (10.5%) 62 (10.4%) 0.975 8 (23.5%) 16 (9.1%) 0.016 0 (0.0%) 9 (15.5%) 0.093
Diseases of the digestive system (K00-K95) 5 (3.1%) 69 (11.6%) 0.001 2 (5.8%) 15 (8.5%) 0.600 3 (18.7%) 4 (6.9%) 0.151
Diseases of the skin and subcutaneous tissue (L00-L99) 6 (3.7%) 10 (1.6%) 0.112 3 (8.8%) 4 (2.2%) 0.053 0 (0.0%) 2 (3.4%) 1.000
Diseases of the musculoskeletal system and connective 
tissue (M00-M99)
8 (4.9%) 35 (5.9%) 0.647 3 (8.8%) 9 (5.1%) 0.399 2 (12.5%) 4 (6.9%) 0.467
Diseases of the genitourinary system (N00-N99) 9 (5.5%) 24 (4.0%) 0.399 1 (2.9%) 5 (2.8%) 1.000 0 (0.0%) 1 (1.7%) 1.000
Symptoms, signs and abnormal clinical and laboratory 
findings, not elsewhere classified (R00-R99)
9 (5.5%) 42 (7.0%) 0.501 1 (2.9%) 16 (9.1%) 0.226 1 (6.2%) 8 (13.7%) 0.414
Injury, poisoning and certain other consequences of 
external causes (S00-T88)
16 (9.9%) 98 (16.5%) 0.038 5 (14.7%) 33 (18.8%) 0.566 0 (0.0%) 6 (10.3%) 0.180
Factors influencing health status and contact with health 
services (Z00-Z99)
3 (1.8%) 11 (1.8%) 0.997 0 (0.0%) 2 (1.2%) 1.000 0 (0.0%) 0 (0.0%) -
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Figure 1: Location of the three study sites (University Hospital Geelong, South West Healthcare Warrnambool and Western District Health Service
Hamilton) in Victoria, Australia.
108
Chapter Four
Figure 2: Inpatient prevalence of diabetes mellitus at each hospital in the study. UHG (University Hospital Geelong) SWH (South West Healthcare), and
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Figure 3: Prevalence of selected chronic conditions among inpatients with and without diabetes, combined and at each hospital in the study, UHG 
(University Hospital Geelong), SWH (South West Healthcare), and WDHS (Western District Health Service). COPD (chronic obstructive pulmonary 
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Objective To determine whether adults with
normoglycaemia, impaired fasting glucose (IFG) and
diabetes differed according to the incidence, rate, length
and primary reasons for hospital admission.
Design Retrospective cohort study.
setting Barwon Statistical Division, Geelong,Australia.
Participants Cohort included 971 men and 924 women,
aged 20+ years, participating in the Geelong Osteoporosis
Study. Glycaemic status was assessed at cohort entry
using fasting plasma glucose, use of antihyperglycaemic
medication and/or self-report.
Primary and secondary outcome measures Primary
outcome measure was any admission to the major tertiary
public hospital in the study region over the follow-up
period. Secondary outcome measures were admission rate
and length (days).
r esults Over a median follow-up of 7.4 years (IQR
5.3–9.6), participants with diabetes, compared with those
with normoglycaemia, were two times as likely to be
hospitalised (OR 2.07, 95%CI 1.42 to 3.02), had a higher
admission rate (incidence rate ratio 1.61, 95%CI 1.17 to
2.23) and longer hospital stay (third quartile difference 7.7,
95%CI 1.3 to 14.1 and ninth decile difference 16.2, 95%CI
4.2 to 28.3). IFG group was similar to normoglycaemia for
the incidence, rate and length of admission. Cardiovascular
disease-related diagnoses were the most common primary
reasons for hospitalisation across all glycaemic categories.
Conclusions Our results show increased incidence, rate
and length of all-cause hospital admission in adults with
diabetes as compared with normoglycaemia; however,
we did not detect any associations for IFG. Interventions
should focus on preventing IFG-to-diabetes progression
and reducing cardiovascular risk in IFG and diabetes.
Int r ODuCt IOn
The rapid increase in the prevalence of
diabetes mellitus poses a significant challenge
for health planners globally. Diabetes causes
deterioration in physical health , mental
well-being and quality of life, resulting in
adverse outcomes including increased risk of
hospitalisation.1 2 According to the Australian
Institute of Health and Welfare (AIHW) ,
diabetes is one of the major causes of
Potentially Preventable Hospitalisations
in Australia, where hospitalisation may be
avoidable through timely and adequate
non-hospital care.3–5
It has been reported that people with
diabetes have higher rates of hospitalisation
as compared with those without the condi-
tion.6–9 Previous research , however, has
main ly focused on individuals with a diag-
nosis of diabetes. The association of in terme-
diate deteriorations in glucose metabolism
such as impaired fasting glucose (IFG) and
the risk of hospitalisation remains largely
unexplored. IFG represents levels of fasting
plasma glucose (FPG) that are above normal
(100 mg/ dL or 5.5 mmol/ L) but below the
diagnostic threshold for diabetes (126 mg/
dL or 7.0mmol/ L) .1 IFG is known to increase
the risk of cardiovascular disease in addition
strengths and limitations of this study
Retrospective cohort design with long-term
follow-up.
Randomly selected sample of general population,
including both men and women.
Robust method of identi cation of normoglycaemia,
impaired fasting glucose and diabetes mellitus.
To our knowledge, this is the rst study to investi-
gate the relationship between impaired fasting glu-
cose and hospitalisation.
Hospital admissions data were limited to the sole
tertiary public hospital in the study region.
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to being a risk factor for diabetes.10 11 As evidence builds 
for IFG as a disease condition rather than just a risk factor 
for diabetes, investigating adverse outcomes including 
hospitalisations in this grouping is warranted. The aim 
of this study was to compare the incidence, rate and 
length of all-cause hospital admissions between adults 
with normoglycaemia, IFG and diabetes mellitus over a 
median period of 7.4 years. Moreover, we aimed to high-
light primary reasons for hospital admissions for individ-
uals in different glycaemic categories.
MethODs
study design and participants
We retrospectively analysed data from the Geelong Osteo-
porosis Study, a longitudinal cohort study including 3034 
residents of the Barwon Statistical Division (BSD), located 
in Southeastern Australia, with a population of around 
280 000. A detailed cohort profile, recruitment strategy 
and methodology have been described elsewhere.12 In 
brief, during 1993–1997, an age-stratified sample of 
1494 women aged 20–94 years was recruited from the 
Commonwealth electoral rolls with an overall participa-
tion of 77.1%. Of the original sample, 881 women partic-
ipated in the 10-year follow-up commencing 2004 and an 
additional 246 women aged 20–29 years were recruited in 
2006–2008. Of these two groups, we included 924 women 
for whom glycaemic status could be confirmed based on 
FPG measurement, self-reported diabetes and/or use of 
antihyperglycaemic agents.
Similarly, during 2001–2006, 1540 men were recruited 
and assessed, followed by a 5-year reassessment 
commencing 2006. We used either baseline or 5-year 
follow-up as the point of cohort entry depending on 
when FPG was measured. The final sample for this anal-
ysis included 971 men for whom we were able to ascer-
tain glycaemic status using FPG measurement, self-report 
and/or use of antihyperglycaemic agents. All participants 
provided informed consent.
baseline measures
Cohort entry or ‘baseline’ was defined as the point when 
glycaemic status was confirmed and the follow-up was 
up to 31 December 2012 or date of death where appli-
cable. At baseline, body weight and height were measured 
using electronic scales and a wall-mounted stadiometer, 
respectively. Venous blood was collected after an over-
night fast and FPG was measured using an adaptation 
of the hexokinase-glucose-6-phosphate dehydrogenase 
method.13 Participants were categorised into normogly-
caemia, IFG and diabetes according to the 2003 American 
Diabetes Association’s diagnostic criteria where diabetes 
was defined as FPG ≥7.0 mmol/L (126 mg/dL), self-re-
port of diabetes or use of antihyperglycaemic agents. 
IFG was considered present if FPG level was between 5.5 
and 6.9 mmol/L (100–125 mg/dL). Participants with a 
FPG level ≤5.5 mmol/L in the absence of self-reported 
diabetes or use of antihyperglycaemic agents were classi-
fied as having normoglycaemia.
A series of questionnaires was administered seeking 
information on sociodemographic characteristics, use of 
medications and supplements, physical activity, alcohol 
consumption, and cigarette smoking.12
Levels of physical activity were determined using a 
multiple choice question with responses ranging from 
‘very active and active’ (aggregated as ‘high mobility’) 
to ‘sedentary, limited, inactive, chair/bedridden and 
bedfast’ (aggregated as ‘low mobility’). Frequency of 
alcohol consumption was measured using the Cancer 
Council Victoria Dietary Questionnaire for Epidemio-
logical Studies.14 The Australian National Health and 
Medical Research Council guidelines were used to clas-
sify alcohol consumption into a binary variable; ‘low 
use’ (≤2 standard drinks/day) and ‘high use’ (>2 stan-
dard drinks/day), where a standard drink equals 10 g of 
alcohol.15 The Australian Bureau of Statistics Index of 
Relative Socioeconomic Advantage and Disadvantage was 
derived from the participants’ area of residence, as an 
indicator of socioeconomic status.16
Outcome measures
Our primary outcome measure was any hospital admis-
sion, planned or unplanned, to the University Hospital 
Geelong (UHG) during the follow-up period; women 
(median follow-up of 7.1 years, IQR 5.7–8.5) and men 
(median follow-up of 8.3 years, IQR 5.6–11.0). Secondary 
outcomes included admission rate based on the total 
number of hospital admissions over the follow-up period 
and length of admission in days, calculated from the 
admission and discharge dates, considering each admis-
sion as a separate occasion. Baseline data were linked to 
the admissions data using unique identification codes 
used by the hospital, referred to as Unit Record numbers.
The UHG is the largest public hospital and the sole 
health service in the study region classified as a ‘principal 
referral hospital’ according to the Australian hospitals 
peer-group classification.17 It has 370 inpatient beds, 24 
intensive care unit beds and had the only 24 hours Emer-
gency Department in the region during the study period. 
It provides a full spectrum of care, including community 
care, aged care, rehabilitation, mental health, emergency 
and acute care.18
Primary reasons for hospital admission
Australian hospitals use an alphanumeric coding system 
for diseases and external causes of injury, referred to as 
the 10th revision of the International Classification of 
Diseases, Australian Modification (ICD-10).19 It comprises 
three, four and five character categories, structured by 
body system and aetiology and is updated regularly.19 
We classified primary diagnoses into broad categories 
by aggregating individual disease codes, for instance, 
primary ICD-10 diagnoses codes of I21.0 ‘acute trans-
mural myocardial infarction (MI) of anterior wall’, I21.1 
‘acute transmural MI of inferior wall’ and I21.4 ‘acute 
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subendocardial MI’ were combined as a single category 
of I21 ‘acute MI’.
Deaths
All deaths during the follow-up period were confirmed 
using the National Death Index, a national register main-
tained by the AIHW containing records of all deaths 
registered in Australia since 1980.20 To identify deaths, a 
combination of surname, first and second given names, 
address, date of birth and date of last contact with the 
study were used.
Potential confounders
The risk of hospital admission in diabetes is reported 
to vary by age,4 sex,4 9 unhealthy weight,21 cigarette 
smoking,22 physical inactivity22 and socioeconomic depri-
vation.23 In addition, high alcohol use may cause difficul-
ties in management of diabetes, resulting in early onset 
of complications.23 Hence, we included these potential 
confounders in our analyses to investigate the relationship 
between glycaemic status and hospitalisation outcomes. 
Furthermore, due to previously reported differences in 
hospitalisation patterns between men and women with 
diabetes,4 9 we stratified our cohort by sex, in addition to 
reporting findings for the overall sample.
statistical analysis
We used t-tests for continuous data and χ2 tests for cate-
gorical data to compare baseline characteristics of partici-
pants in different glycaemic categories (normoglycaemia, 
IFG and diabetes).
For the analysis of association between glycaemic status 
and the incidence of all-cause hospital admission, χ2 test 
followed by incidence difference (ie, risk difference) and 
95% CIs have been reported for examining bivariate asso-
ciation (ie, the outcome and glycaemic status as exposure 
of interest). A set of trivariate analyses (ie, the outcome 
and glycaemic status as exposure of interest and one poten-
tial confounder) was performed to examine the impact of 
each potential risk factor above and beyond the glycaemic 
category association with the study outcomes. We used 
(1) trivariate logistic regressions for admission incidence,
(2) trivariate Poisson regressions for admission rate and
(3) two-way analyses of variance (ANOVAs) on rank of
admission length. ORs, risk ratios and partial eta-squared
effect size were used to illustrate the impact of poten-
tial risk factors, respectively. Partial eta-squared values
of 0.009, 0.0588 and 0.1379 were considered as bench-
marks for small, medium and large effect sizes, respec-
tively.24 Multivariate logistic regression was performed
to evaluate the association of admission incidence and
glycaemic status after adjusting for potential confounders
that were significant at 0.1 level in trivariate analyses and
two-way interactions of confounders and glycaemic status;
model-adjusted OR and 95% CI are reported. Admis-
sion rate was calculated as frequency of hospitalisation
divided by total person-years of follow-up for normo-
glycaemia, IFG and diabetes groups. χ2 test followed by
incidence rate ratio (IRR) and its 95% CI were illustrated 
for examining bivariate associations. Poisson regression 
with glycaemic status as factor and the frequency as the 
outcome and total person-years of follow-up as the offset 
was implemented for multivariate analysis. All potential 
confounders that were significant at 0.1 from the Poisson 
trivariate analyses were included in the primary multivar-
iate Poisson regression model. Sensitivity of the Poisson 
models against any deviations from model assumptions, 
including zero inflation was examined by implementing 
negative binomial regression models.
Medians and IQRs of admission length were reported 
in the three groups. In order to deal with positively 
skewed nature of admission length and possible outliers, 
a non-parametric median-based regression based on 
L1-norm estimation25 26 was performed as multivariate 
model. Simultaneous quantile regression on median, 
third quartile and ninth decile using bootstrapping tech-
nique for estimating SEs27 was used to analyse the rela-
tionship between glycaemic status and upper quartile 
and last decile of admission length. Similarly, all poten-
tial confounders that were significant at 0.1 from the 
two-way ranked ANOVAs were included in the primary 
multivariate linear regression model. Backward variable 
selection approach with P-entry=0.1 and P-exit=0.05 was 
implemented to all multivariate models obtain the final 
models.
Statistical analyses were conducted using Stata soft-
ware V.14 and Minitab statistical software package (V.17; 
Minitab, State College, Pennsylvania, USA).
results
Table 1 shows baseline characteristics of participants 
by glycaemic status. In men, 615 (63.3%) had normo-
glycaemia, 275 (28.3%) had IFG and 81 (8.3%) had 
diabetes. In women, 694 (75.1%) had normoglycaemia, 
159 (17.2%) had IFG and 71 (7.6%) had diabetes.
For both men and women, those with diabetes were 
older and had higher body mass index (BMI) as compared 
with normoglycaemia group. Women with diabetes were 
more likely to have ‘low mobility’ at baseline as compared 
with those with normoglycaemia. Participants with 
normoglycaemia, IFG and diabetes did not differ signifi-
cantly at baseline in terms of current smoking status and 
socioeconomic status.
Incidence of all-cause hospital admission (admission 
incidence)
Bivariate analyses showed that men with IFG had 10% 
more admission incidence (risk difference 0.10, 95% CI 
0.02 to 0.17, P=0.006) and men with diabetes had almost 
40% more admission incidence (risk difference 0.28, 
95% CI 0.17 to 0.39, P<0.001), compared with men with 
normoglycaemia.
Similarly, women with IFG and diabetes were also more 
likely to be admitted as compared with normoglycaemia 
(risk difference 0.10, 95% CI 0.01 to 0.18, P=0.024) and 
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(risk difference 0.28, 95% CI 0.16 to 0.39, P<0.001), 
respectively.
After accounting for glycaemic category through trivar-
iate analyses for both men and women in the study, older 
age and lower socioeconomic status were associated with 
increased admission incidence (table 2). In addition, a 
higher BMI in men and low mobility in women were asso-
ciated with increased admission incidence after adjusting 
for glycaemic category (table 2).
A significant age–sex interaction was observed and, 
therefore, included in the multivariate models (OR 1.3, 
95% CI 1.0 to 1.6, P=0.04). After adjustments for age, 
sex and socioeconomic status, participants with diabetes 
were twice likely to be hospitalised for any cause, as 
compared with normoglycaemia (OR 2.0, 95% CI 1.4 to 
3.0, P<0.001). Having IFG at baseline was not significantly 
associated with admission incidence (OR 1.1, 95% CI 0.8 
to 1.4, P=0.38).
Admission rate
Overall, 50.6% of the participants with diabetes were 
admitted more than once over the follow-up period, 
compared with 30.8% and 22.0% of those with IFG and 
normoglycaemia, respectively. In men, admission rate was 
0.43 per person per year for those with diabetes (95% CI 
0.32 to 0.57), 0.21 per person per year in IFG (95% CI 
0.17 to 0.27) and 0.19 per person per year in those with 
normoglycaemia (95% CI 0.15 to 0.23). Admission rate 
was 0.50 per person per year for women with diabetes 
(95% CI 0.30 to 0.84), 0.24 per person per year for those 
with IFG (95% CI 0.18 to 0.31) and 0.16 per person per 
year in those with normoglycaemia (95% CI 0.14 to 0.19). 
In men, older age, BMI, high alcohol use, low mobility 
and low socioeconomic status were associated with higher 
admission rate (table 2). In women, older age, high 
alcohol use and low mobility were associated with higher 
admission rate (table 2).










Age (years) 56.9 (28.0–84.0) 52.0 (24.0–80.0) 62.0 (40.0–84.0) 67.0 (53.0–81.0) <0.001
BMI 26.9 (21.9–31.9) 26.3 (21.6–31.0) 28.0 (23.1–32.9) 28.6 (24.3–32.9) <0.001
Current smoking 141 (14.5) 98 (15.9) 33 (12.0) 10 (12.3) 0.25
High alcohol use 233 (23.9) 138 (22.4) 82 (29.8) 13 (16.0) 0.008
Low mobility 292 (30.0) 180 (29.2) 85 (30.9) 27 (33.3) 0.7
IRSAD
 1 166 (17.0) 96 (15.6) 49 9 (17.8) 21 (25.9) 0.39
 2 204 (21.0) 126 (20.4) 59 (21.4) 19 (23.4)
 3 189 (19.4) 126 (20.4) 52 (18.9) 11 (13.5)
 4 201 (20.7) 131 (21.3) 58 (21.0) 12 (14.8)
 5 211 (21.7) 136 (22.1) 57 (20.7) 18 (22.2)










Age (years) 53.0 (25.0–81.0) 49.0 (20.0–78.0) 63.0 (41.0–85.0) 66.0 (46.0–86.0) <0.001
BMI 26.3 (19.1–33.5) 25.6 (19.3–31.9) 29.5 (22.3–36.7) 31.5 (21.4–41.6) <0.001
Current smoking 109 (11.7) 83 (11.9) 21 (13.2) 5 (7.0) 0.44
High alcohol use 55 (5.9) 45 (6.4) 9 (5.6) 1 (1.4) 0.24
Low mobility 202 (22.0) 121 (17.5) 48 (30.3) 33 (48.5) <0.001
IRSAD
 1 150 (16.2) 97 (13.9) 37 (23.2) 16 (22.5) 0.41
 2 186 (20.1) 145 (20.8) 30 (18.8) 11 (15.4)
 3 213 (23.0) 162 (23.3) 33 (20.7) 18 (25.3)
 4 187 (20.2) 141 (20.3) 32 (20.1) 14 (19.7)
 5 188 (20.3) 149 (21.4) 27 (16.9) 12 (16.9)
Person-years of follow-up 6434.1 4843.1 1104.4 486.6
Data presented as median (IQR) or n (%). Significant p values (p<0.05) are shown in bold. 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the final multivariate model, admission rate was 
significantly higher in the diabetes group, as compared 
with normoglycaemia (IRR 1.6, 95% CI 1.1 to 2.2, 
P<0.05). The IFG group was not significantly different 
from normoglycaemia in terms of admission rate (IRR 
0.9, 95% CI 0.7 to 1.1, P=0.67).
Admission length (days)
The effect sizes of individual baseline characteristics on 
admission length based on two-way ranked ANOVA are 
illustrated in table 2. For men, older age, higher BMI and 
lower socioeconomic status were associated with increased 
admission length (table 2). Older age had a large effect 
on admission length, while high BMI and low socioeco-
nomic status had medium and small effects, respectively 
(partial eta squared=0.160, 0.011 and 0.007) (table 2).
Median regression analysis did not show a difference 
between the glycaemic categories in terms of median 
admission length (table 3). In additional analysis, third 
quartile and ninth decile comparison was performed 
showing that having diabetes at baseline was associated 
with an increased admission length (third quartile differ-
ence 7.7, 95% CI 1.3 to 14.1, P=0.01) and (ninth decile 
difference 16.2, 95% CI 4.2 to 28.3, P=0.008) in patients 
with longer than median admission length. Hence, in 
participants who spent longer than the median admission 
length in the hospital, having diabetes was associated with 
longer hospital stay.
Primary reasons for hospital admission
Figures 1 and 2 show the 10 most common primary 
reasons for hospitalisation by glycaemic category for men 
and women in the study, respectively.
Among men with diabetes, the most commonly encoun-
tered diagnosis was ‘angina pectoris’, with 20.0% of the 
group having at least one hospitalisation primarily for the 
condition. It was followed by ‘type 2 diabetes mellitus’ 
(14.5%). ‘Pain in throat and chest’ was the most common 
reason for hospitalisation for men in the IFG (14.6%) 
and normoglycaemia (9.8%) groups.
In women with diabetes, ‘type 2 diabetes mellitus’ 
was the most commonly documented primary reason 
for hospitalisation (12.5%), followed by ‘heart failure’ 
(10.4%). For the IFG and normoglycaemia groups, ‘pain 
in throat and chest’ was the most common reason for 
hospitalisation, 11.4% and 11.6%, respectively.
DIsCussIOn
This study reports that, compared with normoglycaemia, 
having diabetes is associated with a higher incidence, rate 
and length of hospital admission. During the follow-up, 
68.0% of participants with diabetes had at least one hospital 
admission as compared with 50.0% with IFG and 40.0% 
with normoglycaemia. The incidence of hospital admis-
sion was two times in those with diabetes as compared with 
normoglycaemia. Previous studies reporting admission 
incidence have varied depending on the study population 
and duration of follow-up. Only one study in the literature 
has examined hospitalisations in the Australian popula-
tion with diabetes.28 The study followed individuals aged 
45 years and over, with and without diabetes, for a year, 
reporting that 32.8% of participants with diabetes had 
one or more hospitalisations as compared with 24.2% of 
those with normoglycaemia.28 Similar studies have been 
performed in other countries, for example, a New Zealand 
study conducted over a 3-year period reported an all-cause 
hospitalisation rate of 43.5% in those with diabetes.29 An 
Italian study showed an even higher proportion of partic-
ipants with diabetes (55.0%) being hospitalised at least 
once over a 4.5-year follow-up.7
There are a number of factors which could explain 
the higher risk of hospitalisation in people with diabetes. 
Comorbid coronary heart disease, stroke, depression, 
musculoskeletal disease and cancer are common in 
people with diabetes and can increase the risk of hospi-
talisation.30 31 In addition, diabetes shares common risk 
factors with other chronic diseases (particularly cardio-
vascular disease) such as obesity, physical inactivity and 
unhealthy diet. In our study, half of the 10 most common 
primary reasons for hospitalisation in participants with 
diabetes were related to complications and/or diagnoses 
related to cardiovascular disease. This is consistent with 
studies showing that a significant proportion of morbidity 
and mortality associated with diabetes is due to cardio-
vascular disease.10 Some recent studies have reported a 
decline in incident cardiovascular disease in people with 
diabetes; however, the risk is still double that of those with 
normoglycaemia.32
In our sample, older age was independently associ-
ated with both having diabetes and the risk of hospital-
isation. Elderly patients with diabetes often present with 
multiple and advanced complications and are more likely 
to be readmitted and spend longer in hospital beds as 
compared with younger counterparts.33
Other factors predisposing people with diabetes to 
hospitalisation are related to disease management that 
involves maintaining a balance between lowering blood 
glucose levels and preventing hypoglycaemic events. One 
of the goals of management is achieving tight glycaemic 
control (FPG <6 mmol/L), while this has been shown to 
reduce microvascular complications, it may simultane-
ously increase the incidence of hypoglycaemic events.6 
Therefore, the benefits of obtaining optimum blood 
glucose levels have to be weighed against the risk of severe 
hypoglycaemic episodes that could result in frequent 
Emergency Department visits and hospital admissions.34 
Furthermore, optimal diabetes care requires active 
involvement by the patients and their ability to navigate 
the health system, hence, health literacy plays a key role. 
Health outcomes are poorer in population subgroups 
with diabetes having low health literacy levels such as 
migrants from non-English-speaking backgrounds and 
indigenous people.35 36
In our study, 14.5% of men and 12.5% of women with 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































or complication related to diabetes mellitus. Other studies 
have reported higher proportions of diabetes-related 
hospitalisations in the group with diabetes ranging from 
18.8% to 33.0% per year.6 9 28 29 This could be explained by 
the fact that our sample was derived from general popula-
tion which may be healthier than clinical samples used in 
other studies. It might also be a ‘healthy participant bias’ 
where individuals with less severe disease agree to partic-
ipate in research resulting in an underestimation of the 
outcome. It could also have resulted from not being able 
to capture admissions to private hospitals and smaller 
hospitals in the study region. Furthermore, definitions of 
diabetes-related hospitalisations are inconsistent between 
countries and thus, comparisons need to be made 
cautiously. In Australia, diabetes coding standards have 
changed significantly over the last decade making it prob-
lematic to compare diabetes-related hospitalisation rates 
over time.4 Nonetheless, our results highlight an opportu-
nity to devise interventions aimed specifically at reducing 
or delaying complications in those with diabetes. Previous 
evidence suggests that microvascular complications can 
be reduced by up to 50%–60% and macrovascular compli-
cations by 40%–45% with improved outpatient manage-
ment.9 The Diabetes Control and Complications Trial 
demonstrated that intensive diabetes treatment delayed 
the onset of complications in adolescents and young 
adults with type 1 diabetes mellitus.34 The trial concluded 
that intensive therapy aimed at achieving non-diabetic 
glucose levels slowed the progression of diabetic reti-
nopathy, nephropathy and neuropathy.34 Similarly, the 
United Kingdom Prospective Diabetes Study showed a 
substantial decrease in microvascular complications of 
type 2 diabetes through intensive blood glucose control37 
and Steno study showed reduced rates of cardiovascu-
lar-related mortality with multifactorial intervention.38
We did not detect an association between IFG and the 
incidence, rate and length of hospital admission. To our 
knowledge, this is the first study to investigate the relation-
ship between IFG and hospitalisation, thus, comparable 
data are not available. Studies have reported a moderate 
increase in the risk of cardiovascular disease in the ‘predi-
abetes’ group as compared with normoglycaemia, which 
increases significantly once diabetes develops.39 Current 
rates of IFG-to-diabetes progression are alarmingly high, 
with studies reporting development of diabetes in up to 
two-thirds of individuals with prediabetes.39 The authors 
of this study have previously reported that approximately 
one-third of Australian women have IFG, with a sixfold 
higher risk of progressing to diabetes over a decade 
if FPG ≥6.1 mmol/L.11 The greatest reductions in the 
occurrence of diabetes have been achieved through 
intensive lifestyle interventions for weight loss (5%–10% 
of body weight), dietary modification and physical activity 
(~30 min/day).39 Pharmacological therapy such as 
metformin has also shown some promise, particularly in 
the younger and obese individuals.40 Our findings show 
that the incidence of hospital admission multiplies as IFG 

























































































































































































































































































































































































































































































































































health campaigns, could help reduce progression in the 
population.
This study has a number of distinct advantages over 
previous studies that have explored the relationship 
between diabetes and hospital admissions. Our sample 
comprised randomly selected community-dwelling adults 
living in a well-defined area. Previous studies have used 
self-report,28 hospital admissions data,9 29 41 general practice 
registers6 42 or data from diabetes clinics7 to identify individ-
uals with diabetes. We used a more robust method for iden-
tifying diabetes using a combination of FPG measurement, 
self-report and/or use of antihyperglycaemic medication. 
Through this approach, we were able to identify individ-
uals with dysglycaemia, even in the absence of fully devel-
oped diabetes. Furthermore, we followed participants for 
hospital admissions over a longer period as compared with 
previous studies.28 29 Finally, we used unique identifiers to 
capture hospital admissions and mortality data, hence, we 
were able to obtain this information even if we lost contact 
with participants over the study period. Our study has some 
limitations. First, we obtained linked hospital admissions 
data from one major public hospital in the study region. 
It is possible that some of our participants were admitted 
to a private hospital or a smaller hospital. We consider this 
Figure 1 Primary reasons for hospital admission by glycaemic category (percentage of men).
Figure 2 Primary reasons for hospital admission by glycaemic category (percentage of women).
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unlikely as UHG is the only major tertiary hospital in the 
study area and our sample was derived from a region in the 
immediate vicinity of the hospital. Second, although our 
study region (BSD) is considered to have a stable popula-
tion, it is still possible that some of the participants might 
have moved intercity or interstate during the follow-up 
period. Furthermore, the results from our study, which 
included mainly Caucasian individuals, may not be general-
isable to other populations. Finally, we did not differentiate 
between the types of diabetes at baseline and are, therefore, 
unable to comment on the proportion of different types of 
diabetes in our sample.
COnClusIOn
Our study confirms existing evidence showing higher 
incidence, rate and length of hospital admissions in indi-
viduals with diabetes mellitus. Further research should 
focus on identifying individual risk factors for hospital-
isation in dysglycaemia. Strategies to reduce the need 
for hospitalisation should include preventing the disease 
itself (primary prevention), early diagnosis and treat-
ment (secondary prevention) and preventing compli-
cations (tertiary prevention). Finally, adverse outcomes 
related with diabetes including hospital admissions could 
be reduced by preventing the progression from IFG to 
diabetes. We recommend screening for IFG in the popu-
lation combined with targeted interventions to prevent 
diabetes in high-risk individuals.
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Optimal primary care management of diabetes should reduce the risk of acute health service 
use. We aimed to assess primary care management of diabetes in a sample of inpatients with 
a preventable long-term complication (foot ulcers), and to highlight their perspectives of key 
enabling and impeding factors for optimal care.
Study design and setting 
A mixed-methods, cross-sectional, exploratory study at University Hospital Geelong, a 
tertiary public hospital in Victoria, Australia.
Participants
A purposive sample of 31 admitted adults with diabetes-related foot ulcers.
Methods
Survey questionnaires and content analysis of semi-structured interviews. 
Results
Participants were predominantly Australian-born, older adults (age, mean ± SD 64.9 ± 15.4 
years); 26 (83.8%) had type 2 diabetes; duration since diagnosis of diabetes mean ± SD was 
20 ±13.4 years. We identified shortfalls in primary care management of diabetes. Major 
themes highlighted perceived enabling factors: supportive health professionals, peer and 
social support, established routines and access to information; impeding factors: delayed or 
incorrect diagnosis, ineffective communication, lack of access to ongoing diabetes education, 
impact of diabetes on social interaction, fear of complications and lack of patient involvement 




Our study provides new insights into the lived experiences of individuals with diabetes, 
hospitalised with a preventable complication. Future research could utilise our findings to 
identify individual determinants of acute health service use in those with diabetes.  




Diabetes mellitus is a leading cause of mortality and ill health globally [1, 2]. Suboptimal 
management increases the risk of short- and long-term complications, often requiring 
hospitalisation [3, 4]. Diabetes-related foot disease (DRFD) results from long-term effects of 
peripheral neuropathy and peripheral vascular disease, often requires surgical amputation [5] 
and gives rise to significant disability associated costs [6]. Currently, an estimated 50,000 
Australians are living with DRFD and ~27,600 are hospitalised for it every year [7]. Along 
with other diabetes complications, DRFD contributes substantially to potentially preventable 
hospitalisations, where optimal outpatient management could significantly reduce hospital 
admissions [3, 7].  
Previous studies indicate that many individuals with diabetes do not meet recommendations 
for appropriate care. For instance, the Australian CareTrack study showed that ‘appropriate 
care’, defined as ‘care in line with evidence-based or consensus-based guidelines’, was 
provided in only 37% of individuals with diabetes [8]. The Australian Institute of Health and 
Welfare reported that during 2009–2010, less than one-fifth of individuals with diabetes had 
completed an ‘annual cycle of care’, a set of recommendations for diabetes management [9]. 
Despite such low uptake of recommended care, to date few Australian studies have explored 
the perspectives of people with diabetes, therefore, the aim of the current study was to identify 
perceived enabling and impeding factors for optimal diabetes management in primary care.
Methods
Study design and sample 
This mixed-methods, cross-sectional study was conducted at University Hospital Geelong, 
which is the largest public hospital with a nationally accredited Diabetes Centre in western 
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Victoria, Australia [10]. During the period July 2017 to April 2018, we invited all inpatients 
with diabetes-related foot ulcers to participate in the study, excluding those in the Intensive 
Care Unit and psychiatric wards. Of the 34 invited, three refused participation because they 
were ‘not comfortable’ or ‘not interested’. All participants provided informed consent. Survey 
questionnaires were completed by all participants, followed by semi-structured interviews with 
30 participants. One person who had completed the survey was not interviewed because the 
diagnosis of diabetes was made during the current admission. 
Data collection procedures 
Detailed questionnaires were administered, with questions seeking information on:
•  Demographics, including age, sex, marital status, education, employment, country of
birth and Indigenous status.
•  Diabetes status, type and time since diagnosis, anti-hyperglycaemic medication use and
comorbid conditions. Type of diabetes was also confirmed through medical records
(100% match with self-report).
•  Diabetes management, including health professionals consulted, general practice
management plan for diabetes (GPMP) [11], knowledge of and testing for glycosylated
haemoglobin (HbA1c), frequency of complications surveillance, membership and use
of the National Diabetes Services Scheme (NDSS) [12], a national support scheme
providing subsidised diabetes-related supplies. The questions in this section were
derived from the guidelines of The Royal Australasian College of General Practitioners
for management of diabetes [13].
Semi-structured interviews 
These were undertaken to seek patients’ perspectives of enabling and impeding factors to 
optimal management of diabetes in primary care. We conducted two ‘pilot’ interviews using 
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broad-based, open-ended questions to generate prompts that guided the remaining interviews. 
The interviews sought participants’ views on, 1) accounts of diagnosis, 2) impact of diabetes 
on life, 3) enabling and 4) impeding factors for optimal diabetes management, 5) health 
professional support, 6) adherence to medication, 7) social support, 8) diabetes-related stressors 
and 8) affordability of diabetes care. Bedside interviews were conducted during hospitalisation, 
thus it was not possible to record them. I (MAS) conducted the interviews, which lasted 30–45 
minutes each. In view of participant comfort and time constraints, responses were recorded 
verbatim or condensed into meaningful shorter phrases by the interviewer. At the end of each 
interview, the participants were shown the notes or they were read out to them to make sure 
they represented their views accurately. The handwritten transcriptions and notes were keyed 
into a MS Excel spreadsheet for analysis. The interviews were continued until no new 
information emerged and thematic saturation was attained [14]. 
Survey data analysis
Statistical measures of frequencies, central tendency and variability were used to summarise 
the demographic characteristics of the sample. 
Qualitative content analysis 
Content analysis was used to analyse and interpret the interview data. Using Graneheim and 
Lundman’s (2004) protocol [15], we recorded participants’ responses as the unit of analysis, 
condensed them into ‘meaning units’ expressed as codes, followed by ‘abstraction’ or grouping 
together under higher-order headings, which resulted in categories (groups of content that 









Table 1 shows key socio-demographic characteristics of the 19 men and 12 women in the study. 
The majority of study participants was born in Australia (n=24). None of the participants 
identified as Aboriginal or Torres Strait Islander. Of 31 participants, 20 had completed high 
school or higher education. Eighty per cent were retirees or unemployed, of whom five were 
out of work because of a diabetes complication.  
Age and self-reported method and time since diagnosis of diabetes
Mean ± SD age at diagnosis for the sample was 44.9 ± 17.2 years: type 1 diabetes 27.5 ± 15.5 
years and type 2 diabetes 49.1 ± 15.1 years. Of the 31 participants, one-third recalled that they 
had experienced physical symptoms that led to a diagnosis of diabetes; 11 (35.4%) reported 
that the diagnosis had occurred during routine testing for other conditions and 6 (19.3%) had 
been diagnosed during hospital admission. Median duration since diagnosis of diabetes for the 
sample was 20 years (IQR 2.0–38.0): type 1 diabetes (20.5 years, IQR 7.0–34.0) and type 2 




The majority of participants (n=24) were using oral anti-hyperglycaemic agents, insulin or a 
combination of both to manage blood glucose. Approximately 13% (4) managed their blood 
glucose using diet and exercise.
General Practice Management Plan for Diabetes 
Half of the sample did not have either a GPMP or knowledge about the service.  
Knowledge and testing for HbA1c 
The majority of participants (66.6%) recalled having an HbA1c test in the previous year. Six 
participants did not have knowledge of HbA1c. 
Complications surveillance 
The proportions of participants reporting recommended surveillance for complications were as 
follows: eye check-up with retinal examination in the previous 12 months – 21 (70.0%), feet 
examination by a health professional – 24 (80.0%), lipid testing – 26 (86.6%), urinary protein 
testing – 21 (70.0%), kidney function testing – 27 (90.0%), body weight measurement – 25 
(83.3%) and regular blood pressure testing – 31 (100.0%). 
Health professional visits for diabetes management 
All of the participants reported visiting their General Practitioner or specialist for diabetes 
management in the previous year. Eighteen participants (60.0%) reported having visited a 
diabetes educator, 9 (30.0%) had seen a dietitian and 21 (70.0%) had consulted a podiatrist.  
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National Diabetes Services Scheme membership 
The majority of the participants (n=26, 86.9%) had knowledge of the NDSS and 77.4% held 
membership and regularly used the service, primarily to buy blood glucose management 
supplies such as insulin syringes and blood glucose measuring strips.
Prevalence of comorbid conditions  
Out-of-range (high) lipids were reported by 20 (64.5%) participants, high blood pressure by 23 
(74.2%), retinopathy by 11 (35.5%), nephropathy or reduced kidney function by 11 (35.5%), 
heart condition by 15 (48.4%) and previous stroke by 5 (16.1%) of participants. 
To summarise, none of the participants in our study had completed all components of the 
annual cycle of care for diabetes in the previous year. Specifically, recommended care was not 
achieved in terms of HbA1c testing (33.3%), eye check-up (30%), urinary proteins testing 
(30%) and professional dietary advice (30%). The components of blood pressure testing, 
medication review, kidney function and lipid testing showed good adherence. All participants 
regularly visited their General Practitioner or specialist for diabetes management; however, 
70% had not seen a dietitian and 40% had not visited a diabetes educator in the previous year. 
Half of the participants did not recall having a diabetes management plan with their General 
Practitioner.  
Results (interviews)
Thirty participants were interviewed. Major themes/subthemes emerging from the interviews 
are summarised in Table 2 and important enabling and impeding factors for optimal diabetes 
are listed here.
Participants identified the following key enabling factors:
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Supportive health professional 
Participants defined the ‘supportive’ role of primary care provider as ‘feeling understood by 
the GP’ and ‘My GP is honest, doesn’t waste time, I get a quick referral if I have a problem 
and I trust him’. Some recalled ‘struggling with obtaining optimal blood glucose levels’ and 
acknowledged the help of a diabetes educator. 
Peer support 
‘Learning from the experiences of others with diabetes’ or ‘talking to other people with 
diabetes’ was considered helpful. They acknowledged the significance of peer support in 
‘reducing the anxiety’, ‘gaining a better understanding of the disease’ and ‘learning about the 
new research and technology [related to diabetes]’.  
Lifestyle changes
Eleven participants reported that lifestyle changes, particularly dietary modifications, helped 
them manage their blood glucose effectively. Participants identified skills such as ‘learning to 
cook from an early age’ as having helped them become ‘self-reliant’ and keeping their ‘eating 
out under control’. Being physically active to ‘maintain a healthy weight’ was also considered 
helpful. 
Adherence to medication 
Participants identified ‘following a set daily routine’ as being helpful in adherence to 
medication:
‘I have a set routine in the morning that helps me take my medicine regularly: take milk, 
take meds, turn on toaster; same routine every day. That’s why I don’t forget.’ 
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Another participant highlighted that a ‘stable blood glucose level’ helped with following 
medication advice:
‘I have been lucky enough to be stable. If it [blood glucose level] stays stable, it helps 
[with medication] because you take fixed doses.’  
Social support 
In some cases, the perceived social support meant that they had delegated aspects of diabetes 
management such as medication intake to family members:
‘My son lives with me and does all the medication, and everything’ or ‘my daughter 
takes care of all my needs, including diabetes’.
In other instances, participants felt ‘supported’ when family and friends made efforts to include 
them in social activities so that they ‘didn’t feel left out’. 
Other enabling factors 
Other enablers of optimal diabetes management included ‘availability of diabetes-related 
information’ and ‘having family members with diabetes’. 
Study participants highlighted the following impeding factors:
Delayed/incorrect diagnosis 
Some participants recalled delays in their diagnosis:
‘I think I was undiagnosed for about a year where I was having symptoms like being 
tired, losing weight, fever and then went to GP a couple of times, who thought it was a 




Another participant recalled misclassification of diabetes at diagnosis:  
‘I was not diagnosed properly even though I was in the hospital. I was put on oral tablets 
even though I needed insulin. I was on them for almost four years before they got it 
right and put me on insulin.’
Communication from health professionals 
Several problem areas related to health professionals’ communication were highlighted: 
‘Sometimes doctors use technical language and patient is getting confused, they should 
explain everything to the patient and also encourage questioning.’ 
Participants suggested ways to ensure simple and effective communication:
‘I would advise them [health professionals] to keep it simple, don’t make it too 
complicated for people to understand what they need to do [for diabetes].’ 
Some participants felt that detailed information on potential complications would help people 
with diabetes to be more vigilant: 
‘I find that when I was diagnosed, I was told diabetes can affect kidneys, heart etc. but 
it was not explained to me how it all happens. I understand there is a fine line between 
creating panic and being more aggressive about it. Maybe I could have tested more 
frequently.’ 
Lack of diabetes-related education/awareness
The need for ongoing education and information related to diabetes was widely expressed. 
Perceived lack of diabetes education/awareness applied to individuals with diabetes, health 
professionals, friends/family and the public:  
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‘GPs should have better knowledge, not just basic knowledge about diabetes. There 
should be GPs with specialist diabetes qualifications.’
Another participant suggested improving diabetes education among family members of those 
with diabetes:
‘They [family members] are not aware of the disease. It would help to educate them 
about it [diabetes], like they don't understand what hypo means, does it mean your sugar 
is high or low?’ 
While some participants acknowledged ‘better availability of diabetes-related information’ 
over time, others expressed the need for increased role of media to create diabetes awareness: 
‘It helps when you have more people on TV with diabetes, it helps in creating the 
awareness’ and ‘There needs to be more education, more ads on TV. You see too many 
ads for smoking but not many for diabetes.’ 
Limitations on family/social life
Eight participants highlighted the impact of diabetes on family or social life. Some expressed 
frustration over not being able to spend more time outdoors with family: 
‘I can’t do as much as a normal mother would do for children and house; for example, 
I can't go on excursions with my kids [due to diabetes].’ 
In some cases, limitations on social interaction resulted from reduced mobility:
‘The only thing is because of foot ulcers I can’t move easily or go places. That is why 
I have lost touch with many friends.’ 
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Another participant reported avoiding social gatherings for the fear of being ‘treated 
differently’. Some other ways in which having diabetes affected participants’ lives included 
‘not being as free’, not being able to maintain employment and inability to perform everyday
chores or physically demanding tasks. Eight participants stated that diabetes had ‘no impact’ 
on their lives. 
Lack of patients’ involvement in clinical decision-making 
Participants stressed that physicians should encourage their involvement in clinical decision-
making. The decision to stop or add a medication or modify treatment regimen should be done 
in consultation with patients: 
‘I would say that if they are changing your meds or starting a new one, they should 
explain in plain simple words what the patient needs to do and why.’ 
Another participant appreciated the option given by her physician to determine her insulin dose:
‘Making my own decision about how much insulin to use [has helped]. Before, the 
doctors were strict but now they give me a range [of insulin units] to make my own 
decision based on what I eat.’ 
Cost of diabetes care 
A majority (n=24, 80.0%) of participants acknowledged the support they obtained from the 
government in the form of universal insurance (Medicare) and diabetes support services 
(NDSS); however, some identified ‘cost of care’ as a concern: 
‘The NDSS helps but I still have to pay eight dollars for [glucose] strips box that I go 
through in a week and a hundred dollars roughly on medicine per month. It gets stressful 
when there is a huge energy bill or car registration but mostly it has not been that bad.’
Another participant cited the cost of comorbid conditions associated with diabetes: 
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‘Diabetes care is not that expensive itself but the conditions related to it, for example,
heart conditions are expensive to manage, especially the medicines.’
Other impeding factors.  Some participants expressed self-blame, regret and guilt for having a 
diabetes complication:
‘I am here mostly due to my own fault. I don’t think I followed the advice’. 
A participant reported facing discrimination at work and that employers failed to understand 
his limitations because of diabetes:
‘I have faced discrimination from bosses at work before. They [employers] don’t 
understand that with diabetes, things take longer to get better. If you have a flu or even 
a small cut, you can take sick leave often. I had to resign from previous job because of 
this.’ ‘Easy availability of unhealthy foods’ and ‘complicated food labelling’ were also 
considered problematic. 
Discussion
To our knowledge, this is the first Australian study to use a mixed-methods approach to 
highlight the perspective of inpatients with a known complication of diabetes (DRFD) to 
identify enabling and impeding factors to optimal diabetes management in primary care. In this 
predominantly Australian-born sample of older adults, the ratio of participants with type 2 and 
type 1 diabetes was 5:1. Participants with type 2 diabetes were older, but duration since 
diagnosis was comparable between the two groups. Approximately two-thirds of the sample 
had coexisting hypertension and dyslipidaemia, with high rates of treatment. We also found 
that many of the participants did not meet recommendations for optimal primary care for 
diabetes; self-perceived blood glucose control, knowledge and testing of HbA1c, health 
professional visits and surveillance for complications.  
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Six of the participants in our study (19.3%) had type 1 diabetes, which is disproportionately 
higher than its estimated prevalence of 9.2% in the Australian population with diabetes [12]. 
The only previous Australian study that reported the prevalence of DRFD included individuals 
with type 2 diabetes [16], thus its prevalence in those with type 1 diabetes remains unknown. 
A global systematic review reported that the prevalence of type 2 diabetes in DRFD is higher 
than Type 1 diabetes [17]. We are unable to comment whether the higher proportion of type 1 
diabetes in our sample reflects on the quality and adequacy of its management in the 
community; however, it would be pertinent to explore this further. 
Our sample consisted largely of retirees, of whom one in five had taken early retirement due to 
a diabetes complication. In Australia, ~38% of the adults aged 45–64 years with diabetes are 
currently out of the workforce [18]. Individuals with diabetes are vulnerable to financial 
hardship due to the impact of diabetes on their ability to work. An Australian study reported 
that people with diabetes who were out of the workforce were more likely to face poverty, 
compared to those with other chronic conditions [19]. Reduced productivity, absenteeism, early 
retirement and premature mortality contribute substantially to the indirect costs associated with 
diabetes [18].  
Over half of the hospitalised patients with diabetes-related foot ulcers in our study were also 
using medication for three or more comorbid chronic conditions. Hypertension, dyslipidaemia 
and cardiovascular disease were the most common coexisting chronic conditions. Presence of 
comorbid conditions increases the likelihood of hospitalisation and the cost of management in 
people with diabetes [20]. One in five participants in our study did not have an understanding 
of HbA1c testing. The role of intensive glycaemic control and long-term blood glucose testing 
is vital in preventing hospitalisation in diabetes [21]. Similarly low HbA1c testing rates have 
been shown in other studies; for instance, 24% reported in a US study [8]. It was reported that 
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during 2011-2012, just over half of the adults with diabetes in Australia achieved the 
recommended HbA1c levels of less than 7% [22].  
We found that, although all of the study participants regularly visited their General Practitioner, 
40% had not seen a diabetes educator and 70% had not visited a dietitian in the previous year. 
Another Australian study of individuals hospitalised for diabetes reported similarly low rates 
of diabetes educator and/or dietitian consultations [23]. Healthcare in Australia is subsidised 
through a universal insurance scheme (Medicare), which for people with diabetes covers up to 
eight visits annually to allied health professionals (dietitians, diabetes educators, podiatrists) 
[24]. Although participants did not cite specific reasons for not using the available services, we 
suggest that inadequate health literacy could be an underlying barrier. Health literacy is an 
important determinant of diabetes knowledge, self-care, communication with health care 
providers, medication adherence, self-efficacy, achieving glucose control targets and delayed 
onset of complications [25]. Moreover, low health literacy is an independent risk factor for all-
cause hospital admission [26].  
Adequate access to and uptake of available health services are vital for improving health 
outcomes in chronic conditions [27]. In our sample, approximately 22% of participants did not 
have membership of the National Diabetes Services Scheme and half of our sample did not 
have a General Practice Management Plan (GPMP) for diabetes. Studies show that having a 
GPMP improves patient outcomes, including reductions in HbA1c levels, blood pressure, lipid 
levels and body weight [28]. The underlying reasons for the gaps in uptake of these primary 
care services need to be explored in more detail.   
Analysis of diagnosis accounts showed that in the majority of our study participants, the 
diagnosis was made coincidentally during routine testing or hospital admission for other 
conditions. Some participants cited missed diagnosis and delayed diagnosis as possible reasons 
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for developing diabetes complications. Early diabetes may have no obvious symptoms or signs, 
and may sometimes remain unrecognised until complications develop. Currently, there are an 
estimated 500,000 Australians with undiagnosed diabetes, which equals one undiagnosed case 
for every three diagnosed cases [29]. General Practitioners are usually the first point of contact 
with the health system in Australia and nearly 90% of the population visits their General 
Practitioners each year [8], therefore, improved primary care screening for diabetes would help 
identify those with undiagnosed diabetes.  
We found that individuals with diabetes identified having a supportive health professional as 
the most helpful factor for achieving their diabetes management goals. Participant responses 
affirmed previous findings that better communication and interpersonal care from primary care 
providers result in improved adherence to recommended guidelines [30]. Previous studies also 
report that physician communication and participatory decision-making improve health 
outcomes in many chronic conditions, including diabetes [31]. Participants in our study 
indicated that discussing management strategies with other people with diabetes (peer support) 
helped them manage their diabetes more effectively. This is confirmed by other studies that 
show face-to-face or online/telephonic interaction with other individuals with diabetes (peer 
educators and coaches) improves self-management skills and blood glucose management [32]. 
Similarly, improvements in diabetes management have been reported through patient 
empowerment programs that enable people with diabetes to take control of their health through 
consultative decision-making and improvements in self-care skills [33]. Another study showed 
that a structured education program with primary focus on patient empowerment reduces 
emergency department presentations and hospitalisations in diabetes [34]. Many of our study 
participants expressed the need to be involved in the decision-making regarding their diabetes 
management. Persons with diabetes who have good self-management skills usually have better 
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outcomes, such as reduced likelihood of hypoglycaemic episodes, infections, electrolyte 
disturbances and long-term complications [35].  
A majority of our participants acknowledged the role of social support in management of 
diabetes. Close family members are important partners in diabetes care. Our study affirms 
previous reports that diabetes may put limitations on social interaction [31]. Limitations on 
driving, travelling, diet and the need for regular self-injection restrict freedom of movement 
and contribute to the stigma associated with diabetes [36]. Finally, cost of care was generally 
not perceived as a barrier; however, it became significant in times of financial stress. 
The main strength of this study is that we used a mixed-methods approach to determine the 
extent to which diabetes care guidelines were adhered to, and to identify perceived enabling 
and impeding factors for optimal care. Our results provide a fresh insight into the primary care 
experiences of people with diabetes, hospitalised for a preventable complication. There were 
some limitations. This study highlights the perspectives of ‘users’ of acute health services for 
a specific diabetes-related complication, on primary care diabetes management. The sample 
size was small and limited only to diabetes-related foot disease. We, therefore, did not plan to 
generate a representative population sample and our study had limited scope. A representative 
sample of individuals with diabetes, drawn from the general population would show a different 
perspective on the adequacy and quality of primary care. The details of self-management and 
complications surveillance were self-reported, which could be subject to recall bias. Our 
sample consisted of mainly Australian-born, Caucasian adults hospitalised for a specific 
complication. We, therefore, do not recommend generalising the findings of this study to other 





Many people hospitalised for diabetes-related foot ulcers do not meet guidelines for optimal 
diabetes care in terms of knowledge and uptake of primary care services. Our findings 
underline the perceived significance of the health professionals’ role in diabetes care. Peer 
support, self-reliance, lifestyle modifications, media awareness and the ease of navigating the 
health system were other perceived helpful factors in diabetes management. Ineffective 
communication and time constraints of health professionals, stigma and discrimination, lack of 
continuity of care and fear of complications were identified as factors impeding optimal 
diabetes care. The focus of diabetes care has shifted from care provider to the individual with 
diabetes, therefore, studies should focus on the needs and expectations of those with diabetes 
to provide individualised care that achieves better psychological outcomes and quality of life, 
in addition to biomedical targets such as HbA1c levels. Health literacy is the key determinant 
of diabetes care as diabetes is largely a self-managed condition. Long term population studies 
are needed to identify the areas of health literacy that need improvement and ways of improving 
it. Finally, personality traits have shown to affect individuals’ ability to manage many chronic 
conditions, however, little is currently known about their role in diabetes prevention and 
management. Key recommendations from this study are summarised in Table 3, and could be 
utilised to address the perceived needs of people with diabetes.
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Table 1: Socio-demographic characteristics of participants, n=31
Character istic n=31

















Country of bir th n (% )
Australia 24 (77.4)
Highest qualifications n (%)






Work status n (%)
Full-time
Part-time






Table 2: Content analysis of interview data with key themes/subthemes and illustrative quotations.
Content areas Illustrative quotations Themes/subthemes (n)
Impact of diabetes on
life
‘I took more control over what I ate. I had a shocking diet before. I used to have too
much Coke and McDonald’s but then I changed it.’ [Now] I read labels on food items
to see what is in them.’ (64-year-old man with type 2 diabetes)
I can’t do as much as a normal mother would do for children and house; for example,
I can't go on excursions with my kids [due to diabetes].’ (49-year-old woman with
type 1 diabetes)
‘Diabetes does not affect my life that much. It does not stop me from doing anything.
It is my own choice whether I do something or not.’ (58-year-old man with type 2
diabetes)
‘My condition [diabetes] does not allow me to work but I would like to get back to
work.’ (44-year-old woman with type 1 diabetes)













‘Having a good GP who understands my needs.’ (75- year-old man with type 2
diabetes)
‘I know many people who have diabetes and it helps to learn from their experiences.’
(64-year-old man with type 2 diabetes)
‘When I was first diagnosed, awareness about diabetes was not that good but it has
definitely improved.’ (45-year-old man with type 1 diabetes)
‘It helps when you have more people on TV [with diabetes], it helps creating the
awareness.’ (45-year-old man with type 1 diabetes)
‘Learning to cook at a young age helped me become self-reliant and control it














‘There was an information overload in the beginning but after that there was not much
information or education.’ (43-year-old man with type 2 diabetes)








‘The reason for not getting them [feet] examined by doctors was because I feared that
something might be wrong.’ (45-year-old man with type 1 diabetes)
‘Other illnesses, operations. I have had two cataract surgeries, hysterectomy, a lot of
family stressors in the last 3 years old.’ (69-year-old woman with type 2 diabetes)
I think I was not careful with my diet, I used to work a lot, no proper routine for
eating etc. that's why I got diabetes.






Fear of complications (1)
Health professionals limited
diabetes knowledge (1)




‘All of my diabetes team endo, educators, referral team, foot clinic, people at hospital
are very helpful. I don't think I'd cope without hospital staff support.’ (49-year-old
man with type 1 diabetes)
‘They should not just notify you of your lab results but make sure you come back and
then they should explain your results and see what to do if something is not right. The
confusion scares people away.’ (45-year-old man with type 1 diabetes)
‘I would advise health professionals to keep it simple, don’t make it too complicated
for people to understand what they need to do for diabetes. Also, educate people
earlier in life about diabetes, especially kids need to be educated about it.’ (64-year-
old man with type 2 diabetes)
‘I would say that if they are changing your meds or starting a new one, they should
explain in plain simple words what the patient needs to do and why.’ (75-year-old
woman with type 2 diabetes)
‘I would like doctors to include patients in their conversations. I think most people
can grasp the information about diabetes. Some doctors are good at explaining why
things are happening. I would suggest maybe have the patient repeat the information.
Sometimes doctors use technical language with each other and patient is getting
confused so after they have had their discussion in Latin, they should explain







Need for better surveillance
of complications (4)







‘Health professionals working with diabetes should properly explain and stress about
the damage it causes.’ (74-year-old man with type 2 diabetes)
‘Always read the history. Most or all, treat people on one-on-one basis. Everyone
with diabetes is different. Sometimes doctors put us all in one bracket.’ (49-year-old
man with type 1 diabetes)
Adherence to
medication
‘I have a set routine in the morning that helps me take my medicine regularly, take
milk, take meds, turn on toaster, same routine every day. That’s why I don’t forget.’
(58-year-old man with type 2 diabetes)
I use Webster packs and keep medicine on top of my microwave so that I remember
to take them when I am having my meals.’ (85-year-old man with type 2 diabetes)
‘Simple doses, I know I need to take med when I get up and go to sleep. I never
forget.’ (74-year-old man with type 2 diabetes)
‘I take my medicines and keep appointments religiously. Having diabetes educator
has helped me with that.’ (75-year-old woman with type 2 diabetes)
Having a routine/being
organized (10)
Use of Webster packaging
(4)
Role of diabetes educator
(3)
Simple dosage (2)
Stable blood glucose levels
(1)
Social suppor t ‘It would help to educate people who don’t have diabetes about it, like they don't
understand what hypo means. Does it mean your sugar is high or low?’ (45-year-old
man with type 1 diabetes)
‘Kids are very understanding, I have a good family and they understand my condition,
they include me in everything. Even friend make plans keeping in mind to include
me.’ (49-year-old man with type 1 diabetes)
‘I have to tell everyone that I have diabetes and what to do if something goes wrong.
People I am with get a bit concerned and I don't like this. I get annoyed that I have to
divulge to everyone that I have diabetes.’ (56-year-old woman with type 1 diabetes)
Acknowledgement of family
support (14)




‘My biggest fear was amputation and it happened to me.’ (45-year-old man with type
1 diabetes)
‘Just with the foot ulcer, I have got frustrated because I have been having them for
more than 4 years and they don’t seem to get better.’ (75-year- old woman with type 2
diabetes)
‘Losing my feet now [is stressful]. Before I was worried about not being to keep my
blood sugar normal and getting hypo/hyper attacks.’ (49-year-old man with type 1
diabetes)
Fear of complications (9)
Fear of disability (5)
Living alone (3)
Not getting results even
when ‘doing everything
right’ (3)
Cost of care (2)




‘I find it frustrating that blood sugar varies so much, even when I am doing
everything right I still get these complications like foot problems.’ (56-year-old
woman with type 1 diabetes)
‘NDSS helps but I still have to pay 8 dollars for strips box that I go through in a week,
$100 dollar roughly on medicine per month. It gets stressful when there is a huge
energy bill or car registration but mostly it has not been that bad.’ (56-year-old
woman with type 1 diabetes)
‘[My] biggest worry is being fit for as long as I can and not having amputation. My
son requires support as he has autism and epilepsy and I worry a lot about not being
able to care for him if I am not mobile [due to amputation].’ (56-year-old woman with
type 1 diabetes)
Affordability of care ‘Diabetes care is not that expensive itself but the conditions that come with it, for
example, heart conditions are expensive to manage, especially the medicines.’ (45-
year-old man with type 1 diabetes))
Specialist fees are high but other than that, it is not expensive. I get strips from NDSS
so it is okay.’ (43-year-old man with type 2 diabetes)
Acknowledgement of
government’s support (24)
Cost of comorbid conditions
(7)




Table 3: Summary of identified enabling and impeding factors for optimal diabetes management and participants’ recommendations. 
Enabling factors of optimal 
diabetes management 




Health professional support Time constraints of health 
professionals
Simple and effective communication by 
health professionals
Lifestyle changes (dietary 
modification and physical 
activity)
Lack of ongoing diabetes 
education
Ongoing diabetes education for patients, 
family members and health professionals 
Availability of quality 
information
Long waiting times to consult 
specialists
Reduced waiting times for specialist 
consultations
Peer support Stigma/discrimination Reduce stigma/discrimination associated 
with diabetes 
Self-reliance Multiple comorbid conditions Improved surveillance of complications 
by primary care physicians
Media awareness Fear of complications Increased patient involvement in health-
related decision making
Ease of navigating the health 
system
Cost of diabetes care Media campaigns for improved diabetes 
awareness
Good medication intake routine Individualized diabetes care
Support from family/friends Financial support for people with diabetes
Simple and effective 
communication from health 
professionals
Patient inclusion in decision 
making regarding their health
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Discussion
This doctoral project was conceived against the background of diabetes mellitus emerging as
a global pandemic in recent decades [1, 2]. Despite being acondition that should be managed
adequately in primary care, diabetes is associated with a disproportionately high use of
hospital services [3]. A thorough understanding of the determinants of acute health service
use in diabetes is needed, however, previous research has several limitations, as underlined in
Chapter One. Quality data from regional and remote areas are particularly scant, although
they experience a greater burden of diabetes-related acute care use than metropolitan areas.
The overarching aim of this doctoral project was to provide a better understanding of the
factors associated with acute care use in diabetes in a regional Australian setting. Outcomes
of the various sub-studies have already been discussed extensively in the relevant
manuscripts, thus the purpose of this discussion is to summarise and link key findings, and
discuss strengths, limitations, potential implications and directions for future research.
In aggregate, findings from this thesis affirm that diabetes is associated with higher
incidence, rate, and length of hospitalisation, however, there is no increased risk in impaired
fasting glucose (IFG) (Chapter Five). Social advantage and better accessibility are associated
with higher rates of hospitalisation among individuals with diabetes (Chapter Three).
Moreover, hospitalised individuals with diabetes differ from those without it, in terms of
socio-demographic and clinical characteristics, including reasons for hospitalisation (Chapter
Four). This project also identified shortfalls in the uptake of primary care services for
diabetes and highlighted perspectives of hospitalised patients on the enabling and impeding
factors for optimal primary care management of diabetes (Chapter Six).
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A breakdown of the key issues addressed in this discussion is as follows:
Glycaemic status and the incidence, frequency rate and length of hospitalisation.
Burden of diabetes and its comorbidities in regional Australian hospitals.
Demographic and clinical profiles of inpatients with diabetes.
Socioeconomic status, remoteness and diabetes hospitalisations.
Shortfalls in the primary care management of diabetes in Australia.
Perspectives of inpatients with diabetes-related foot disease (DRFD), on its primary
care management.
The increased risk of hospitalisation in diabetes is well known [4, 5], however, no previous
studies have investigated the association in those with  impaired fasting glucose. In this
project, using data from the population-based Geelong Osteoporosis Study (GOS) [6], the
incidence, frequency rate, length and causes of hospitalisation were compared among adults
with normoglycaemia, IFG and diabetes (Chapter Five). Whereas previous studies relied on
self-report [7] or admission records [8], this project used a combination of fasting plasma
glucose, self-report and/or use of anti-hyperglycaemic medication, which allowed the
distinction between normoglycaemia, IFG and diabetes at baseline. Furthermore,
participants were followed for hospitalisations using unique identifiers, over a median
duration of ~7.5 years, which is longer than previous studies [7, 8]. The study indicated that
the incidence, frequency rate and length of all-cause hospitalisation were higher in
individuals with diabetes, as compared to normoglycaemia, however, IFG did not differ
from the normoglycaemia. These findings suggest that risk of hospitalisation multiplies with
IFG-to-diabetes progression and, therefore, reiterate the significance of identifying and
managing  IFG  in the population.
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As some previous Australian data had reported higher diabetes-related hospitalisation rates in
regional and remote areas [9], another aim of this project was to determine the burden of
diabetes in regional hospitals. An inpatient audit was performed, over a 7-day period at three
different-sized regional hospitals in Victoria (Australia), to compare inpatient prevalence and
profiles of hospitalised adults with and without diabetes (Chapter Four). The audit showed
that one in five adult inpatients had diabetes, of whom 95% had type 2 diabetes. The reported
prevalence of diabetes is likely to be an underestimate of its true prevalence due, at least in
part, to incomplete documentation of diabetes in hospital records [10, 11] and undiagnosed
diabetes [12]. The inpatient prevalence of diabetes was three to four times its estimated
prevalence in the population, which is comparable with a previous Australian study of
metropolitan hospitals [13].
Inpatients with type 1 and type 2 diabetes differed from each other in terms of some
demographic characteristics. For type 1 diabetes, hospitalisation rate increased up to 60-69
years of age, followed by a decline in older age groups (Chapter Three). Type 2 diabetes
hospitalisation rates were the highest in older age groups. Hospitalisation rates were higher in
men with diabetes, as compared to women (Chapters Three and Five). In the survey of
inpatients with DRFD (Chapter Six), the ratio between type 2 and type 1 diabetes was 5:1,
which showed an overrepresentation of type 1 diabetes. The inpatient audit, however, showed
that only 11 of the 211 inpatients with diabetes had type 1 diabetes (Chapter Four).
Associations of socioeconomic position and remoteness with hospitalisations in individuals
with diabetes were investigated as part of the Ageing, Chronic Disease and Injury study
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(ACDI), across a regional Australian population (Chapter Three) [14]. Better geographic
accessibility and social advantage were associated with higher rates of hospitalisation. This
finding contradicted previous reports that location remoteness, rurality and socioeconomic
disadvantage were associated with a higher incidence of diabetes hospitalisations [15]. A
likely explanation is that due to the availability of universal insurance and bulk billing options
in Australia, General Practitioners (GPs) are usually the first point of contact with the health
system for most people [16]. In regional and remote areas where specialists are in short
supply, GPs often facilitate hospital admissions. Over-servicing, resulting from availabil ity of
primary care and hospital services could also explain the high rates of diabetes-related
hospitalisations in more accessible areas [17].
Analysis of inpatient principal diagnosis codes showed that individuals with diabetes were
more likely to be admitted for ‘diseases of circulatory system’, as compared to those without
(Chapter Four). Similarly in Chapter Five, over half of the ten most common principal
diagnoses were related to cardiovascular disease. Other studies have also reported that
individuals with diabetes are often hospitalised for conditions other than diabetes, most
commonly heart disease [18]. The categor y ‘ infe c ti ous and parasit ic diseas es’ was also m ore
common in among inpatients with diabetes. Diabetes is known to increase the risk of
infections due to the intermittent hyperglycaemia and reduced immunity levels [19].
Hypertension and chronic obstructive pulmonary disease were more prevalent among
inpatients with diabetes, whereas the prevalence of arthritis, mental health condition, cancer,
asthma, and back pain was similar between the two groups (Chapter Four). Similarly, among
inpatients with DRFD (Chapter Six), two-thirds of the sample were taking antihypertensive or
lipid-lowering medication.
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A majority of hospital admissions in individuals with diabetes were not directly related to
diabetes complications. In the GOS cohort (Chapter Five), only 14.5% of men and 12.5% of
women with diabetes were hospitalised for its complications. The inpatient audit (Chapter
Four) also revealed that less than 10% of hospitalisations in people with diabetes were related
to a specific complication of diabetes. Diabetes-related foot disease was the most common
reason for admission in those cases, which highlights the need for improved screening for foot
disease and improved access to podiatry services in the Australian population with diabetes.
Prior to this project, few studies had explored the perspectives of inpatients with diabetes-
related complications to identify the enabling and impeding factors for optimal primary care
management. A mixed-methods approach was employed, using surveys and semi-structured
interviews of inpatients with a known complication of diabetes (DRFD), at a tertiary hospital
(Chapter Six). Shortfalls related to many aspects of primary care management of diabetes
were identified, for instance, knowledge and testing of HbA1c, visits to dietitians and
diabetes nurse educators, membership of diabetes support scheme, and surveillance for
complications (Chapter Six). One-fifth of patients hospitalised for DRFD did not have
knowledge of HbA1c. Previous studies, for instance, the Australian CareTrack study showed
that ‘appropriate care’ , defined as ‘care in line with evidence-based or consensus-based
guidelines’ , was provided in only 37% of individuals with diabetes [16]. The study reported
that care quality and adherence to treatment regimens varied widely, despite universal health
insurance. Moreover, many participants did not consult dietitians and diabetes educators
167
Chapter Seven: Final Discussion
regularly, although support for  up to eight visits is provided through universal insurance
(Medicare) [20]. A more comprehensive examination of the underlying reasons for the low
uptake of diabetes-related primary care services is needed.
Detailed interviews of admitted patients provided valuable information on the perceived
enabling and impeding factors for optimal diabetes care (Chapter Six). Delayed diagnosis and
misclassification of diabetes was reported by many participants. Diabetes often remains
undiagnosed until complications develop, which could be prevented by improved screening in
primary care. The role of health professionals’ sup port emerged as a key enabler for achieving
optimal diabetes care. Peer support, social support and participatory decision-making were
also highlighted as enablers. Ineffective communication, lack of access to ongoing diabetes
education, limits on social interaction, and stigma of diabetes were some of the main
perceived impeding factors.
Strengths and limitations
This project had some strengths and weaknesses. Various study designs were used to explore
the determinants of acute service use in diabetes, including an ecological study (Chapter
Three), an audit of hospital medical records (Chapter Four), a longitudinal study (Chapter
Five), and a mixed-methods study (Chapter Six). Data were acquired from comprehensive
disease registers, general population, electronic medical records, and individuals. The ACDI
study region (Chapter Two) covers a large regional population, spanning areas with varying
levels of remoteness and socioeconomic status. These unique features provided an ideal
setting to examine the association of socioeconomic status and remoteness with diabetes
hospitalisations (Chapter Three). Data from GOS were utilised to compare the incidence,
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frequency rate and length of hospitalisation between individuals in different glycaemic
categories (Chapter Five). Some strengths of GOS include a representative sample drawn
from electoral rolls, a robust method for classification of glycaemic status, and a long follow-
up. Availability of modern health information systems at the hospitals included in the
inpatient audit ensured robustness of hospitalisation data (Chapter Four). Finally, a mixed-
methods design was used to explore the perspectives of acut e healt h se rvice ‘users’ (Ch apter
Six), that provided useful recommendations for improvements in primary care diabetes
management.
However, the ACDI study was limited by use of aggregate hospitalisation data and measures
of area-level socioeconomic status and geographic remoteness (Chapter Three). Lack of
reliable diabetes prevalence estimates was also problematic. Diabetes Australia reported that
in 2009, an estimated 80-90% of Australian with diabetes held NDSS membership [21],
however, there are no independent recent data available. Some limitations were related to data
acquisition, for instance, data from the Victorian Admitted Episodes Dataset (Chapter Three)
could have underestimated hospitalisations in low prevalence areas, as disease registers
withhold data where cell values are below certain thresholds. It is likely that a small number
of patients was admitted with more serious complications, had longer hospital stays and
repeated admissions. However, as data on individual admissions were not available, we were
not able to investigate this further. Admissions data for GOS participants were obtained from
the only tertiary hospital in the study region (Chapter Five). Although it is the largest hospital
in the study region and the only one with a 24-hour emergency department, it is possible that
some hospitalisation data were not captured. We used Fasting Plasma Glucose, however, use
of 2-hour glucose testing or HbA1c may be more sensitive in differentiating between
glycaemic categories. Furthermore, accuracy of diabetes documentation in hospital medical
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records is arguable. Studies using diabetes hospitalisations rely on accuracy of coding, which
varies widely between hospitals depending on experience and training of staff, variations in
coding quality and resources allocated for coding [11]. Previous data from the United
Kingdom [11] demonstrate that nearly 40% of inpatients with previously diagnosed diabetes
did not have it documented in hospital records. Similarly, studies from Spain [22] and France
[12] concluded that hospital records underestimated the inpatient diabetes prevalence due to
inaccuracies in its coding and recording in hospital records. Finally, socioeconomic status,
ethnicity and Indigenous status of patients could not be ascertained from medical records
(Chapters Three and Four).
Implications
Within its limitations, this project has potential implications for health policy and clinical
practice. As part of the larger ACDI study (Chapters Two and Three), a number of sub-studies
has used routinely collected data to describe the disease and injury status of a large regional
population. To date, data on hospitalisations for hip fractures [23] and joint replacements [24]
have been reported for the region. This thesis adds to the knowledge base by mapping
diabetes-related hospitalisation rates across the region with varying levels of socioeconomic
position and remoteness (Chapter Three). The ACDI study offers a model for using routinely
collected data for research outcomes, which could be replicated in other geographical settings.
The thesis also signifies the role of screening and management of individuals in the
community with  impaired fasting glucose (Chapter Five). It has also determined the
previously unknown prevalence of diabetes among inpatients in regional Australian hospitals
and the reasons for hospitalisation (Chapter Four). Such information is vital for planning
resource allocation and projecting demand for hospital services in the future. Moreover, it has
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identified shortfalls in the primary care management of diabetes, for instance, suboptimal
complications surveillance and visits to health professionals, which need to be addressed
(Chapter Six). Finally, it has identified areas in the primary care management of diabetes that
could be targeted to minimise reliance on hospital services.
Future research directions
While this thesis has provided useful new insights into the area- and person-level factors
associated with acute health service use in diabetes, knowledge gaps still remain. Use of
acute health service is determined by complex behavioural and systemic factors, which need
to be examined in more detail. In particular, the role of health literacy, health workforce
dist ributi on, ph ysicians’ care pref er ences and hospital policies needs further investigation.
Future studies could also benefit from this project to develop hypotheses for in-depth
evaluation of the individual determinants of acute health service use in diabetes.
There are currently a wide range of reported estimates of prevalence of diabetes in the
Australian population. Studies rely on self-reported or doctor diagnosed diabetes but it  is
widely acknowledged that a significant proportion of diabetes remains undiagnosed. As more
than 90% of Australian population visits there GPs at least once a year, that could be an ideal
setting for diabetes screening and to estimate the true prevalence of diabetes in the Australian
population. My project also highlighted need to prevent the IFG-to-diabetes progression,
however, current evidence is limited on the most useful strategies to achieve it. Research also
needs to focus on accessible screening questionnaires to assess diabetes risk in the
community. Diabetes coding in hospital records remains problematic and more studies are
needed to investigate the quality and accuracy of coding. The focus of diabetes care has
shifted from care provider to the individual with diabetes [25], therefore, studies should focus
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on the needs and expectations of those with diabetes to provide individualised care that
achieves the biomedical targets (HbA1c levels), as well as, psychological outcomes and
quality of life. Health literacy is a key determinant of diabetes care as it is largely a self-
managed condition. Long term population studies are warranted to identify the areas of health
literacy that need improvement and ways of improving it. Finally, personality traits have
shown to affe ct i ndivi duals’ abil it y to manage many chronic conditions, however, little is
currently known about their role in diabetes prevention and management.
Conclusions
The incidence, frequency rate, and length of hospitalisation is higher in those with diabetes,
however, IFG does not appear to be at increased risk. Hospital medical records show that one
in five adult inpatients in regional Australian hospitals has diabetes; however, due to the
incomplete documentation of diabetes, the true prevalence of diabetes is likely to be higher.
Higher diabetes-related hospitalisation rates may indicate better access to hospital services
and social advantage, thus the relationship between socioeconomic status, remoteness and
diabetes-related hospitalisation may be more complex than currently understood. Health
professional and peer support, availability of reliable information, self-reliance, lifestyle
modifications, increased media awareness and participatory decision-making facilitate
optimal diabetes management. Perceived barriers to optimal care include complicated
communication, time constraints of health professionals, stigma and discrimination associated
with diabetes. Although early detection of diabetes is vital, its benefits have to be balanced
against the costs of mass screening, and the psychological and physical costs of managing a
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lifelong chronic condition [26]. Some recent studies recomm end ‘ tar geted’ rather than ‘mass
screening’ [27], thus, it is vital to identify population subgroups for targeted diabetes
screening. Strategies to reduce diabetes-related acute care use should focus on prevention of
IFG-to-diabetes progression, early and accurate diagnosis, surveillance of complications,
improving uptake of primary services, and eliminating the barriers to optimal care.
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Protocol Template Version 4 – December 2014
The protocol is defined as a document that provides sufficient detail to
enable understanding of the background, rationale, objectives, study
population, interventions, methods, statistical analyses, ethical
considerations, dissemination plans, and administration of the project;
replication of key aspects of project methods and conduct; and appraisal of
the project’s scientific and ethical rigor from ethics approval to
dissemination of results.
The protocol is more than a list of items. It should be a cohesive document
that provides appropriate context and narrative to fully understand the
elements of the project. For example, the description of a complex
intervention may need to include training materials and figures to enable
replication by persons with appropriate expertise.
The full protocol must be submitted together with associated documents
for approval by Barwon Health’s Human Research Ethics Committee
(HREC).
If the details for certain items have not yet been finalized, then this should
be stated in the protocol and the items updated as they evolve.
The protocol is a “living” document that may require to be modified during
the project. A transparent audit trail with dates of important changes in
project design and conduct is an essential part of the scientific record.
Project investigators and sponsors are expected to adhere to the protocol
as approved by the Barwon Health HREC and to document amendments
made in the most recent protocol version.
Important protocol amendments should be reported to the Research
Ethics, Governance & Integrity (REGI) Unit as they occur by submitting a
completed HREC amendment form and subsequently be described in
project reports.
Definition of a Protocol
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1. Barwon Health Reference: 15/11
2. Project Tit le: Chronic disease, injury and ageing in Western Victoria: opportunities to
improve health delivery
3. Protocol Version No: 2
4. Protocol Date: 6 October 2016
5. Body Responsible for this Project:
6. Principal Investigator and Contact Information: Professor Julie Pasco
7. Contact Information: T +61 3 42153331; E juliep@barwonhealth.org.au
8. Background:
What research has been undertaken in this subject area before?
The patterns of some chronic diseases and injury have been documented for different
geographical areas (eg for the whole of Victoria, or for individual Medicare Local regions) but
not specifically for our study region.
What are the limitations of these previous studies?
Previous data have not been presented in terms of age, sex and region (eg postcode) within our
study region, which we intend to do.
Why is this project important and what will it add to the literature or how will it improve patient
care?
The burden of disease and injury has not been described for this region as a whole, nor by
location. This project will collate existing databases to provide a comprehensive snapshot of the
health and wellbeing of the region. In order to plan future interventions and evaluate their
effectiveness, it is essential to have a contemporary evidence base and processes in place for
monitoring ongoing change. The data can be used to establish and target the appropriate
allocation of resources to deal with the burden of disease and injury. The project is innovative
because data will be sourced and integrated from multiple existing datasets; this undertaking
requires a dedicated research effort. We will also plan how to collect new data from individuals
residing in the region.
9. Study Objective and Hypotheses:
Specific study aims and/or any scientific hypotheses to be answered.
The aims of this project are to:
• Describe burden of chronic disease and injury
• Identify health inequalities between population sub-groups
• Establish processes for capturing data concerning chronic disease, psychological stress,
dementia, risk factors for disease and health behaviours
Protocol Template
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Our objectives  are to:
• Collate hospital separation and emergency admission data for disease and injury
• Access  health registries  including  the National Diabetes  Support Scheme (NDSS);
Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), Victorian
Cancer Registry (VCR), Transport Accident Commission (TAC); Rural Ambulance Victoria,
Victorian Emergency Management Database (VEMD), Victorian Admitted Episodes  Dataset
(VAED), the State Major Trauma database (V-STORM) and the Victorian Orthopaedic Trauma
Outcomes  Registry (VOTOR)
• Obtain Medicare data on medication use (prescriptions  filled and possession ratio)
• Establish processes  for capturing individualised data concerning  injuries  (eg falls, farm
accidents), health and disease, together with health behaviours.
10. Study Design and Methods:
This  project will draw on existing  information collected by various  agencies, and plan collection
of new data, to provide a detailed snapshot of the health and safety of people living in the
region and its  relationship to age. This  information is  required to identify gaps  and to plan
changes  to services  and infrastructure to better serve the community.
10.1 Participant recruitment: 
Where, by whom and who will be asked to participate (Inclusion/Exclusion criteria)?
We will access  data from existing datasets. The data will relate to individuals   residing  in western 
Victoria. At a later stage we collect new data from individuals  and an amendment will be lodged 
when this  is required.
10.2 Study Procedures:
How will the specific study be carried out? 
Hospital separations  and Emergency Department (ED) presentations  will provide a 
comprehensive dataset of serious  health issues  requiring  these health services  in the region. 
Data  abstraction from national, state and local registries  will be obtained as aggregate data to 
inform summary statistics  for rates  of disease and injury according  to age, sex, time and 
location. Registers  to be accessed include, but are not limited to:
• The National Diabetes  Support Scheme (NDSS), established in 1987 with approximately
30,000 registrants  has  now grown to over 1 million. The scheme supports people with
diabetes  and provides  reliable and affordable access  to supplies  and services  for
managing  their disease.
• The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR)
– implementation of the AOANJRR  began in 1999 and was  complete nationally by mid-
2002; since that time, all hospitals  undertaking arthroplasty procedures  submit data to
the registry.
• The Victorian Cancer registry (VCR), a population-based cancer registry that was  formed
to provide comprehensive, information for cancer control. Notifications  about cancer
diagnoses  are provided to the VCA  by hospitals, pathology laboratories  and cancer
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screening registers. We will access demographic information together with tumour
details for each case.
• The Transport Accident Commission (TAC) is a Victorian-government owned
organisation. Details of claims provide information about crash injury types, injury
severity and other road trauma data.
• Ambulance Victoria –local ambulance services have existed (and merged) in Victoria
since the late 19th century and 2008 saw the amalgamation of the Metropolitan
Ambulance Service, the Rural Ambulance Victoria and the Alexandra District Ambulance
Service to form Ambulance Victoria. Collation of information documented by this service
will provide demographic data together with injury type and severity.
• University Hospital, Geelong, Ballarat and Warrnambool Base Hospitals all contribute to
the Victorian Emergency Management Database (VEMD), which has a specific injury
sub-set (a computer-based database of all injuries presenting to those emergency
departments). Hamilton Base may also contribute to that database and South West
Alliance of Rural Health (SWARH) has also extended that database to include Portland,
Colac and Camperdown.
• The state-wide Victorian Admitted Episodes Dataset (VAED) also records details of all
inpatient admissions to all hospitals within Victoria and the State Major Trauma
database (V-STORM) records admission and follow-up data (for two years) of all major
trauma admissions to Victorian hospitals
• Victorian Orthopaedic Trauma Outcomes Registry (VOTOR), out of Monash University
will be accessed – VOTOR includes all of orthopaedic trauma referrals from Western
Victoria (and it links to V-STORM) providing a range of injury as well as 6 and 12 month
follow-up data with near 90% completeness.
• Medicare data will be accessed for providing aggregate data on medication use
(prescription fulfilment) and health service utilisation.
• Hospitals, Community Health and Rehabilitation Centres, aged care facilities, pathology
laboratories and imaging centres will be accessed to provide details of in-patient and
out-patient health service utilisation and diagnostic testing.
For later amendment: The collation of existing health and administrative databases will be later
complemented by new clinical and questionnaire data collected from individual residents.
What will the participant’s have to do during the study, when and how often?
N/A.
What will the investigator do and when?
Data will be sourced from existing datasets and registries (refer to 10.2). Where practical, data
will be requested in aggregate form according to age (eg 5-year age group), time (eg month),
sex, location (eg postcode, local government area). Individual data will be requested when
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required for data linkage and/or statistical modelling. Data acquisition will commence in 2015 
and will extend through to 2020. 
10.3 Data Collection and Storage:
What data will be collected and how (from medical records, questionnaires)?
Refer to 10.2
How will data be stored (electronically, paper, etc)?
Data will be stored electronically in password-protected databases  at Barwon Health.
How long will data be stored and how will it be destroyed?
Data will be stored for a minimum of seven years. To destroy the data, electronic files  will be 
deleted.
11. Data Analysis
11.1 Justification of sample size: 
Describe how the sample size was  determined; based on a power calculation, a  convenience 
sample of all people attending  a clinic or program, etc. 
Data will be drawn from the whole region; sampling  will not be undertaken in this  phase of the 
project.
11.2  Proposed means  for analyzing the data citing specific  statistical techniques: 
What statistical techniques  will be used to analyze the data?  Descriptive statistics  such as  
percentages  and means  or medians  may be sufficient dependent on the project.
The information is  descriptive. Prevalence data will be presented by age, sex and location. 
Overall prevalence estimates  will be age-standardised and presented per 100, 1000 or 10000 
population, depending on how prevalent (how common) the disease or injury type may be.
11.3 Dissemination of Results
Describe how you are intending to inform others  of the results  e.g. publishing, conference 
presentations. 
Reports  to the funding  bodies  (including the Western Alliance), publications  in peer-reviewed 
scientific journals, conference presentations, academic reports  (including PhD and Honours  
theses), newsletters  and annual reports  (including those from the Epi-Centre for Healthy Ageing  
and the IMPACT  Strategic Research Centre).
12. References:
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Internal / External External
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Excludes Albury-Wodonga Health - Albury Campus which does not report to the VAED
The tables report the number of occurrence of diabetes codes and does not refer to the number of
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Period included: 2011 to 2014
Selection codes: Inclusions
- 'Western' defined by these confirmed: LGA Codes:
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20570 Ballarat (C)
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26490 Surf Coast (S)
26730 Warrnambool (C)
26890 West Wimmera (S)
27630 Yarriambiack (S)
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Research / Clinical Audit
Please submit this form to the Quality Depa ment for submission with the research approval committee
This form is for formal human research NOT a routine clinical audit





The Grange Other (please speci )
f B. Applicant Deta-1s
Name and Depa mental Address Student details
Chief Investigator Name:  Julie Pasco N/A
(cannot not be a Position:  Professor/Head Epi-Centre for Healthy
student) Ageing (ECHA)
Depa ment:  School of Medicine
Institution:  Deakin University
Email address:  Julie @barwonhealth.org.au
Additional Name:  Muhammad Amber Sajjad Student no. 215010242
Investigators Position:  PhD candidate
Department:  School of Medicine Degree enrolled  PhD
Institution:  Deakin University
Email address:  msa ad@barwonhealth.org.au
Name: Student no.
Position:
Depa ment: Degree enrolled
Institution:
Email address:
Contact Person Name:  Muhammad Amber Sajjad
Position:  PhD candidate
Department:  School of Medicine
Institution:  Deakin University
Email address:  msajjad@barwonhealth.org.au
Phone: +61 3 42153339
-P ject Details
1. Title  (the title should indicate the area of clinical activity to be audited)
Chronic disease, inju and ageing in western Victoria: opportunities to improve health delive
2.Timeframe - please provide a data collection commencement date that reflects when the audit
wi!I actually begin.
WDHS Human Research Committee clinical audit template May 2016
Source: Sou e Adelaide Clinical Human Research Ethics Committee (June 2015)
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Research / Clinical Audit
Date data collection to commence t r g st 20 6
Date data collection expected to be completed t rL 17
Date project expected to be completed i \p ·;i C\ $
3. Is this audit covering content that has currently or previously been audited by WDHS
XNo Yes
4. Is the audit just a clinical audit or an audit done as a research pr ect?
Only Clinical Audit X Clinical Audit done as Research Project
Chnical Audit Rese ch
Aim: Askes how close is cu ent practice to best prac ce Aim: Asks what is best practice?
Improves healthcare se ices Improves knowl ge
Practice based Theory driven
An ongoing process A one o project
Usua y small sample over a sho time ame Usua ycar ed out on a large scale over a prolonged period
of time
Collects u ne data Collects complex data
Never involves a patient r eiving a mpletely new May involve patients receiving completely new treatment or
treatment or placebo placebo
Findings in uence activities of lo l clinicians and teams Findings in uen activities of clinical practice as a whole
Does not usually r uire ethical approval• Usually requires ical approval
5. Descri ion of the audit
Background (provide background information on the clinical issue being audited, including
references)
Individuals with diabetes are at a higher risk of hospital admission as compared to those without the
condition. Data on the inpatient prevalence of diabetes in Australian hospitals are limited,
particularly in regional areas.
Aim
This PhD project forms part of a broader study investigating prevalence of chronic disease and injury
in western Victoria. The aim of this project is to determine the inpatient prevalence of diabetes
mellitus at hospitals providing di erent levels of acute care in western Victoria and to perform
comparative analysis of inpatient pro les between them.
WDHS Human Research Committee clinical audit template May 2016
Source: Southe Adelaide C nical Human Research hics Committee (June 2015)
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Research / Clinical Audit
Patient inclusion cri
All patients occupying a bed at Hamilton Base Hospital between August 1, 2016 and August 7, 2016
(inclusive).
Data to be co e ed  (please include a copy of the data collection f orm available}
The following data are requested r each individual patient (Excel sheet attached): age, sex, date of
admission, date of discharge, discharge method (hospital, nursing home, death, statistical discharge,
le against medical advice), primary diagnosis, seconda diagnoses, any admissions in the 12 month
prior to current admission, postcode and SLA/LGA of residence.
Sou e of data and method of data access
Data warehouse/retrospective access to data is requested.
Da analysis, including sample s e with justi cation
N/A
6. What standards (if any) will be used to evaluate the data obtained?
N/A
7. Outcomes
When and how will the audit findings be fed back to the clinical team?
Findings will be reported through doctoral thesis, peer-reviewed publications, research conferences
and repo s to Western Victoria Primary Health Network.
How will the impact of the audit be monitored?
It will be monitored through on line tools r measuring the impact of scholarly content such as
Altmetric.
I D. Privacy and Confidentiality
1. How will the audit be conducted?
x Retrospectively D Prospectively
Will patients be impacted by the audit beyond that experience during normal clinical
management?  (E.g. phone calls, additional hospital visits or completion of questionnaires)
X No Yes (please describe)
WDHS Human Research Committee clinical audit templateMay2016
Source: Southe Adelaide C nical Human Research Ethics Committee (June 2015}
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2. What type of data will be used?
X Non-identifiable - Data that have never been labelled with individual identifiers or from which
identifiers have been permanently removed, and by means of which no specific individual can be
identified. Consent is not required for audit purposes.
D Identifiable - Consent should be obtained. If a waiver of consent is requested, a full ethics
application will be required.
Re-identifiable - Data which identifiers have been removed and replaced by a code, but it remains
possible to re-identi a specific individual by, for example, using the code or linking di erent data
sets. Please justi and describe how accidental re-identification will be avoided.
3. Will consent be obtained from patients?
XNo Yes (please provide a copy of in rmation sheet and consent form)
4.Who will collect the data?
Data will be collected through the o ice of Health In rmation Manager, Western District Health
Se ice.
Does this person normally have access to these records?*  X Yes No
If a student is not attached to the department where they wish to conduct their audit, please
provide a letter or email of suppo from the head of department, endorsing the audit in their area.
N/ A
Suggested wording:
---------- (department/doctors name)  support the  ------------- (name of student) f or the purpose of
conducting---------- (name of project). ------------- (name of student)  will be attached to this
department whilst undergoing this project and will be under my super ion. I support their access to
patient records for this project. ey will be providing me with a copy of the completed projec audit
at its conclusion
* A student of the clinical team in a hospital or an authorised quality assurance o icer would be
considered to have access. A student external to the clinical team would not.
Yes No
Will confidential information be available to anyone who would X
not usually have such access?
Will the audit require a breach of confidentiality beyond that O X
experienced during routine care?
WDHS Human Research Committee clinical audit template May 2016
Source: Southe Adelaide Clinical Human Research Ethics Committee (June 2015)
191
Application Form
Research / Clinical Audit
If 'yes' to either question, please describe
5. How will confidentiality be maintained?
Only de-identified data are requested. Furthermore, published datawill only be presented in
aggregate form.
6. Describe how the data will be held, including relevant security provisions.
Datawill be stored electronically and password protected at IMPACT Strategic Research Centre,
Barwon Health/Deakin University, Geelong.
7.When and how will data be disposed of?
Electronically stored data will be deleted on completion of the PhD project or publication (April
2019).
Please note that chapter 2.1.1 of The Australian Code for the Responsible Conduct of Research
advises 12 months is sufficient for short term projects completed by students. The WDHS HRC
require all audit data to be maintained for 12 months
Overlap of clinical audit as research and clinical care
Yes No
Does conducting the audit alter routine care?* D X
(e.g. is any inte ention or alternative care involved)
Are randomization, use of a control group or placebo needed?* D x
(not including comparison with published or prior studies)
Does the study gather information beyond that collected in routine D X
care?
Will the audit generate data that are likely to lead to publication in x 
peer-reviewed or professional journals?
* If Yes, a full application may be required
F.Statement of compliance with NH&MRC National Statement on Ethical Conduct in Human
Research (2007) & the Australian Code for the Responsible Conduct of Resea h (2007)
By submitting this application the applicant(s) will comply with both of the above documents. All
researchers are expected to be familiar with their responsibilities under each document.
The chief investigator MUST sign and date this statement
WDHS Human Research Committee clinical audit template May 2016
Sou e: Southe Adelaide Clinical Human Research Ethics Committee (June 2015)
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HREC Amendment Form Page 1 of 3
August 2014
Research Project Details
HREC Reference Number CPI for Research Project
Local Reference Number HREC Approval Date
Date of this Form
Project Title




Explain the changes that have occurred or are intended (may include changes in procedure, direction of project,
source/manner of recruitment, number of participants or changes to research personnel)
Reason for the changes (include a comment on the impact on the research project and the participants at sites for which the
reviewing HREC is responsible)
Do these changes raise any ethical issues? Yes No
If Yes, identify the ethical issues
HREC Amendment Form
In the event that an ethically approved research project requires amendment, this form must be submitted to the
reviewing HREC by the Coordinating Principal Investigator (CPI).
The CPI is responsible for notifying all site Principal Investigators (PIs) of the amendment, in order for them to discuss it
with their Research Governance Officer (RGO).
An amendment must not be implemented at a site until the HREC amendment has been approved by the reviewing HREC
and (if applicable) Site Specific Assessment (SSA) amendment has been authorised at the site.
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Documents
List all amended documents to be reviewed.
Document Title (include version number, if applicable) Version Date Office Use Only
Attach one copy of each amended document to this form; all changes must be clearly indicated on the document(s).
Sponsor
Did a commercial sponsor initiate this amendment? Yes No
Sponsor Email
Contact Person (Australia) Telephone
Drug/ Device Research under the CTN Scheme
If this is a drug/device research project, does the amendment include additional and/or
different drugs/devices or involve a new indication for any drug/device other than that
approved in the original application?
Yes No N/A
Supporting Departments
Does this amendment impact the type or frequency of service provided by a supporting
department at participating sites?
Yes No
If Yes, indicate the relevant department(s)
Anaesthesia EEG/EMG Medical Staff Pharmacy
Anatomical Pathology Emergency Molecular Biology Physiotherapy
Cardiology/ECG Endocrinology Nuclear Medicine Radiology
Chemical Pathology Haematology Nursing Services Social Work
Clinical Immunology Health Information Occupational Therapy Speech Pathology
Clinical Pharmacology Interpreter Services Ophthalmology Tissue Typing
Other (please specify)
Provide written approval from the relevant department(s) to the Research Governance Officer at the relevant site(s).
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Participating Sites
Are all participating sites affected by this amendment? Yes No
If No, list all affected sites below.
Site (Organisation) State Site (Organisation) State
An amendment to ethically approved research may also impact the SSAs. The Research Governance Officer (RGO) at each
affected site must be notified of the HREC amendment by their site PI to determine if the SSA needs to be amended. Final
appr oval to im plement an amendment at a s ite will be is sued by that site’s RGO.
Declaration
I confirm that this project is being conducted in keeping with the conditions of approval of the reviewing HREC (and subject
to any changes subsequently approved).
I confirm that the project is being conducted in compliance with the NHMRC National Statement on Ethical Conduct in
Human Research (NHMRC, 2007) or as amended.
I confirm that I have not received any information in any form from anyone involved in the trial to suggest this report does
















DEMOGRAPHIC AND SOCIOECONOMIC PARAMATERS
Date of birth Medical Record Date of birth/age
Sex (1) Male (2) Female (3) Other
The accomodation where you were living prior to hospitalisation, was it? Participant (1) Own house (2) Rented (2) Boarding house (3) Hostel (4) Other (Please specify)
What is your marital status? Participant (1) Married (2) De-facto (3) Separated or divorced (4) Widowed (5) Never married
Were you born in Australia? If not, what country were you born in? Participant (1) Yes (2) No (Specify country name)
Do you speak a language other than English at home? Participant (1) Yes (Specify language) (2) No
How far did you get in school? Participant (1) Never attended school (2) Primary school (3) Part high school (4) Completed high school (5) Completed university/TAFE.
Were you working prior to current hospitalisation? Participant (1) Full-time (2) Part-time (3) Casual (4) Not working or retired.
(If currently working) How many hours did you work in the week prior to hospitalisation? Participant No. of hours in 7 days
(If currently working) How many hours did you work in the 4 weeks prior to current hospitalisation? Participant No. of hours in 28 days
If NOT WORKING or RETIRED, are you currently not working or retired because of diabetes? Participant (1) Yes (2) No (3) Other reason (specify)
CURRENT ADMISSION DETAILS/COMORBID CONDITIONS
Current admission diagnoses or presenting complaints Medical Record (1) Principal diagnosis or presenting complaint (2) Additional diagnoses.
DIABETES STATUS/MANAGEMENT 
What type of diabetes do you have? Participant/Medical Record (1) Type 1 (2) Type 2 (3) Other (4) Don't know
When did you first come to know that you had diabetes? Participant Year of diagnosis or age at diagnosis
How was the diagnosis of diabetes made? Participant (1) Physical symptoms (2) Routine testing  (3) During hospital admission (4) Other (5) Can’t recall
When your diabetes was first diagnosed, what advice/treatment were you given? Participant (1) None (2) Diet and exercise (3) Oral hypoglycaemic agents (tablets) (4) Insulin (5) Other
What treatment are you currently using to control your blood sugar? Participant (1) None (2) Diet/exercise only (3) Oral hypoglycaemic agents (tablets) only (4) Insulin only (5) Oral hypoglycaemic agents and insulin (6) Other  (7) Don't know
What type of health professionals have you ever seen for diabetes management? (Choose all that apply) Participant (1) GP (2) Diabetes specialist (3) Nurse or health worker (4) Specialized centre for diabetes care (5) Other
Do you have a diabetes care plan? It is a structured plan agreed between you and your GP for the management of diabetes. Participant (1) Yes (2) No (3) Don’t know
In the last 12 months, how well do you think your diabetes has been controlled? Participant (1) Very well controlled (2) Well controlled (3) Average control (4) Poorly controlled (5) Very poorly controlled (6) Don’t know
DIABETES MONITORING/COMPLICATIONS SURVEILLANCE Participant
Have you ever been shown how to test your blood sugar level? Participant (1) Yes (2) No (3) Don’t know
Have you ever been shown how to test your urine for sugar? Participant (1) Yes (2) No (3) Don’t know
What method do you mainly use for testing your own sugar level? Participant (1) At doctor’s office only (2) blood glucose strips read visually (3) Blood glucose strips read by glucometer (4) Urine strips at home (4) None
How often have you tested your sugar  levels in the 4 weeks prior to hospitalisation? Participant (1) None (2) Once a week or less (3) 2-6 times a week (4) Once a day (5) 2 or more times a day (6) Use 'diabetic sensing' (continuous glucose monitoring device) or other method
Over the past month (prior to hospitalisation), your glucose results have been? Participant (1) Within normal limits (2) Higher than normal (3) Variable (4) Don’t know
Have you ever heard of glycosylated haemoglobin or HbA1c, sometimes referred to as ‘long term sugar test’? Participant (1) Yes (2) No
If Yes, how many times has a health professional checked your HbA1c level in the last 12 months? Participant (1) None (2) Once (3) Twice (4) Three or more times (5) Don’t know
Have you ever had the back of your eyes (retinas) examined by a health professional? Participant (1) Yes (2) No (3) Can’t recall
If yes, who conducted the eye examination? Participant (1) Optometrist or eye doctor (2) GP (3) Diabetes specialist (4) Can’t recall.
How long has it been since you last had the back of your eyes (retina) checked? Participant (1) Within 1 year (2) 1-2 years (3) 2-5 years (4) 5-10 years (5) More than 10 years (6) Can’t recall
Apart from current hospitalisation, has a health professional ever measured your weight and height ? Participant (1) In the last 3 months (2) 3-6 months (3) 6-12 months (4) Once in last 3 years (5) Never measured (6) Don’t know
Do you know your current weight and height? Participant/Medical Record (1) Height (2) Weight (3) BMI
During the past year, has a doctor or other health professional examined your feet? Participant (1) Yes (2) No (3) Can’t recall
How often have you examined your feet in the week prior to current hospitalisation? Participant (1) None (2) 1-3 times (3) 4 or more times
When did you last have your blood lipids (cholesterol/tr iglycerides/HDL) checked (excluding current hospitalisation)? Participant (1) In the last 3 months (2) 3-6 months (3) 6-12 months (4) Once in last 3 years (5) Never measured (6) Don’t know
Have you ever been told by a doctor or other health professional that your blood cholesterol or  tr iglycer ides are high? Participant (1) Yes (2) No (3) Can't recall
Are you currently taking tablets to lower your cholesterol/triglycerides? Participant/Medical Record (1) Yes (2) No
When was the last time you had your urine tested for  proteins? Participant (1) In the last 3 months (2) 3-6 months (3) 6-12 months (4) Once in last 3 years (5) Never measured (6) Don’t know
When was the last time you had your blood tested to determine if your kidneys were functioning properly? Participant (1) In the last 3 months (2) 3-6 months (3) 6-12 months (4) Once in last 3 years (5) Never measured (6) Don’t know.
Within the past 12 months, have you visited any of the following health professionals? (i) Diabetes educator Participant (1) Yes (2) No (3) Can’t recall
(iv) Dietitian Participant (1) Yes (2) No (3) Can’t recall
(v) Podiatrist Participant (1) Yes (2) No (3) Can’t recall
In the 12 months prior to current hospitalisation, how often did you get your blood pressure measured? Participant (1) Every 3 months (2) Every 3-6 months (3) Every 6-12 months (4) Once in last 3 years (5) Never measured (6) Don’t know
Have you ever been told by a doctor or nurse that you have high blood pressure/hypertension? Participant (1) Yes (2) No (3) Don’t know
Were you  taking medication for high blood pressure prior to hospitalisation? Participant (1) Yes (2) No (3) Don’t know
Have you ever been treated or suffered from any of the following conditions? Participant
Problems with back of your eyes or retinopathy (1) Yes (2) No
Kidney disease (1) Yes (2) No
Nerve damage (1) Yes (2) No
Gangrene (1) Yes (2) No
Heart disease (1) Yes (2) No
Stroke (1) Yes (2) No
Poor circulation to feet or legs/foot ulcer (1) Yes (2) No
Erectile dysfunction (men only) (1) Yes (2) No
LIFESTYLE FACTORS
In terms of drinking alcohol, which category would you generally put yourself in? Participant (1) Never drunk (2) Used to drink but gave up (3) Heavy drinker (4) Moderate drinker (5) Light drinker
In the 12 month period prior to current hospitalisation, on average, how many standard drinks did you have in a week? Participant (1) Number of standard drinks (2) Number of days during a week when no alcohol is consumed
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IF MODERATE/HEAVY Use, have you ever been treated for alcohol or drinking related problem? Participant (1) Yes (details) (2) No
I would like to ask you some questions about smoking. In the 12 months prior to current hospitalsation, did you smoke cigarettes, pipes 
or any other tobacco products? Participant (1) None (2) Daily (3) At least weekly (4) Less often than weekly
IF USING , how many [TOBACCO PRODUCT] do you smoke on average? For how many years? Participant (1) Number or packs per day/week (2) Duration in years
IF USING, has a health professional ever discussed quitting smoking with you or provided advice in this regard? Participant (1) Yes (2) No (3) Don't know/can't recall
In the 12 months prior to current hospitalisation, how much of the following did you do weekly (i) walking continuously for recreation, 
exercise or to get to and from places. Participant Time in minutes on average during a week
(iii) exercise (jogging, sport excludes house work) that made you out of breath/puff? Participant Time in minutes on average during a week
(v) sitting down while doing this like visiting friends, driving, reading, watching television, or working at desk or computer? Participant Time in minutes on average during a week
(vi) Specifically number of hours spent watching TV or working on a computer. Participant Time in minutes on average during a week
Has a health professional ever provided you advice regarding physical activity (exercise)? Participant (1) Yes (2) No (3) Don't know/can't recall
NDSS MEMBERSHIP
The National Diabetes Services Scheme (NDSS) is a Federal Government funded scheme that provides subsidised blood testing
equipment and syringes for insulin injection. Are you aware of this scheme? Participant (1) Yes (2) No (3) Not sure
If yes, are you registered on the NDSS? Participant (1) Yes (2) No (3) Not sure
Have you used the scheme in the last 12 months? Participant (1) Yes (2) No (3) Not sure
IF NOT A MEMBER, can you tell me why you don’t use the scheme, is it because… Participant (1) You can get items cheaper elsewhere (2) It is difficult to access (3) There is a language barrier (4) Other reason
HEALTH LITERACY/PSYCHOLOGICAL DISTRESS/PERSONALITY TRAITS Participant
Health literacy (HLQ) Participant
Psychological distress screening: Kessler  10 Participant 10 items
In the last 4 weeks, about how often…
1. Did you feel tired out for no good reasons? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
2. Did you feel nervous? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
3. Did you feel so nervous that nothing could calm you down? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
4. Did you feel hopeless? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
5. Did you feel restless or fidgety? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
6. Did you feel so restless that you could not sit still? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
7. Did you feel depressed? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
8. Did you feel that everything was an effort? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
9. Did you feel so sad that nothing could cheer you up? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
10. Did you feel worthless? (1) All of the time (2) Most of the time (3) Some of the time (4) A little of the time (5) None of the time
Personality questionnaire: Standardised Assessment of Personality: Abbreviated Scale (SAPAS) Participant 8 items
1. In general, do you have difficulty making and keeping friends? (1) Yes (2) No
2. Would you normally describe yourself as a loner? (1) Yes (2) No
3. In general, do you trust other people? (1) Yes (2) No
4. Do you lose your temper easily? (1) Yes (2) No
5. Are you normally an impulsive sort of person? (1) Yes (2) No
6. Are you normally a worrier? (1) Yes (2) No
7. In general, do you depend on others a lot? (1) Yes (2) No
8. In general, are you a perfectionist? (1) Yes (2) No
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